{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:12:02Z","timestamp":1793772722715,"version":"4.6.1"},"reference-count":629,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00134-026-08361-1","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T13:19:42Z","timestamp":1774271982000},"page":"863-936","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8442-6724","authenticated-orcid":false,"given":"Hallie C.","family":"Prescott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3007-1670","authenticated-orcid":false,"given":"Massimo","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Alhazzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Hylander","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayez","family":"Alshamsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano C. P.","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Belley-Cote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"De Waele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennie","family":"Derde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna C.","family":"Dionne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley B.","family":"Gershengorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol L.","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimia","family":"Honarmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozef","family":"Kesecioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauralyn","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mervyn","family":"Mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Nunnally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J. W.","family":"Oczkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Rochwerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olurotimi Olaolu","family":"Akinola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwame A.","family":"Akuamoah-Boateng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Alberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek C.","family":"Angus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaseen M.","family":"Arabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Cecconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline F.","family":"Convocar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"De Pascale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritoki","family":"Egi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Carmelle","family":"Elie-Turenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricard","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Fox-Robichaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonathan","family":"Freund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle Ng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb P.","family":"Hale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi E.","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madiha","family":"Hashmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Heunks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore J.","family":"Iwashyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shevin T.","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Klompas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Kwizera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murdoch","family":"Leeies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna D.","family":"Lejnieks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell M.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia R.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo O.","family":"Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Masur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan C.","family":"Maves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"McGloughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"McPeake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas M.","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila Nainan","family":"Myatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies","family":"Ostermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Peake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias W.","family":"Pletz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regis G.","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa A.","family":"Schorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Q.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Joost","family":"Wiersinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig M.","family":"Coopersmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"8361_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW et al (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:801\u2013810","journal-title":"JAMA"},{"key":"8361_CR2","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1056\/NEJMp1707170","volume":"377","author":"K Reinhart","year":"2017","unstructured":"Reinhart K, Daniels R, Kissoon N et al (2017) Recognizing sepsis as a global health priority\u2014a WHO resolution. N Engl J Med 377:414\u2013417","journal-title":"N Engl J Med"},{"key":"8361_CR3","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1056\/NEJMra2403213","volume":"391","author":"NJ Meyer","year":"2024","unstructured":"Meyer NJ, Prescott HC (2024) Sepsis and septic shock. N Engl J Med 391:2133\u20132146","journal-title":"N Engl J Med"},{"key":"8361_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM et al (2020) Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the global burden of disease study. Lancet 395:200\u2013211","journal-title":"Lancet"},{"key":"8361_CR5","unstructured":"Global Sepsis Alliance. 2030 global agenda for sepsis; making the next success story in global health. https:\/\/static1.squarespace.com\/static\/58a7025b8419c215b30b2df3\/t\/67d1879b8dbfb06f8c3be697\/1741784989573\/2030_Global_Agenda_for_Sepsis_Online.pdf. Accessed 27 Sept 2025"},{"key":"8361_CR6","doi-asserted-by":"publisher","first-page":"e2013","DOI":"10.1016\/S2214-109X(25)00356-0","volume":"13","author":"GBDGS Collaborators","year":"2025","unstructured":"Collaborators GBDGS (2025) Global, regional, and national sepsis incidence and mortality, 1990\u20132021: a systematic analysis. Lancet Glob Health 13:e2013\u2013e2026","journal-title":"Lancet Glob Health"},{"key":"8361_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/jama.2017.17687","volume":"319","author":"HC Prescott","year":"2018","unstructured":"Prescott HC, Angus DC (2018) Enhancing recovery from sepsis: a review. JAMA 319:62\u201375","journal-title":"JAMA"},{"key":"8361_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.101066","volume":"46","author":"C Fleischmann-Struzek","year":"2024","unstructured":"Fleischmann-Struzek C, Born S, Kesselmeier M et al (2024) Functional dependence following intensive care unit-treated sepsis: three-year follow-up results from the prospective Mid-German Sepsis Cohort (MSC). Lancet Reg Health Eur 46:101066","journal-title":"Lancet Reg Health Eur"},{"key":"8361_CR9","doi-asserted-by":"publisher","first-page":"i2016","DOI":"10.1136\/bmj.i2016","volume":"353","author":"P Alonso-Coello","year":"2016","unstructured":"Alonso-Coello P, Sch\u00fcnemann HJ, Moberg J, GRADE Working Group et al (2016) GRADE evidence to decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction. BMJ 353:i2016","journal-title":"BMJ"},{"key":"8361_CR10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jclinepi.2019.10.014","volume":"119","author":"N Santesso","year":"2020","unstructured":"Santesso N, Glenton C, Dahm P et al (2020) GRADE Working Group: GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions. J Clin Epidemiol 119:126\u2013135","journal-title":"J Clin Epidemiol"},{"key":"8361_CR11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jclinepi.2014.12.011","volume":"68","author":"GH Guyatt","year":"2015","unstructured":"Guyatt GH, Sch\u00fcnemann HJ, Djulbegovic B et al (2015) Guideline panels should not GRADE good practice statements. J Clin Epidemiol 68:597\u2013600","journal-title":"J Clin Epidemiol"},{"key":"8361_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jclinepi.2016.07.006","volume":"80","author":"GH Guyatt","year":"2016","unstructured":"Guyatt GH, Alonso-Coello P, Sch\u00fcnemann HJ et al (2016) Guideline panels should seldom make good practice statements: guidance from the GRADE Working Group. J Clin Epidemiol 80:3\u20137","journal-title":"J Clin Epidemiol"},{"key":"8361_CR13","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1007\/s00134-024-07509-1","volume":"50","author":"Y Freund","year":"2024","unstructured":"Freund Y, Cancella de Abreu M, Lebal S et al (2024) Effect of the 1-h bundle on mortality in patients with suspected sepsis in the emergency department: a stepped wedge cluster randomized clinical trial. Intensive Care Med 50:1086\u20131095","journal-title":"Intensive Care Med"},{"key":"8361_CR14","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1001\/jama.2024.25982","volume":"333","author":"YM Arabi","year":"2025","unstructured":"Arabi YM, Alsaawi A, Alzahrani M et al (2025) SCREEN Trial Group and the Saudi Critical Care Trials Group: electronic sepsis screening among patients admitted to hospital wards: a stepped-wedge cluster randomized trial. JAMA 333:763\u2013773","journal-title":"JAMA"},{"key":"8361_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125827","volume":"10","author":"E Damiani","year":"2015","unstructured":"Damiani E, Donati A, Serafini G et al (2015) Effect of performance improvement programs on compliance with sepsis bundles and mortality: a systematic review and meta-analysis of observational studies. PLoS ONE 10:e0125827","journal-title":"PLoS ONE"},{"key":"8361_CR16","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1164\/rccm.201712-2545OC","volume":"198","author":"MM Levy","year":"2018","unstructured":"Levy MM, Gesten FC, Phillips GS et al (2018) Mortality changes associated with mandated public reporting for sepsis. The results of the New York state initiative. Am J Respir Crit Care Med 198:1406\u20131412","journal-title":"Am J Respir Crit Care Med"},{"key":"8361_CR17","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1001\/jama.2019.9021","volume":"322","author":"JM Kahn","year":"2019","unstructured":"Kahn JM, Davis BS, Yabes JG et al (2019) Association between state-mandated protocolized sepsis care and in-hospital mortality among adults with sepsis. JAMA 322:240\u2013250","journal-title":"JAMA"},{"key":"8361_CR18","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s00134-009-1738-3","volume":"36","author":"MM Levy","year":"2010","unstructured":"Levy MM, Dellinger RP, Townsend SR et al (2010) The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 36:222\u2013231","journal-title":"Intensive Care Med"},{"key":"8361_CR19","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/CCM.0000000000005267","volume":"50","author":"Y Tarabichi","year":"2022","unstructured":"Tarabichi Y, Cheng A, Bar-Shain D et al (2022) Improving timeliness of antibiotic administration using a provider and pharmacist facing sepsis early warning system in the emergency department setting: a randomized controlled quality improvement initiative. Crit Care Med 50:418\u2013427","journal-title":"Crit Care Med"},{"key":"8361_CR20","unstructured":"CDC (2023) Hospital sepsis program core elements. https:\/\/www.cdc.gov\/sepsis\/media\/pdfs\/sepsis-core-elements-H.pdf. Accessed 14 Aug 2025"},{"key":"8361_CR21","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1001\/jama.2023.16693","volume":"330","author":"HC Prescott","year":"2023","unstructured":"Prescott HC, Posa PJ, Dantes R (2023) The centers for disease control and prevention\u2019s hospital sepsis program core elements. JAMA 330:1617\u20131618","journal-title":"JAMA"},{"key":"8361_CR22","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1164\/rccm.202406-1167OC","volume":"211","author":"CS Scheer","year":"2025","unstructured":"Scheer CS, Giamarellos-Bourboulis EJ, Ferrer R et al (2025) European Sepsis Care Study Group: status of sepsis care in european hospitals: results from an international cross-sectional survey. Am J Respir Crit Care Med 211:587\u2013599","journal-title":"Am J Respir Crit Care Med"},{"key":"8361_CR23","doi-asserted-by":"publisher","first-page":"907","DOI":"10.15585\/mmwr.mm7234a2","volume":"72","author":"RB Dantes","year":"2023","unstructured":"Dantes RB, Kaur H, Bouwkamp BA et al (2023) Sepsis program activities in acute care hospitals - national healthcare safety network, United States, 2022. MMWR Morb Mortal Wkly Rep 72:907\u2013911","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"8361_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.882340","volume":"9","author":"D Schwarzkopf","year":"2022","unstructured":"Schwarzkopf D, R\u00fcddel H, Brinkmann A et al (2022) The German quality network sepsis: evaluation of a quality collaborative on decreasing sepsis-related mortality in a controlled interrupted time series analysis. Front Med (Lausanne) 9:882340","journal-title":"Front Med (Lausanne)"},{"key":"8361_CR25","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.cmi.2024.05.014","volume":"30","author":"T Schoffelen","year":"2024","unstructured":"Schoffelen T, Papan C, Carrara E et al (2024) ESCMID Study Group for Antimicrobial Stewardship (ESGAP): European society of clinical microbiology and infectious diseases guidelines for antimicrobial stewardship in emergency departments (endorsed by European association of hospital pharmacists). Clin Microbiol Infect 30:1384\u20131407","journal-title":"Clin Microbiol Infect"},{"key":"8361_CR26","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jcrc.2017.04.005","volume":"40","author":"FW Guirgis","year":"2017","unstructured":"Guirgis FW, Jones L, Esma R et al (2017) Managing sepsis: Electronic recognition, rapid response teams, and standardized care save lives. J Crit Care 40:296\u2013302","journal-title":"J Crit Care"},{"key":"8361_CR27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.medin.2016.08.001","volume":"41","author":"L Garcia-Lopez","year":"2017","unstructured":"Garcia-Lopez L, Grau-Cerrato S, de Frutos-Soto A et al (2017) Grupo de Trabajo Multidisciplinar en C\u00f3digo Sepsis del Hospital Cl\u00ednico Universitario de Valladolid: Impact of the implementation of a Sepsis Code hospital protocol in antibiotic prescription and clinical outcomes in an intensive care unit. Med Intensiva 41:12\u201320","journal-title":"Med Intensiva"},{"key":"8361_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13613-017-0280-7","volume":"7","author":"YM Arabi","year":"2017","unstructured":"Arabi YM, Al-Dorzi HM, Alamry A et al (2017) The impact of a multifaceted intervention including sepsis electronic alert system and sepsis response team on the outcomes of patients with sepsis and septic shock. Ann Intensive Care 7:57","journal-title":"Ann Intensive Care"},{"key":"8361_CR29","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1513\/AnnalsATS.202403-286OC","volume":"21","author":"ID Peltan","year":"2024","unstructured":"Peltan ID, Bledsoe JR, Jacobs JR et al (2024) Effectiveness and safety of an emergency department code sepsis protocol: a pragmatic clinical trial. Ann Am Thorac Soc 21:1560\u20131571","journal-title":"Ann Am Thorac Soc"},{"key":"8361_CR30","first-page":"483","volume":"41","author":"SL Jones","year":"2015","unstructured":"Jones SL, Ashton CM, Kiehne L et al (2015) Reductions in sepsis mortality and costs after design and implementation of a nurse-based early recognition and response program. Jt Commun J Qual Patient Saf 41:483\u2013491","journal-title":"Jt Commun J Qual Patient Saf"},{"key":"8361_CR31","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.3390\/jcm8111800","volume":"8","author":"J Song","year":"2019","unstructured":"Song J et al (2019) The effect of the intelligent sepsis management system on outcomes among patients with sepsis and septic shock diagnosed according to the sepsis-3 definition in the emergency department. J Clin Med 8:1800","journal-title":"J Clin Med"},{"key":"8361_CR32","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/j.ajem.2018.01.060","volume":"36","author":"T Shah","year":"2018","unstructured":"Shah T, Sterk E, Rech MA (2018) Emergency department sepsis screening tool decreases time to antibiotics in patients with sepsis. Am J Emerg Med 36:1745\u20131748","journal-title":"Am J Emerg Med"},{"issue":"Suppl 3","key":"8361_CR33","doi-asserted-by":"publisher","first-page":"P104","DOI":"10.1186\/cc11791","volume":"16","author":"R Champunot","year":"2012","unstructured":"Champunot R, Kamsawang N, Thimsri D et al (2012) Effects on outcome of patients with severe sepsis and septic shock admitted to the ICU after implementation cooperative sepsis management protocol. Crit Care 16(Suppl 3):P104","journal-title":"Crit Care"},{"key":"8361_CR34","first-page":"A7175","volume":"199","author":"R Elias","year":"2019","unstructured":"Elias R, MacPherson-Dias R, Kurtz A et al (2019) ICU sepsis response team and septic shock mortality: a pre\u2013post intervention study. Am J Respir Crit Care Med 199:A7175\u2013A7175","journal-title":"Am J Respir Crit Care Med"},{"key":"8361_CR35","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s15010-022-01957-x","volume":"51","author":"M Schinkel","year":"2023","unstructured":"Schinkel M, Holleman F, Vleghels R et al (2023) The impact of a sepsis performance improvement program in the emergency department: a before\u2013after intervention study. Infection 51:945\u2013954","journal-title":"Infection"},{"key":"8361_CR36","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1080\/23744235.2017.1293840","volume":"49","author":"M Rosenqvist","year":"2017","unstructured":"Rosenqvist M, Fagerstrand E, Lanbeck P et al (2017) Sepsis alert\u2014a triage model that reduces time to antibiotics and length of hospital stay. Infect Dis (Lond) 49:507\u2013513","journal-title":"Infect Dis (Lond)"},{"key":"8361_CR37","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1093\/intqhc\/mzy121","volume":"30","author":"CM McDonald","year":"2018","unstructured":"McDonald CM, West S, Dushenski D et al (2018) Sepsis now a priority: a quality improvement initiative for early sepsis recognition and care. Int J Qual Health Care 30:802\u2013809","journal-title":"Int J Qual Health Care"},{"key":"8361_CR38","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/NCQ.0000000000000430","volume":"35","author":"DL Threatt","year":"2020","unstructured":"Threatt DL (2020) Improving sepsis bundle implementation times: a nursing process improvement approach. J Nurs Care Qual 35:135\u2013139","journal-title":"J Nurs Care Qual"},{"key":"8361_CR39","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/CCM.0000000000004179","volume":"48","author":"M Rosenqvist","year":"2020","unstructured":"Rosenqvist M, Bengtsson-Toni M, Tham J et al (2020) Improved outcomes after regional implementation of sepsis alert: a novel triage model. Crit Care Med 48:484\u2013490","journal-title":"Crit Care Med"},{"key":"8361_CR40","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/1742-6723.14168","volume":"35","author":"CP Roman","year":"2023","unstructured":"Roman CP, Dooley M, Nevill A et al (2023) Introduction of an emergency medicine pharmacist-led sepsis alert response system in the emergency department: a cohort study. Emerg Med Australas 35:564\u2013571","journal-title":"Emerg Med Australas"},{"key":"8361_CR41","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/jhq.12055","volume":"36","author":"C Patocka","year":"2014","unstructured":"Patocka C, Turner J, Xue X et al (2014) Evaluation of an emergency department triage screening tool for suspected severe sepsis and septic shock. J Healthc Qual 36:52\u201361 (quiz 59)","journal-title":"J Healthc Qual"},{"key":"8361_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajem.2015.08.039","volume":"34","author":"GE Hayden","year":"2016","unstructured":"Hayden GE, Tuuri RE, Scott R et al (2016) Triage sepsis alert and sepsis protocol lower times to fluids and antibiotics in the ED. Am J Emerg Med 34:1\u20139","journal-title":"Am J Emerg Med"},{"key":"8361_CR43","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.ajem.2018.10.036","volume":"37","author":"G Borrelli","year":"2019","unstructured":"Borrelli G, Koch E, Sterk E et al (2019) Early recognition of sepsis through emergency medical services pre-hospital screening. Am J Emerg Med 37:1428\u20131432","journal-title":"Am J Emerg Med"},{"key":"8361_CR44","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ajem.2023.06.024","volume":"71","author":"R Troncoso Jr","year":"2023","unstructured":"Troncoso R Jr, Garfinkel EM, Hinson JS et al (2023) Do prehospital sepsis alerts decrease time to complete CMS sepsis measures? Am J Emerg Med 71:81\u201385","journal-title":"Am J Emerg Med"},{"key":"8361_CR45","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/1742-6723.12581","volume":"28","author":"M Idrees","year":"2016","unstructured":"Idrees M, Macdonald S, Kodali K (2016) Sepsis early alert tool: early recognition and timely management in the emergency department. Emerg Med Australas 28:399\u2013403","journal-title":"Emerg Med Australas"},{"key":"8361_CR46","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jen.2019.05.005","volume":"45","author":"WR Moore","year":"2019","unstructured":"Moore WR, Vermuelen A, Taylor R et al (2019) Improving 3-hour sepsis bundled care outcomes: implementation of a nurse-driven sepsis protocol in the emergency department. J Emerg Nurs 45:690\u2013698","journal-title":"J Emerg Nurs"},{"key":"8361_CR47","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ajem.2022.12.006","volume":"64","author":"KE Currie","year":"2023","unstructured":"Currie KE, Barry H, Scanlan JM et al (2023) Impact of a multidisciplinary sepsis huddle in the emergency department. Am J Emerg Med 64:150\u2013154","journal-title":"Am J Emerg Med"},{"key":"8361_CR48","doi-asserted-by":"crossref","unstructured":"Petit J, Passerieux J, Ma\u00eetre O et al (2020) qSOFAST study group: impact of a qSOFA-based triage procedure on antibiotic timing in ED patients with sepsis: a prospective interventional study. Am J Emerg Med 38:477\u2013484","DOI":"10.1016\/j.ajem.2019.05.022"},{"key":"8361_CR49","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/jamia\/ocx072","volume":"25","author":"JS Austrian","year":"2018","unstructured":"Austrian JS, Jamin CT, Doty GR et al (2018) Impact of an emergency department electronic sepsis surveillance system on patient mortality and length of stay. J Am Med Inform Assoc 25:523\u2013529","journal-title":"J Am Med Inform Assoc"},{"key":"8361_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.iccn.2025.104032","volume":"90","author":"G Williams","year":"2025","unstructured":"Williams G, Alberto L, Taha M et al (2025) The challenges of compliance with sepsis management protocols in low and low-middle income countries\u2014a cross-sectional study. Intensive Crit Care Nurs 90:104032","journal-title":"Intensive Crit Care Nurs"},{"key":"8361_CR51","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13049-017-0393-x","volume":"25","author":"PB Pedersen","year":"2017","unstructured":"Pedersen PB, Henriksen DP, Mikkelsen S et al (2017) Dispatch and prehospital transport for acute septic patients: an observational study. Scand J Trauma Resusc Emerg Med 25:51","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"8361_CR52","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/MEJ.0000000000000091","volume":"21","author":"M Groenewoudt","year":"2014","unstructured":"Groenewoudt M, Roest AA, Leijten FMM et al (2014) Septic patients arriving with emergency medical services: a seriously ill population. Eur J Emerg Med 21:330\u2013335","journal-title":"Eur J Emerg Med"},{"key":"8361_CR53","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ajem.2020.08.021","volume":"45","author":"A Loza-Gomez","year":"2021","unstructured":"Loza-Gomez A, Hofmann E, NokLam C et al (2021) Severe sepsis and septic shock in patients transported by prehospital services versus walk in patients to the emergency department. Am J Emerg Med 45:173\u2013178","journal-title":"Am J Emerg Med"},{"key":"8361_CR54","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1161\/CIRCOUTCOMES.112.965210","volume":"5","author":"CB Lin","year":"2012","unstructured":"Lin CB, Peterson ED, Smith EE et al (2012) Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke. Circ Cardiovasc Qual Outcomes 5:514\u2013522","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"8361_CR55","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1056\/NEJMsa063117","volume":"355","author":"EH Bradley","year":"2006","unstructured":"Bradley EH, Herrin J, Wang Y et al (2006) Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med 355:2308\u20132320","journal-title":"N Engl J Med"},{"key":"8361_CR56","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011218","volume":"6","author":"MA Smyth","year":"2016","unstructured":"Smyth MA, Brace-McDonnell SJ, Perkins GD (2016) Identification of adults with sepsis in the prehospital environment: a systematic review. BMJ Open 6:e011218","journal-title":"BMJ Open"},{"key":"8361_CR57","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/10903127.2023.2224862","volume":"28","author":"RD Oanesa","year":"2024","unstructured":"Oanesa RD, Su TW, Weissman A (2024) Evidence for use of validated sepsis screening tools in the prehospital population: a scoping review. Prehosp Emerg Care 28:485\u2013493","journal-title":"Prehosp Emerg Care"},{"key":"8361_CR58","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1136\/emermed-2015-205261","volume":"33","author":"D Lane","year":"2016","unstructured":"Lane D, Ichelson RI, Drennan IR et al (2016) Prehospital management and identification of sepsis by emergency medical services: a systematic review. Emerg Med J 33:408\u2013413","journal-title":"Emerg Med J"},{"key":"8361_CR59","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s15010-024-02181-5","volume":"52","author":"S Piedmont","year":"2024","unstructured":"Piedmont S, Goldhahn L, Swart E et al (2024) Sepsis incidence, suspicion, prediction and mortality in emergency medical services: a cohort study related to the current international sepsis guideline. Infection 52:1325\u20131335","journal-title":"Infection"},{"key":"8361_CR60","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.aucc.2023.01.001","volume":"36","author":"A Kumar","year":"2023","unstructured":"Kumar A, Abbenbroek B, Delaney A et al (2023) Sepsis triggers and tools to support early identification in healthcare settings: an integrative review. Aust Crit Care 36:1117\u20131128","journal-title":"Aust Crit Care"},{"key":"8361_CR61","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ajem.2018.09.034","volume":"37","author":"CL Hunter","year":"2019","unstructured":"Hunter CL, Silvestri S, Stone A et al (2019) Prehospital sepsis alert notification decreases time to initiation of CMS sepsis core measures. Am J Emerg Med 37:114\u2013117","journal-title":"Am J Emerg Med"},{"key":"8361_CR62","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.jemermed.2012.11.003","volume":"44","author":"WF Guerra","year":"2013","unstructured":"Guerra WF, Mayfield TR, Meyers MS et al (2013) Early detection and treatment of patients with severe sepsis by prehospital personnel. J Emerg Med 44:1116\u20131125","journal-title":"J Emerg Med"},{"key":"8361_CR63","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ajem.2020.04.008","volume":"44","author":"M Mixon","year":"2021","unstructured":"Mixon M, Dietrich S, Floren M et al (2021) Time to antibiotic administration: sepsis alerts called in emergency department versus in the field via emergency medical services. Am J Emerg Med 44:291\u2013295","journal-title":"Am J Emerg Med"},{"key":"8361_CR64","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jama.2016.0288","volume":"315","author":"CW Seymour","year":"2016","unstructured":"Seymour CW, Liu VX, Iwashyna TJ et al (2016) Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:762\u2013774","journal-title":"JAMA"},{"key":"8361_CR65","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W et al (2021) Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 47:1181\u20131247","journal-title":"Intensive Care Med"},{"key":"8361_CR66","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W et al (2021) Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med 49:e1063\u2013e1143","journal-title":"Crit Care Med"},{"key":"8361_CR67","doi-asserted-by":"publisher","first-page":"266","DOI":"10.7326\/M17-2820","volume":"168","author":"SM Fernando","year":"2018","unstructured":"Fernando SM, Tran A, Taljaard M et al (2018) Prognostic accuracy of the quick sequential organ failure assessment for mortality in patients with suspected infection: a systematic review and meta-analysis. Ann Intern Med 168:266\u2013275","journal-title":"Ann Intern Med"},{"key":"8361_CR68","volume":"1","author":"V Herwanto","year":"2019","unstructured":"Herwanto V, Shetty A, Nalos M et al (2019) Accuracy of quick sequential organ failure assessment score to predict sepsis mortality in 121 studies including 1,716,017 individuals: a systematic review and meta-analysis. Crit Care Explor 1:e0043","journal-title":"Crit Care Explor"},{"key":"8361_CR69","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.chest.2017.12.015","volume":"153","author":"R Serafim","year":"2018","unstructured":"Serafim R, Gomes JA, Salluh J et al (2018) A comparison of the quick-SOFA and systemic inflammatory response syndrome criteria for the diagnosis of sepsis and prediction of mortality: a systematic review and meta-analysis. Chest 153:646\u2013655","journal-title":"Chest"},{"key":"8361_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101184","volume":"42","author":"BR Adegbite","year":"2021","unstructured":"Adegbite BR, Edoa JR, Ndzebe Ndoumba WF et al (2021) A comparison of different scores for diagnosis and mortality prediction of adults with sepsis in low-and-middle-income countries: a systematic review and meta-analysis. EClinicalMedicine 42:101184","journal-title":"EClinicalMedicine"},{"key":"8361_CR71","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1111\/jocn.17061","volume":"33","author":"WL Chua","year":"2024","unstructured":"Chua WL, Rusli KDB, Aitken LM (2024) Early warning scores for sepsis identification and prediction of in-hospital mortality in adults with sepsis: a systematic review and meta-analysis. J Clin Nurs 33:2005\u20132018","journal-title":"J Clin Nurs"},{"key":"8361_CR72","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/01.ccm.0000910508.20663.6f","volume":"51","author":"J Elperin","year":"2023","unstructured":"Elperin J, Van Perre K, Bryant NH (2023) 1193: Sepsis: Is it time to leave sirs behind? A systematic review and meta-analysis of sepsis definitions. Crit Care Med 51:59","journal-title":"Crit Care Med"},{"key":"8361_CR73","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1080\/14787210.2023.2237192","volume":"21","author":"X Qiu","year":"2023","unstructured":"Qiu X, Lei Y, Zhou RX (2023) SIRS, SOFA, qSOFA, and NEWS in the diagnosis of sepsis and prediction of adverse outcomes: a systematic review and meta-analysis. Expert Rev Anti Infect Ther 21:891\u2013900","journal-title":"Expert Rev Anti Infect Ther"},{"key":"8361_CR74","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1164\/rccm.201905-0917OC","volume":"201","author":"FR Machado","year":"2020","unstructured":"Machado FR, Cavalcanti AB, Monteiro MB et al (2020) Instituto Latino-Americano de Sepsis network investigators: predictive accuracy of the quick sepsis-related organ failure assessment score in Brazil. A prospective multicenter study. Am J Respir Crit Care Med 201:789\u2013798","journal-title":"Am J Respir Crit Care Med"},{"key":"8361_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cmpb.2018.12.027","volume":"170","author":"MM Islam","year":"2019","unstructured":"Islam MM, Nasrin T, Walther BA et al (2019) Prediction of sepsis patients using machine learning approach: a meta-analysis. Comput Methods Programs Biomed 170:1\u20139","journal-title":"Comput Methods Programs Biomed"},{"key":"8361_CR76","first-page":"2","volume":"2022","author":"R Hass","year":"2022","unstructured":"Hass R, McGill SR (2022) Artificial Intelligence for the prediction of sepsis in adults. Can J Health Tech 2022:2","journal-title":"Can J Health Tech"},{"key":"8361_CR77","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1097\/CCM.0000000000003799","volume":"47","author":"ED Crouser","year":"2019","unstructured":"Crouser ED, Parrillo JE, Seymour CW et al (2019) Monocyte distribution width: a novel indicator of sepsis-2 and sepsis-3 in high-risk emergency department patients. Crit Care Med 47:1018\u20131025","journal-title":"Crit Care Med"},{"key":"8361_CR78","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.chest.2017.05.039","volume":"152","author":"ED Crouser","year":"2017","unstructured":"Crouser ED, Parrillo JE, Seymour C et al (2017) Improved early detection of sepsis in the ED with a novel monocyte distribution width biomarker. Chest 152:518\u2013526","journal-title":"Chest"},{"key":"8361_CR79","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/acem.14923","volume":"31","author":"HR O\u2019Neal Jr","year":"2024","unstructured":"O\u2019Neal HR Jr, Sheybani R, Kraus CK et al (2024) Cellular host response sepsis test for risk stratification of patients in the emergency department: a pooled analysis. Acad Emerg Med 31:883\u2013893","journal-title":"Acad Emerg Med"},{"key":"8361_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264220","volume":"17","author":"HR O\u2019Neal Jr","year":"2022","unstructured":"O\u2019Neal HR Jr, Sheybani R, Caffery TS et al (2022) Assessment of a cellular host response test to risk-stratify suspected COVID-19 patients in the emergency department setting. PLoS ONE 17:e0264220","journal-title":"PLoS ONE"},{"key":"8361_CR81","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.3390\/jcm13051194","volume":"13","author":"R Balk","year":"2024","unstructured":"Balk R, Esper AM, Martin GS et al (2024) Validation of SeptiCyte RAPID to discriminate sepsis from non-infectious systemic inflammation. J Clin Med 13:1194","journal-title":"J Clin Med"},{"key":"8361_CR82","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.1038\/s41591-025-03933-y","volume":"31","author":"O Liesenfeld","year":"2025","unstructured":"Liesenfeld O, Arora S, Aufderheide TP et al (2025) Clinical validation of an AI-based blood testing device for diagnosis and prognosis of acute infection and sepsis. Nat Med 31:4044\u20134054","journal-title":"Nat Med"},{"key":"8361_CR83","doi-asserted-by":"publisher","first-page":"AIoa2400867","DOI":"10.1056\/AIoa2400867","volume":"1","author":"A Bhargava","year":"2024","unstructured":"Bhargava A, L\u00f3pez-Espina C, Schmalz L et al (2024) FDA-authorized AI\/ML tool for sepsis prediction: development and validation. NEJM AI 1:AIoa2400867","journal-title":"NEJM AI"},{"key":"8361_CR84","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1186\/s12879-024-09347-4","volume":"24","author":"B Mai","year":"2024","unstructured":"Mai B, Zhou L, Wang Q et al (2024) Diagnostic accuracy of pancreatic stone protein in patients with sepsis: a systematic review and meta-analysis. BMC Infect Dis 24:472","journal-title":"BMC Infect Dis"},{"key":"8361_CR85","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1007\/s00134-024-07694-z","volume":"50","author":"I Martin-Loeches","year":"2024","unstructured":"Martin-Loeches I, Singer M, Leone M (2024) Sepsis: key insights, future directions, and immediate goals. A review and expert opinion. Intensive Care Med 50:2043\u20132049","journal-title":"Intensive Care Med"},{"key":"8361_CR86","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1089\/sur.2020.047","volume":"21","author":"AH Stephen","year":"2020","unstructured":"Stephen AH, Montoya RL, Aluisio AR (2020) Sepsis and septic shock in low- and middle-income countries. Surg Infect (Larchmt) 21:571\u2013578","journal-title":"Surg Infect (Larchmt)"},{"key":"8361_CR87","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-3-319-73506-1_2","volume-title":"Handbook of sepsis","author":"HC Prescott","year":"2018","unstructured":"Prescott HC (2018) The epidemiology of sepsis. In: Wersinga WJ, Seymour CW (eds) Handbook of sepsis. Springer International Publishing, Cham, pp 15\u201328"},{"key":"8361_CR88","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3389\/fmicb.2016.00697","volume":"7","author":"B Lamy","year":"2016","unstructured":"Lamy B, Darg\u00e8re S, Arendrup MC et al (2016) How to optimize the use of blood cultures for the diagnosis of bloodstream infections? A state-of-the art. Front Microbiol 7:697","journal-title":"Front Microbiol"},{"key":"8361_CR89","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.ajic.2025.07.010","volume":"53","author":"A Vashti","year":"2025","unstructured":"Vashti A, Mullan PJ, Nitzberg M (2025) Single-site sampling strategy versus multi-site sampling strategy in blood culture collection within the hospital setting: a systematic review. Am J Infect Control 53:1113\u20131120","journal-title":"Am J Infect Control"},{"key":"8361_CR90","doi-asserted-by":"publisher","first-page":"839","DOI":"10.7196\/SAMJ.4217","volume":"100","author":"N Ntusi","year":"2010","unstructured":"Ntusi N, Aubin L, Oliver S et al (2010) Guideline for the optimal use of blood cultures. S Afr Med J 100:839\u2013843","journal-title":"S Afr Med J"},{"key":"8361_CR91","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/cid\/ciaa039","volume":"71","author":"V Fabre","year":"2020","unstructured":"Fabre V, Sharara SL, Salinas AB et al (2020) Does this patient need blood cultures? A scoping review of indications for blood cultures in adult nonneutropenic inpatients. Clin Infect Dis 71:1339\u20131347","journal-title":"Clin Infect Dis"},{"key":"8361_CR92","doi-asserted-by":"publisher","first-page":"397","DOI":"10.7196\/SAMJ.2022.v112i6.16537","volume":"112","author":"NS Papavarnavas","year":"2022","unstructured":"Papavarnavas NS et al (2022) Practice update to optimise the performance and interpretation of blood cultures: 2022. S Afr Med J 112:397\u2013402","journal-title":"S Afr Med J"},{"key":"8361_CR93","unstructured":"S3-Leitlinie: Sepsis\u2014Pr\u00e4vention, Diagnose, Therapie und Nachsorge\u2014 Update 2025. https:\/\/register.awmf.org\/assets\/guidelines\/079-001l_S3_Sepsis-Praevention-Diagnose-Therapie-Nachsorge_2025-07.pdf. Accessed 12 Aug 2025"},{"key":"8361_CR94","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/cid\/ciy584","volume":"67","author":"JM Miller","year":"2018","unstructured":"Miller JM, Binnicker MJ, Campbell S et al (2018) A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the infectious diseases society of America and the American society for microbiology. Clin Infect Dis 67:813\u2013816","journal-title":"Clin Infect Dis"},{"key":"8361_CR95","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1684-1182(10)60054-0","volume":"43","author":"ML Towns","year":"2010","unstructured":"Towns ML, Jarvis WR, Hsueh PR (2010) Guidelines on blood cultures. J Microbiol Immunol Infect 43:347\u2013349","journal-title":"J Microbiol Immunol Infect"},{"key":"8361_CR96","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/clinids\/5.1.35","volume":"5","author":"MP Weinstein","year":"1983","unstructured":"Weinstein MP, Reller LB, Murphy JR et al (1983) The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis 5:35\u201353","journal-title":"Rev Infect Dis"},{"key":"8361_CR97","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1128\/JCM.00059-07","volume":"45","author":"P Grohs","year":"2007","unstructured":"Grohs P, Mainardi J-L, Podglajen I et al (2007) Relevance of routine use of the anaerobic blood culture bottle. J Clin Microbiol 45:2711\u20132715","journal-title":"J Clin Microbiol"},{"key":"8361_CR98","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12879-020-4854-x","volume":"20","author":"M Lafaurie","year":"2020","unstructured":"Lafaurie M, d\u2019Anglejan E, Donay JL et al (2020) Utility of anaerobic bottles for the diagnosis of bloodstream infections. BMC Infect Dis 20:142","journal-title":"BMC Infect Dis"},{"key":"8361_CR99","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1097\/00007611-200093100-00008","volume":"93","author":"MT Chandler","year":"2000","unstructured":"Chandler MT, Morton ES, Byrd RP et al (2000) Reevaluation of anaerobic blood cultures in a Veteran population. South Med J 93:986\u2013988","journal-title":"South Med J"},{"key":"8361_CR100","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.colegn.2022.12.005","volume":"30","author":"S Yarahmadi","year":"2023","unstructured":"Yarahmadi S, Ebrahimzadeh F, Mohamadipour F et al (2023) Effect of prone position on clinical outcomes of nonintubated patients with COVID-19: a randomised clinical trial. Collegian 30:449\u2013456","journal-title":"Collegian"},{"key":"8361_CR101","doi-asserted-by":"publisher","first-page":"547","DOI":"10.7326\/M19-1696","volume":"171","author":"MP Cheng","year":"2019","unstructured":"Cheng MP, Stenstrom R, Paquette K et al (2019) FABLED Investigators: blood culture results before and after antimicrobial administration in patients with severe manifestations of sepsis: a diagnostic study. Ann Intern Med 171:547\u2013554","journal-title":"Ann Intern Med"},{"key":"8361_CR102","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/cid\/cir034","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE et al (2011) Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 52:285\u2013292","journal-title":"Clin Infect Dis"},{"key":"8361_CR103","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR et al (2016) Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis 62:e1-50","journal-title":"Clin Infect Dis"},{"key":"8361_CR104","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W et al (2017) Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43:304\u2013377","journal-title":"Intensive Care Med"},{"key":"8361_CR105","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","volume":"45","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W et al (2017) Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med 45:486\u2013552","journal-title":"Crit Care Med"},{"key":"8361_CR106","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1513\/AnnalsATS.201304-099OC","volume":"10","author":"V Liu","year":"2013","unstructured":"Liu V, Morehouse JW, Soule J et al (2013) Fluid volume, lactate values, and mortality in sepsis patients with intermediate lactate values. Ann Am Thorac Soc 10:466\u2013473","journal-title":"Ann Am Thorac Soc"},{"key":"8361_CR107","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jama.2016.0289","volume":"315","author":"M Shankar-Hari","year":"2016","unstructured":"Shankar-Hari M, Phillips GS, Levy ML et al (2016) Sepsis Definitions Task Force: Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:775\u2013787","journal-title":"JAMA"},{"key":"8361_CR108","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1164\/rccm.201507-1489OC","volume":"193","author":"VX Liu","year":"2016","unstructured":"Liu VX, Morehouse JW, Marelich GP et al (2016) Multicenter implementation of a treatment bundle for patients with sepsis and intermediate lactate values. Am J Respir Crit Care Med 193:1264\u20131270","journal-title":"Am J Respir Crit Care Med"},{"key":"8361_CR109","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1097\/CCM.0000000000003960","volume":"47","author":"HI Kuttab","year":"2019","unstructured":"Kuttab HI, Lykins JD, Hughes MD et al (2019) Evaluation and predictors of fluid resuscitation in patients with severe sepsis and septic shock. Crit Care Med 47:1582\u20131590","journal-title":"Crit Care Med"},{"key":"8361_CR110","doi-asserted-by":"publisher","first-page":"e557","DOI":"10.1097\/CCM.0000000000006394","volume":"52","author":"KA Corl","year":"2024","unstructured":"Corl KA, Levy MM, Holder AL et al (2024) Moderate IV fluid resuscitation is associated with decreased sepsis mortality. Crit Care Med 52:e557\u2013e567","journal-title":"Crit Care Med"},{"key":"8361_CR111","first-page":"190","volume":"372","author":"SL Peake","year":"2015","unstructured":"Peake SL, Delaney A, Bellomo R (2015) ARISE Investigators: Goal-directed resuscitation in septic shock. N Engl J Med 372:190\u2013191","journal-title":"N Engl J Med"},{"key":"8361_CR112","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1056\/NEJMoa1401602","volume":"370","author":"CI Pro","year":"2014","unstructured":"Pro CI et al (2014) A randomized trial of protocol-based care for early septic shock. N Engl J Med 370:1683\u20131693","journal-title":"N Engl J Med"},{"key":"8361_CR113","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1056\/NEJMoa1500896","volume":"372","author":"PR Mouncey","year":"2015","unstructured":"Mouncey PR, Osborn TM, Power GS et al (2015) ProMISe Trial Investigators: trial of early, goal-directed resuscitation for septic shock. N Engl J Med 372:1301\u20131311","journal-title":"N Engl J Med"},{"key":"8361_CR114","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1056\/NEJMoa1701380","volume":"376","author":"P Investigators","year":"2017","unstructured":"Investigators P et al (2017) Early, goal-directed therapy for septic shock\u2014a patient-level meta-analysis. N Engl J Med 376:2223\u20132234","journal-title":"N Engl J Med"},{"key":"8361_CR115","doi-asserted-by":"publisher","first-page":"e1790","DOI":"10.1097\/CCM.0000000000006769","volume":"53","author":"MA Ward","year":"2025","unstructured":"Ward MA, Kuttab HI, Badgett RG (2025) The effect of early fluid resuscitation on mortality in sepsis: a systematic review and meta-analysis. Crit Care Med 53:e1790\u2013e1802","journal-title":"Crit Care Med"},{"key":"8361_CR116","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jcrc.2017.08.025","volume":"43","author":"SP Taylor","year":"2018","unstructured":"Taylor SP, Karvetski CH, Templin MA et al (2018) Initial fluid resuscitation following adjusted body weight dosing is associated with improved mortality in obese patients with suspected septic shock. J Crit Care 43:7\u201312","journal-title":"J Crit Care"},{"key":"8361_CR117","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1381\/096089206777346673","volume":"16","author":"HJ Lemmens","year":"2006","unstructured":"Lemmens HJ, Bernstein D, Brodsky JB (2006) Estimating blood volume in obese and morbidly obese patients. Obes Surg 16:773\u2013776","journal-title":"Obes Surg"},{"key":"8361_CR118","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1016\/j.chest.2021.08.001","volume":"160","author":"MR Anderson","year":"2021","unstructured":"Anderson MR, Shashaty MGS (2021) Impact of obesity in critical illness. Chest 160:2135\u20132145","journal-title":"Chest"},{"key":"8361_CR119","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1164\/rccm.202309-1617OC","volume":"209","author":"S Gendreau","year":"2024","unstructured":"Gendreau S, Frapard T, Carteaux G et al (2024) Geo-economic influence on the effect of fluid volume for sepsis resuscitation: a meta-analysis. Am J Respir Crit Care Med 209:517\u2013528","journal-title":"Am J Respir Crit Care Med"},{"key":"8361_CR120","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.3390\/ijerph15092017","volume":"15","author":"B Morton","year":"2018","unstructured":"Morton B, Stolbrink M, Kagima W et al (2018) The early recognition and management of sepsis in sub-saharan African adults: a systematic review and meta-analysis. Int J Environ Res Public Health 15:2017","journal-title":"Int J Environ Res Public Health"},{"key":"8361_CR121","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1001\/jama.2017.10913","volume":"318","author":"B Andrews","year":"2017","unstructured":"Andrews B, Semler MW, Muchemwa L et al (2017) Effect of an early resuscitation protocol on in-hospital mortality among adults with sepsis and hypotension: a randomized clinical trial. JAMA 318:1233\u20131240","journal-title":"JAMA"},{"key":"8361_CR122","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1097\/CCM.0000000000000541","volume":"42","author":"B Andrews","year":"2014","unstructured":"Andrews B, Muchemwa L, Kelly P et al (2014) Simplified severe sepsis protocol: a randomized controlled trial of modified early goal-directed therapy in Zambia. Crit Care Med 42:2315\u20132324","journal-title":"Crit Care Med"},{"key":"8361_CR123","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00134-025-07840-1","volume":"51","author":"A Mekontso Dessap","year":"2025","unstructured":"Mekontso Dessap A, AlShamsi F, Belletti A et al (2025) European Society of Intensive Care Medicine: European Society of Intensive Care Medicine (ESICM) 2025 clinical practice guideline on fluid therapy in adult critically ill patients: Part 2-the volume of resuscitation fluids. Intensive Care Med 51:461\u2013477","journal-title":"Intensive Care Med"},{"key":"8361_CR124","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.chest.2024.05.042","volume":"166","author":"C Ahn","year":"2024","unstructured":"Ahn C, Yu G, Shin TG et al (2024) Comparison of early and late norepinephrine administration in patients with septic shock: a systematic review and meta-analysis. Chest 166:1417\u20131430","journal-title":"Chest"},{"key":"8361_CR125","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1164\/rccm.201806-1034OC","volume":"199","author":"C Permpikul","year":"2019","unstructured":"Permpikul C, Tongyoo S, Viarasilpa T et al (2019) Early use of norepinephrine in septic shock resuscitation (CENSER). A randomized trial. Am J Respir Crit Care Med 199:1097\u20131105","journal-title":"Am J Respir Crit Care Med"},{"key":"8361_CR126","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1007\/s00134-005-2688-z","volume":"31","author":"M Varpula","year":"2005","unstructured":"Varpula M, Tallgren M, Saukkonen K et al (2005) Hemodynamic variables related to outcome in septic shock. Intensive Care Med 31:1066\u20131071","journal-title":"Intensive Care Med"},{"key":"8361_CR127","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13054-025-05400-z","volume":"29","author":"R Shi","year":"2025","unstructured":"Shi R, Bra\u00efk R, Monnet X et al (2025) Early norepinephrine for patients with septic shock: an updated systematic review and meta-analysis with trial sequential analysis. Crit Care 29:182","journal-title":"Crit Care"},{"key":"8361_CR128","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/s13054-020-03204-x","volume":"24","author":"Y Li","year":"2020","unstructured":"Li Y, Li H, Zhang D (2020) Timing of norepinephrine initiation in patients with septic shock: a systematic review and meta-analysis. Crit Care 24:488","journal-title":"Crit Care"},{"key":"8361_CR129","doi-asserted-by":"publisher","first-page":"204","DOI":"10.5492\/wjccm.v12.i4.204","volume":"12","author":"HX Zhou","year":"2023","unstructured":"Zhou HX, Yang C-F, Wang H-Y et al (2023) Should we initiate vasopressors earlier in patients with septic shock: a mini systemic review. World J Crit Care Med 12:204\u2013216","journal-title":"World J Crit Care Med"},{"key":"8361_CR130","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.arcmed.2019.10.003","volume":"50","author":"MA Elbouhy","year":"2019","unstructured":"Elbouhy MA, Soliman M, Gaber A et al (2019) Early use of norepinephrine improves survival in septic shock: earlier than early. Arch Med Res 50:325\u2013332","journal-title":"Arch Med Res"},{"key":"8361_CR131","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1186\/s13054-014-0532-y","volume":"18","author":"X Bai","year":"2014","unstructured":"Bai X, Yu W, Ji W et al (2014) Early versus delayed administration of norepinephrine in patients with septic shock. Crit Care 18:532","journal-title":"Crit Care"},{"key":"8361_CR132","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jcrc.2019.11.004","volume":"55","author":"D Colon Hidalgo","year":"2020","unstructured":"Colon Hidalgo D, Patel J, Masic D et al (2020) Delayed vasopressor initiation is associated with increased mortality in patients with septic shock. J Crit Care 55:145\u2013148","journal-title":"J Crit Care"},{"key":"8361_CR133","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1056\/NEJMoa2212663","volume":"388","author":"L National Heart","year":"2023","unstructured":"National Heart L et al (2023) Early restrictive or liberal fluid management for sepsis-induced hypotension. N Engl J Med 388:499\u2013510","journal-title":"N Engl J Med"},{"key":"8361_CR134","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13054-021-03553-1","volume":"25","author":"VS Owen","year":"2021","unstructured":"Owen VS, Rosgen BK, Cherak SJ et al (2021) Adverse events associated with administration of vasopressor medications through a peripheral intravenous catheter: a systematic review and meta-analysis. Crit Care 25:146","journal-title":"Crit Care"},{"key":"8361_CR135","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/1742-6723.13406","volume":"32","author":"DH Tian","year":"2020","unstructured":"Tian DH, Smyth C, Keijzers G et al (2020) Safety of peripheral administration of vasopressor medications: a systematic review. Emerg Med Australas 32:220\u2013227","journal-title":"Emerg Med Australas"},{"key":"8361_CR136","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJM195202142460704","volume":"246","author":"HP Greenwald","year":"1952","unstructured":"Greenwald HP, Gootnick A, Luger NM et al (1952) Tissue necrosis following subcutaneous infiltration with nor-epinephrine; report of two cases. N Engl J Med 246:252\u2013253","journal-title":"N Engl J Med"},{"key":"8361_CR137","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.7480","volume":"7","author":"ES Munroe","year":"2024","unstructured":"Munroe ES, Weinstein J, Gershengorn HB et al (2024) Understanding how clinicians personalize fluid and vasopressor decisions in early sepsis management. JAMA Netw Open 7:e247480","journal-title":"JAMA Netw Open"},{"key":"8361_CR138","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1513\/AnnalsATS.202203-197RL","volume":"19","author":"E Munroe","year":"2022","unstructured":"Munroe E, Claar D, Tamae-Kakazu M et al (2022) Hospital policies on intravenous vasopressor administration and monitoring: a survey of michigan hospitals. Ann Am Thorac Soc 19:1769\u20131772","journal-title":"Ann Am Thorac Soc"},{"key":"8361_CR139","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1097\/CCM.0b013e31828a42c5","volume":"41","author":"JD Ricard","year":"2013","unstructured":"Ricard JD, Salomon L, Boyer A et al (2013) Central or peripheral catheters for initial venous access of ICU patients: a randomized controlled trial. Crit Care Med 41:2108\u20132115","journal-title":"Crit Care Med"},{"key":"8361_CR140","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.aucc.2021.08.005","volume":"35","author":"A Stolz","year":"2022","unstructured":"Stolz A, Efendy R, Apte Y et al (2022) Safety and efficacy of peripheral versus centrally administered vasopressor infusion: a single-centre retrospective observational study. Aust Crit Care 35:506\u2013511","journal-title":"Aust Crit Care"},{"key":"8361_CR141","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/1742-6723.13394","volume":"32","author":"A Delaney","year":"2020","unstructured":"Delaney A, Finnis M, Bellomo R et al (2020) Initiation of vasopressor infusions via peripheral versus central access in patients with early septic shock: a retrospective cohort study. Emerg Med Australas 32:210\u2013219","journal-title":"Emerg Med Australas"},{"key":"8361_CR142","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.chest.2023.10.027","volume":"165","author":"ES Munroe","year":"2024","unstructured":"Munroe ES, Heath ME, Eteer M et al (2024) Use and outcomes of peripheral vasopressors in early sepsis-induced hypotension across Michigan hospitals: a retrospective cohort study. Chest 165:847\u2013857","journal-title":"Chest"},{"key":"8361_CR143","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.29148","volume":"8","author":"ES Munroe","year":"2025","unstructured":"Munroe ES, Co IN, Douglas I et al (2025) NHLBI PETAL Network: peripheral vasopressor use in early sepsis-induced hypotension. JAMA Netw Open 8:e2529148","journal-title":"JAMA Netw Open"},{"key":"8361_CR144","doi-asserted-by":"publisher","first-page":"5734","DOI":"10.3390\/jcm12175734","volume":"12","author":"E Asher","year":"2023","unstructured":"Asher E, Karameh H, Nassar H et al (2023) Jerusalem Platelets Thrombosis and Intervention in Cardiology (JUPITER-16) Study Group: Safety and outcomes of peripherally administered vasopressor infusion in patients admitted with shock to an intensive cardiac care unit\u2014a single-center prospective study. J Clin Med 12:5734","journal-title":"J Clin Med"},{"key":"8361_CR145","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1177\/10600280211053318","volume":"56","author":"LM Groetzinger","year":"2022","unstructured":"Groetzinger LM, Williams J, Svec S et al (2022) Peripherally infused norepinephrine to avoid central venous catheter placement in a medical intensive care unit: a pilot study. Ann Pharmacother 56:773\u2013781","journal-title":"Ann Pharmacother"},{"key":"8361_CR146","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jemermed.2017.09.007","volume":"54","author":"K Medlej","year":"2018","unstructured":"Medlej K, Kazzi AA, El Hajj CA et al (2018) Complications from administration of vasopressors through peripheral venous catheters: an observational study. J Emerg Med 54:47\u201353","journal-title":"J Emerg Med"},{"key":"8361_CR147","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.chest.2023.09.015","volume":"165","author":"ES Munroe","year":"2024","unstructured":"Munroe ES (2024) A case for the evidence-based use of peripheral vasopressors. Chest 165:236\u2013238","journal-title":"Chest"},{"issue":"6 Suppl","key":"8361_CR148","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.7326\/M15-0744","volume":"163","author":"V Chopra","year":"2015","unstructured":"Chopra V, Flanders SA, Saint S et al (2015) Michigan Appropriateness Guide for Intravenouse Catheters (MAGIC) Panel: The Michigan appropriateness guide for intravenous catheters (MAGIC): results from a multispecialty panel using the RAND\/UCLA appropriateness method. Ann Intern Med 163(6 Suppl):S1-40","journal-title":"Ann Intern Med"},{"key":"8361_CR149","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1097\/00003246-200008000-00007","volume":"28","author":"D LeDoux","year":"2000","unstructured":"LeDoux D, Astiz ME, Carpati CM et al (2000) Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 28:2729\u20132732","journal-title":"Crit Care Med"},{"key":"8361_CR150","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/CCM.0000000000003569","volume":"47","author":"L Meng","year":"2019","unstructured":"Meng L, Wang Y, Zhang L et al (2019) Heterogeneity and variability in pressure autoregulation of organ blood flow: lessons learned over 100+ years. Crit Care Med 47:436\u2013448","journal-title":"Crit Care Med"},{"key":"8361_CR151","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1056\/NEJMoa1312173","volume":"370","author":"P Asfar","year":"2014","unstructured":"Asfar P, Meziani F, Hamel J-F et al (2014) SEPSISPAM Investigators: high versus low blood-pressure target in patients with septic shock. N Engl J Med 370:1583\u20131593","journal-title":"N Engl J Med"},{"key":"8361_CR152","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s12630-017-0877-1","volume":"64","author":"M Hylands","year":"2017","unstructured":"Hylands M, Moller MH, Asfar P et al (2017) A systematic review of vasopressor blood pressure targets in critically ill adults with hypotension. Can J Anaesth 64:703\u2013715","journal-title":"Can J Anaesth"},{"key":"8361_CR153","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1001\/jama.2020.0930","volume":"323","author":"F Lamontagne","year":"2020","unstructured":"Lamontagne F, Richards-Belle A, Thomas K et al (2020) 65 Trial Investigators: effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: a randomized clinical trial. JAMA 323:938\u2013949","journal-title":"JAMA"},{"key":"8361_CR154","doi-asserted-by":"publisher","first-page":"EVIDoa2400359","DOI":"10.1056\/EVIDoa2400359","volume":"4","author":"F Angriman","year":"2025","unstructured":"Angriman F, Momenzade N, Adhikari NKJ et al (2025) Blood pressure targets for adults with vasodilatory shock\u2014an individual patient data meta-analysis. NEJM Evid 4:EVIDoa2400359","journal-title":"NEJM Evid"},{"key":"8361_CR155","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s00134-025-07910-4","volume":"51","author":"A Endo","year":"2025","unstructured":"Endo A, Yamakawa K, Tagami T et al (2025) OPTPRESS trial investigators: Efficacy of targeting high mean arterial pressure for older patients with septic shock (OPTPRESS): a multicentre, pragmatic, open-label, randomised controlled trial. Intensive Care Med 51:883\u2013892","journal-title":"Intensive Care Med"},{"key":"8361_CR156","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/trstmh\/try007","volume":"111","author":"D Misango","year":"2017","unstructured":"Misango D, Pattnaik R, Baker T et al (2017) Global Intensive Care Working Group: haemodynamic assessment and support in sepsis and septic shock in resource-limited settings. Trans R Soc Trop Med Hyg 111:483\u2013489","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"8361_CR157","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1164\/rccm.200812-1912OC","volume":"180","author":"R Ferrer","year":"2009","unstructured":"Ferrer R, Artigas A, Suarez D et al (2009) Edusepsis Study Group: Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am J Respir Crit Care Med 180:861\u2013866","journal-title":"Am J Respir Crit Care Med"},{"key":"8361_CR158","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/CCM.0000000000002235","volume":"45","author":"AC Kalil","year":"2017","unstructured":"Kalil AC, Johnson DW, Lisco SJ et al (2017) Early goal-directed therapy for sepsis: a novel solution for discordant survival outcomes in clinical trials. Crit Care Med 45:607\u2013614","journal-title":"Crit Care Med"},{"key":"8361_CR159","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","volume":"376","author":"CW Seymour","year":"2017","unstructured":"Seymour CW, Gesten F, Prescott HC et al (2017) Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med 376:2235\u20132244","journal-title":"N Engl J Med"},{"key":"8361_CR160","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/jama.2018.12179","volume":"320","author":"M Klompas","year":"2018","unstructured":"Klompas M, Calandra T, Singer M (2018) Antibiotics for sepsis-finding the equilibrium. JAMA 320:1433\u20131434","journal-title":"JAMA"},{"key":"8361_CR161","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1513\/AnnalsATS.201809-646PS","volume":"16","author":"HC Prescott","year":"2019","unstructured":"Prescott HC, Iwashyna TJ (2019) Improving sepsis treatment by embracing diagnostic uncertainty. Ann Am Thorac Soc 16:426\u2013429","journal-title":"Ann Am Thorac Soc"},{"key":"8361_CR162","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1093\/jac\/dkab091","volume":"76","author":"C Slimings","year":"2021","unstructured":"Slimings C, Riley TV (2021) Antibiotics and healthcare facility-associated Clostridioides difficile infection: systematic review and meta-analysis 2020 update. J Antimicrob Chemother 76:1676\u20131688","journal-title":"J Antimicrob Chemother"},{"key":"8361_CR163","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/jamainternmed.2017.1938","volume":"177","author":"PD Tamma","year":"2017","unstructured":"Tamma PD, Avdic E, Li DX et al (2017) Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med 177:1308\u20131315","journal-title":"JAMA Intern Med"},{"key":"8361_CR164","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s13054-015-1035-1","volume":"19","author":"PM Klein Klouwenberg","year":"2015","unstructured":"Klein Klouwenberg PM, Cremer OL, van Vught LA et al (2015) Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study. Crit Care 19:319","journal-title":"Crit Care"},{"key":"8361_CR165","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1086\/650580","volume":"50","author":"AC Heffner","year":"2010","unstructured":"Heffner AC, Horton JM, Marchick MR et al (2010) Etiology of illness in patients with severe sepsis admitted to the hospital from the emergency department. Clin Infect Dis 50:814\u2013820","journal-title":"Clin Infect Dis"},{"key":"8361_CR166","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s13054-016-1537-5","volume":"20","author":"D Contou","year":"2016","unstructured":"Contou D, Roux D, Jochmans S et al (2016) Septic shock with no diagnosis at 24 hours: a pragmatic multicenter prospective cohort study. Crit Care 20:360","journal-title":"Crit Care"},{"key":"8361_CR167","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/cid\/ciaf118","volume":"80","author":"CN Shappell","year":"2025","unstructured":"Shappell CN, Yu T, Klompas M et al (2025) Frequency of antibiotic overtreatment and associated harms in patients presenting with suspected sepsis to the emergency department: a retrospective cohort study. Clin Infect Dis 80:1197\u20131207","journal-title":"Clin Infect Dis"},{"key":"8361_CR168","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/cid\/ciad101","volume":"76","author":"GA Hooper","year":"2023","unstructured":"Hooper GA, Klippel CJ, McLean SR et al (2023) Concordance between initial presumptive and final adjudicated diagnoses of infection among patients meeting sepsis-3 criteria in the emergency department. Clin Infect Dis 76:2047\u20132055","journal-title":"Clin Infect Dis"},{"key":"8361_CR169","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1001\/jamainternmed.2022.2291","volume":"182","author":"HC Prescott","year":"2022","unstructured":"Prescott HC, Seelye S, Wang XQ et al (2022) Temporal trends in antimicrobial prescribing during hospitalization for potential infection and sepsis. JAMA Intern Med 182:805\u2013813","journal-title":"JAMA Intern Med"},{"key":"8361_CR170","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejim.2024.06.015","volume":"129","author":"LY Leung","year":"2024","unstructured":"Leung LY, Huang H-L, Hung KK et al (2024) Door-to-antibiotic time and mortality in patients with sepsis: Systematic review and meta-analysis. Eur J Intern Med 129:48\u201361","journal-title":"Eur J Intern Med"},{"key":"8361_CR171","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1093\/cid\/ciad450","volume":"77","author":"TR Pak","year":"2023","unstructured":"Pak TR, Young J, McKenna CS et al (2023) Risk of misleading conclusions in observational studies of time-to-antibiotics and mortality in suspected sepsis. Clin Infect Dis 77:1534\u20131543","journal-title":"Clin Infect Dis"},{"key":"8361_CR172","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1164\/rccm.202310-1800OC","volume":"209","author":"RK Hechtman","year":"2024","unstructured":"Hechtman RK, Kipnis P, Cano J et al (2024) Heterogeneity of benefit from earlier time-to-antibiotics for sepsis. Am J Respir Crit Care Med 209:852\u2013860","journal-title":"Am J Respir Crit Care Med"},{"key":"8361_CR173","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S2213-2600(17)30469-1","volume":"6","author":"N Alam","year":"2018","unstructured":"Alam N, Oskam E, Stassen PM et al (2018) PHANTASi Trial Investigators and the ORCA (Onderzoeks Consortium Acute Geneeskunde) Research Consortium the Netherlands: Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial. Lancet Respir Med 6:40\u201350","journal-title":"Lancet Respir Med"},{"key":"8361_CR174","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1749-7922-7-4","volume":"7","author":"PL Chalya","year":"2012","unstructured":"Chalya PL, Mabula JB, Koy M et al (2012) Typhoid intestinal perforations at a University teaching hospital in Northwestern Tanzania: a surgical experience of 104 cases in a resource-limited setting. World J Emerg Surg 7:4","journal-title":"World J Emerg Surg"},{"key":"8361_CR175","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d3245","volume":"342","author":"J Phua","year":"2011","unstructured":"Phua J, Koh Y, Du B et al (2011) MOSAICS Study Group: Management of severe sepsis in patients admitted to Asian intensive care units: prospective cohort study. BMJ 342:d3245","journal-title":"BMJ"},{"key":"8361_CR176","doi-asserted-by":"crossref","unstructured":"Thwaites CL et al (2019) Infection management in patients with sepsis and septic shock in resource-limited settings. In: Dondorp AM, Dunser MW, Schultz MJ (eds) Sepsis management in resource-limited settings. Cham, pp 163\u2013184","DOI":"10.1007\/978-3-030-03143-5_8"},{"key":"8361_CR177","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1097\/CCM.0000000000003227","volume":"46","author":"O Urayeneza","year":"2018","unstructured":"Urayeneza O, Mujyarugamba P, Rukemba Z et al (2018) Sepsis in Resource-Limited Nations Workgroup of the Surviving Sepsis Campaign: increasing evidence-based interventions in patients with acute infections in a resource-limited setting: a before-and-after feasibility trial in Gitwe, Rwanda. Crit Care Med 46:1357\u20131366","journal-title":"Crit Care Med"},{"key":"8361_CR178","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104475","volume":"9","author":"PK Yokota","year":"2014","unstructured":"Yokota PK, Marra AR, Martino MDV et al (2014) Impact of appropriate antimicrobial therapy for patients with severe sepsis and septic shock\u2014a quality improvement study. PLoS ONE 9:e104475","journal-title":"PLoS ONE"},{"key":"8361_CR179","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/ijgo.12350","volume":"140","author":"M Abdu","year":"2018","unstructured":"Abdu M, Wilson A, Mhango C et al (2018) Resource availability for the management of maternal sepsis in Malawi, other low-income countries, and lower-middle-income countries. Int J Gynaecol Obstet 140:175\u2013183","journal-title":"Int J Gynaecol Obstet"},{"key":"8361_CR180","doi-asserted-by":"publisher","first-page":"R10","DOI":"10.1186\/cc9410","volume":"15","author":"I Baelani","year":"2011","unstructured":"Baelani I, Jochberger S, Laimer T et al (2011) Availability of critical care resources to treat patients with severe sepsis or septic shock in Africa: a self-reported, continent-wide survey of anaesthesia providers. Crit Care 15:R10","journal-title":"Crit Care"},{"key":"8361_CR181","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2471\/BLT.10.077073","volume":"88","author":"O Bataar","year":"2010","unstructured":"Bataar O, Lundeg G, Tsenddorj G et al (2010) Helfen Ber\u00fchrt Study Team: nationwide survey on resource availability for implementing current sepsis guidelines in Mongolia. Bull World Health Organ 88:839\u2013846","journal-title":"Bull World Health Organ"},{"key":"8361_CR182","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/S1473-3099(17)30322-5","volume":"17","author":"FR Machado","year":"2017","unstructured":"Machado FR, Cavalcanti AB, Bozza FA et al (2017) SPREAD Investigators: the epidemiology of sepsis in Brazilian intensive care units (the Sepsis PREvalence Assessment Database, SPREAD): an observational study. Lancet Infect Dis 17:1180\u20131189","journal-title":"Lancet Infect Dis"},{"key":"8361_CR183","doi-asserted-by":"publisher","first-page":"193","DOI":"10.5935\/0103-507X.20190033","volume":"31","author":"LU Taniguchi","year":"2019","unstructured":"Taniguchi LU, de Azevedo LCP, Bozza FA et al (2019) Availability of resources to treat sepsis in Brazil: a random sample of Brazilian institutions. Rev Bras Ter Intensiva 31:193\u2013201","journal-title":"Rev Bras Ter Intensiva"},{"key":"8361_CR184","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00134-024-07735-7","volume":"51","author":"L Thwaites","year":"2025","unstructured":"Thwaites L, Nasa P, Abbenbroek B et al (2025) Management of adult sepsis in resource-limited settings: global expert consensus statements using a Delphi method. Intensive Care Med 51:21\u201338","journal-title":"Intensive Care Med"},{"key":"8361_CR185","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamacardio.2024.1189","volume":"9","author":"S Girotra","year":"2024","unstructured":"Girotra S, Dukes KC, Sperling J et al (2024) Emergency medical service agency practices and cardiac arrest survival. JAMA Cardiol 9:683\u2013691","journal-title":"JAMA Cardiol"},{"key":"8361_CR186","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamasurg.2022.3552","volume":"157","author":"D Muchnok","year":"2022","unstructured":"Muchnok D, Vargo A, Deeb A-P et al (2022) Association of prehospital needle decompression with mortality among injured patients requiring emergency chest decompression. JAMA Surg 157:934\u2013940","journal-title":"JAMA Surg"},{"key":"8361_CR187","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1253\/circrep.CR-22-0060","volume":"4","author":"N Nakayama","year":"2022","unstructured":"Nakayama N, Yamamoto T, Kikuchi M et al (2022) Japan Resuscitation Council (JRC) Acute Coronary Syndrome (ACS) Task Force and the Guideline Editorial Committee on behalf of the Japanese Circulation Society (JCS) Emergency and Critical Care Committee: prehospital administration of aspirin and nitroglycerin for patients with suspected acute coronary syndrome\u2014a systematic review. Circ Rep 4:449\u2013457","journal-title":"Circ Rep"},{"key":"8361_CR188","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1016\/j.injury.2022.09.051","volume":"53","author":"SPJ Philipsen","year":"2022","unstructured":"Philipsen SPJ, Vergunst AA, Tan E (2022) Traction splinting for midshaft femoral fractures in the pre-hospital and emergency department environment\u2014a systematic review. Injury 53:4129\u20134138","journal-title":"Injury"},{"key":"8361_CR189","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.582","volume":"5","author":"J Varney","year":"2022","unstructured":"Varney J, Motawea KR, Kandil OA et al (2022) Prehospital administration of broad-spectrum antibiotics for sepsis patients: A systematic review and meta-analysis. Health Sci Rep 5:e582","journal-title":"Health Sci Rep"},{"key":"8361_CR190","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/27536386231207055","volume":"21","author":"MJ Poynter","year":"2023","unstructured":"Poynter MJ, Farrugia A, Kelly E et al (2023) Prehospital administration of antibiotics in addition to usual care versus usual care alone for patients with suspected sepsis\u2014a systematic review. Paramedicine 21:52\u201365","journal-title":"Paramedicine"},{"key":"8361_CR191","doi-asserted-by":"publisher","first-page":"18586","DOI":"10.1038\/s41598-021-97979-w","volume":"11","author":"J Jones","year":"2021","unstructured":"Jones J, Allen S, Davies J et al (2021) Randomised feasibility study of prehospital recognition and antibiotics for emergency patients with sepsis (PhRASe). Sci Rep 11:18586","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"8361_CR192","doi-asserted-by":"publisher","first-page":"P317","DOI":"10.1186\/cc7481","volume":"13","author":"D Chamberlain","year":"2009","unstructured":"Chamberlain D (2009) Prehospital administered intravenous antimicrobial protocol for septic shock: A prospective randomized clinical trial. Crit Care 13(Suppl 1):P317","journal-title":"Crit Care"},{"key":"8361_CR193","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2147\/OAEM.S413791","volume":"15","author":"R Kotnarin","year":"2023","unstructured":"Kotnarin R, Sirinawee P, Supasaovapak J (2023) Impact of prehospital antibiotics on in-hospital mortality in emergency medical service patients with sepsis. Open Access Emerg Med 15:199\u2013206","journal-title":"Open Access Emerg Med"},{"key":"8361_CR194","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1097\/CCM.0000000000002264","volume":"45","author":"CW Seymour","year":"2017","unstructured":"Seymour CW, Kahn JM, Martin-Gill C et al (2017) Delays from first medical contact to antibiotic administration for sepsis. Crit Care Med 45:759\u2013765","journal-title":"Crit Care Med"},{"key":"8361_CR195","doi-asserted-by":"publisher","first-page":"330","DOI":"10.21037\/atm.2016.09.02","volume":"4","author":"L Lagunes","year":"2016","unstructured":"Lagunes L, Encina B, Ramirez-Estrada S (2016) Current understanding in source control management in septic shock patients: a review. Ann Transl Med 4:330","journal-title":"Ann Transl Med"},{"issue":"Suppl 1","key":"8361_CR196","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1007\/PL00003797","volume":"27","author":"MF Jimenez","year":"2001","unstructured":"Jimenez MF, Marshall JC, International Sepsis F (2001) Source control in the management of sepsis. Intensive Care Med 27(Suppl 1):S49\u2013S62","journal-title":"Intensive Care Med"},{"key":"8361_CR197","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1007\/s00134-022-06852-5","volume":"48","author":"JJ De Waele","year":"2022","unstructured":"De Waele JJ, Girardis M, Martin-Loeches I (2022) Source control in the management of sepsis and septic shock. Intensive Care Med 48:1799\u20131802","journal-title":"Intensive Care Med"},{"key":"8361_CR198","doi-asserted-by":"publisher","first-page":"R87","DOI":"10.1186\/cc13854","volume":"18","author":"T Azuhata","year":"2014","unstructured":"Azuhata T, Kinoshita K, Kawano D et al (2014) Time from admission to initiation of surgery for source control is a critical determinant of survival in patients with gastrointestinal perforation with associated septic shock. Crit Care 18:R87","journal-title":"Crit Care"},{"key":"8361_CR199","doi-asserted-by":"publisher","first-page":"R42","DOI":"10.1186\/cc13755","volume":"18","author":"F Bloos","year":"2014","unstructured":"Bloos F, Thomas-R\u00fcddel D, R\u00fcddel H et al (2014) MEDUSA Study Group: Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study. Crit Care 18:R42","journal-title":"Crit Care"},{"key":"8361_CR200","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1007\/s00134-017-4782-4","volume":"43","author":"F Bloos","year":"2017","unstructured":"Bloos F, R\u00fcddel H, Thomas-R\u00fcddel D et al (2017) MEDUSA study group: effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trial. Intensive Care Med 43:1602\u20131612","journal-title":"Intensive Care Med"},{"key":"8361_CR201","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s00134-022-06883-y","volume":"48","author":"G De Pascale","year":"2022","unstructured":"De Pascale G, Antonelli M, Deschepper M et al (2022) Abdominal Sepsis Study (AbSeS) group and the Trials Group of the European Society of Intensive Care Medicine: poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis. Intensive Care Med 48:1593\u20131606","journal-title":"Intensive Care Med"},{"key":"8361_CR202","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1503\/cjs.009418","volume":"62","author":"CJ Karvellas","year":"2019","unstructured":"Karvellas CJ, Dong V, Abraldes JG et al (2019) The impact of delayed source control and antimicrobial therapy in 196 patients with cholecystitis-associated septic shock: a cohort analysis. Can J Surg 62:189\u2013198","journal-title":"Can J Surg"},{"key":"8361_CR203","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jcrc.2019.06.012","volume":"53","author":"H Kim","year":"2019","unstructured":"Kim H, Chung SP, Choi S-H et al (2019) Korean Shock Society (KoSS) Investigators: impact of timing to source control in patients with septic shock: a prospective multi-center observational study. J Crit Care 53:176\u2013182","journal-title":"J Crit Care"},{"key":"8361_CR204","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/CCM.0000000000002011","volume":"45","author":"ML Martinez","year":"2017","unstructured":"Martinez ML, Ferrer R, Torrents E et al (2017) Edusepsis Study Group: impact of source control in patients with severe sepsis and septic shock. Crit Care Med 45:11\u201319","journal-title":"Crit Care Med"},{"key":"8361_CR205","volume":"4","author":"F Naqvi","year":"2022","unstructured":"Naqvi F, Jain P, Umer A et al (2022) Outcomes of patients with sepsis and septic shock requiring source control: a prospective observational single-center study. Crit Care Explor 4:e0807","journal-title":"Crit Care Explor"},{"key":"8361_CR206","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2024.051","volume":"16","author":"U Onal","year":"2024","unstructured":"Onal U, Akyol Seyhan D, Keteno\u011flu OB et al (2024) Importance of source control in the subgroup of intra-abdominal infections for septic shock patients: analysis of 390 cases. Mediterr J Hematol Infect Dis 16:e2024051","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"8361_CR207","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/jamasurg.2022.2761","volume":"157","author":"KM Reitz","year":"2022","unstructured":"Reitz KM, Kennedy J, Li SR et al (2022) Association between time to source control in sepsis and 90-day mortality. JAMA Surg 157:817\u2013826","journal-title":"JAMA Surg"},{"key":"8361_CR208","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13054-022-03901-9","volume":"26","author":"H Ruddel","year":"2022","unstructured":"Ruddel H, Thomas-R\u00fcddel DO, Reinhart K et al (2022) MEDUSA study group: adverse effects of delayed antimicrobial treatment and surgical source control in adults with sepsis: Results of a planned secondary analysis of a cluster-randomized controlled trial. Crit Care 26:51","journal-title":"Crit Care"},{"key":"8361_CR209","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1086\/649554","volume":"50","author":"JS Solomkin","year":"2010","unstructured":"Solomkin JS, Mazuski JE, Bradley JS et al (2010) Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 50:133\u2013164","journal-title":"Clin Infect Dis"},{"key":"8361_CR210","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1089\/sur.2024.137","volume":"25","author":"JM Huston","year":"2024","unstructured":"Huston JM, Barie PS, Dellinger EP et al (2024) Therapeutics and Guidelines Committee: the surgical infection society guidelines on the management of intra-abdominal infection: 2024 update. Surg Infect (Larchmt) 25:419\u2013435","journal-title":"Surg Infect (Larchmt)"},{"key":"8361_CR211","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13017-023-00509-4","volume":"18","author":"F Coccolini","year":"2023","unstructured":"Coccolini F, Sartelli M, Sawyer R et al (2023) Source control in emergency general surgery: WSES, GAIS, SIS-E, SIS-A guidelines. World J Emerg Surg 18:41","journal-title":"World J Emerg Surg"},{"key":"8361_CR212","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1089\/sur.2020.436","volume":"22","author":"TM Duane","year":"2021","unstructured":"Duane TM, Huston JM, Collom M et al (2021) Surgical infection society 2020 updated guidelines on the management of complicated skin and soft tissue infections. Surg Infect (Larchmt) 22:383\u2013399","journal-title":"Surg Infect (Larchmt)"},{"key":"8361_CR213","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.eururo.2024.03.035","volume":"86","author":"J Kranz","year":"2024","unstructured":"Kranz J, Bartoletti R, Bruy\u00e8re F et al (2024) European association of urology guidelines on urological infections: Summary of the 2024 guidelines. Eur Urol 86:27\u201341","journal-title":"Eur Urol"},{"key":"8361_CR214","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cmi.2023.08.016","volume":"30","author":"J Bodilsen","year":"2024","unstructured":"Bodilsen J, D\u2019Alessandris QG, Humphreys H et al (2024) ESCMID Study Group for Infections of the Brain (ESGIB): European society of clinical microbiology and infectious diseases guidelines on diagnosis and treatment of brain abscess in children and adults. Clin Microbiol Infect 30:66\u201389","journal-title":"Clin Microbiol Infect"},{"key":"8361_CR215","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB et al (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268\u2013281","journal-title":"Clin Microbiol Infect"},{"key":"8361_CR216","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","volume":"28","author":"M Paul","year":"2022","unstructured":"Paul M, Carrara E, Retamar P et al (2022) European society of clinical microbiology and infectious diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clin Microbiol Infect 28:521\u2013547","journal-title":"Clin Microbiol Infect"},{"key":"8361_CR217","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1001\/jama.2020.2717","volume":"323","author":"JL Vincent","year":"2020","unstructured":"Vincent JL, Sakr Y, Singer M et al (2020) EPIC III Investigators: prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA 323:1478\u20131487","journal-title":"JAMA"},{"key":"8361_CR218","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.2899","volume":"3","author":"C Rhee","year":"2020","unstructured":"Rhee C, Kadri SS, Dekker JP et al (2020) CDC Prevention Epicenters Program: prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use. JAMA Netw Open 3:e202899","journal-title":"JAMA Netw Open"},{"key":"8361_CR219","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.cmi.2024.07.005","volume":"30","author":"X Liu","year":"2024","unstructured":"Liu X, Liu X, Jin C et al (2024) Prediction models for diagnosis and prognosis of the colonization or infection of multidrug-resistant organisms in adults: a systematic review, critical appraisal, and meta-analysis. Clin Microbiol Infect 30:1364\u20131373","journal-title":"Clin Microbiol Infect"},{"key":"8361_CR220","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/S1473-3099(16)30267-5","volume":"16","author":"S Aliberti","year":"2016","unstructured":"Aliberti S, Reyes LF, Faverio P et al (2016) GLIMP investigators: global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis 16:1364\u20131376","journal-title":"Lancet Infect Dis"},{"key":"8361_CR221","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1089\/sur.2017.217","volume":"19","author":"FM Labricciosa","year":"2018","unstructured":"Labricciosa FM, Sartelli M, Abbo LM et al (2018) Epidemiology and risk factors for isolation of multi-drug-resistant organisms in patients with complicated intra-abdominal infections. Surg Infect (Larchmt) 19:264\u2013272","journal-title":"Surg Infect (Larchmt)"},{"key":"8361_CR222","first-page":"201","volume":"24","author":"F Callejo-Torre","year":"2016","unstructured":"Callejo-Torre F, Eiros Bouza JM, Olaechea Astigarraga P et al (2016) Risk factors for methicillin-resistant Staphylococcus aureus colonisation or infection in intensive care units and their reliability for predicting MRSA on ICU admission. Infez Med 24:201\u2013209","journal-title":"Infez Med"},{"key":"8361_CR223","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1017\/S095026881200194X","volume":"141","author":"H Aydemir","year":"2013","unstructured":"Aydemir H, Akduman D, Piskin N et al (2013) Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia. Epidemiol Infect 141:1214\u20131222","journal-title":"Epidemiol Infect"},{"key":"8361_CR224","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/S0140-6736(14)62220-0","volume":"385","author":"FM Wagenlehner","year":"2015","unstructured":"Wagenlehner FM, Umeh O, Steenbergen J et al (2015) Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI). Lancet 385:1949\u20131956","journal-title":"Lancet"},{"key":"8361_CR225","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/cid\/civ097","volume":"60","author":"J Solomkin","year":"2015","unstructured":"Solomkin J, Hershberger E, Miller B et al (2015) Ceftolozane\/tazobactam plus metronidazole for complicated intra-abdominal infections in an era of multidrug resistance: results from a randomized, double-blind, phase 3 trial (ASPECT-cIAI). Clin Infect Dis 60:1462\u20131471","journal-title":"Clin Infect Dis"},{"key":"8361_CR226","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s12879-017-2502-x","volume":"17","author":"YB Seo","year":"2017","unstructured":"Seo YB, Lee J, Kim YK et al (2017) Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli. BMC Infect Dis 17:404","journal-title":"BMC Infect Dis"},{"key":"8361_CR227","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S1473-3099(16)30004-4","volume":"16","author":"Y Carmeli","year":"2016","unstructured":"Carmeli Y, Armstrong J, Laud PJ et al (2016) Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study. Lancet Infect Dis 16:661\u2013673","journal-title":"Lancet Infect Dis"},{"key":"8361_CR228","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S1473-3099(20)30731-3","volume":"21","author":"RG Wunderink","year":"2021","unstructured":"Wunderink RG, Matsunaga Y, Ariyasu M et al (2021) Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial. Lancet Infect Dis 21:213\u2013225","journal-title":"Lancet Infect Dis"},{"key":"8361_CR229","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s40121-018-0214-1","volume":"7","author":"RG Wunderink","year":"2018","unstructured":"Wunderink RG, Giamarellos-Bourboulis EJ, Rahav G et al (2018) Effect and safety of meropenem-vaborbactam versus best-available therapy in patients with carbapenem-resistant enterobacteriaceae infections: the TANGO II randomized clinical trial. Infect Dis Ther 7:439\u2013455","journal-title":"Infect Dis Ther"},{"key":"8361_CR230","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/cid\/ciw378","volume":"63","author":"FM Wagenlehner","year":"2016","unstructured":"Wagenlehner FM, Sobel JD, Newell P et al (2016) Ceftazidime-avibactam versus doripenem for the treatment of complicated urinary tract infections, including acute pyelonephritis: RECAPTURE, a phase 3 randomized trial program. Clin Infect Dis 63:754\u2013762","journal-title":"Clin Infect Dis"},{"key":"8361_CR231","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/S1473-3099(18)30554-1","volume":"18","author":"S Portsmouth","year":"2018","unstructured":"Portsmouth S, van Veenhuyzen D, Echols R et al (2018) Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial. Lancet Infect Dis 18:1319\u20131328","journal-title":"Lancet Infect Dis"},{"key":"8361_CR232","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S1473-3099(20)30796-9","volume":"21","author":"M Bassetti","year":"2021","unstructured":"Bassetti M, Echols R, Matsunaga Y et al (2021) Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial. Lancet Infect Dis 21:226\u2013240","journal-title":"Lancet Infect Dis"},{"key":"8361_CR233","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1093\/jac\/dkad078","volume":"78","author":"GB Carey","year":"2023","unstructured":"Carey GB, Holleck JL, Ein Alshaeba S et al (2023) Estimated mortality with early empirical antibiotic coverage of methicillin-resistant Staphylococcus aureus in hospitalized patients with bacterial infections: a systematic review and meta-analysis. J Antimicrob Chemother 78:1150\u20131159","journal-title":"J Antimicrob Chemother"},{"key":"8361_CR234","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa1914433","volume":"382","author":"JA Jernigan","year":"2020","unstructured":"Jernigan JA, Hatfield KM, Wolford H et al (2020) Multidrug-resistant bacterial infections in US hospitalized patients, 2012\u20132017. N Engl J Med 382:1309\u20131319","journal-title":"N Engl J Med"},{"key":"8361_CR235","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"Collaborators, G.B.D.A.R.","year":"2024","unstructured":"Collaborators, G.B.D.A.R. (2024) Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet 404:1199\u20131226","journal-title":"Lancet"},{"key":"8361_CR236","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.18923","volume":"7","author":"C Rhee","year":"2024","unstructured":"Rhee C, Chen T, Kadri SS et al (2024) CDC Prevention Epicenters Program: trends in empiric broad-spectrum antibiotic use for suspected community-onset sepsis in US hospitals. JAMA Netw Open 7:e2418923","journal-title":"JAMA Netw Open"},{"key":"8361_CR237","doi-asserted-by":"publisher","first-page":"ciae403","DOI":"10.1093\/cid\/ciae403","volume":"7","author":"PD Tamma","year":"2024","unstructured":"Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA (2024) Infectious diseases society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections. Clin Infect Dis 7:ciae403","journal-title":"Clin Infect Dis"},{"key":"8361_CR238","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00134-014-3310-z","volume":"40","author":"M Bassetti","year":"2014","unstructured":"Bassetti M, Righi E, Ansaldi F et al (2014) A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. Intensive Care Med 40:839\u2013845","journal-title":"Intensive Care Med"},{"key":"8361_CR239","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/cid\/cis305","volume":"54","author":"M Kollef","year":"2012","unstructured":"Kollef M, Micek S, Hampton N et al (2012) Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis 54:1739\u20131746","journal-title":"Clin Infect Dis"},{"key":"8361_CR240","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","volume":"370","author":"SS Magill","year":"2014","unstructured":"Magill SS, Edwards JR, Bamberg W et al (2014) Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team: multistate point-prevalence survey of health care-associated infections. N Engl J Med 370:1198\u20131208","journal-title":"N Engl J Med"},{"key":"8361_CR241","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/cc6212","volume":"12","author":"M Mean","year":"2008","unstructured":"Mean M, Marchetti O, Calandra T (2008) Bench-to-bedside review: Candida infections in the intensive care unit. Crit Care 12:204","journal-title":"Crit Care"},{"key":"8361_CR242","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1086\/504810","volume":"43","author":"KW Garey","year":"2006","unstructured":"Garey KW, Rege M, Pai MP et al (2006) Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 43:25\u201331","journal-title":"Clin Infect Dis"},{"key":"8361_CR243","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1186\/cc7964","volume":"13","author":"DJ Marriott","year":"2009","unstructured":"Marriott DJ, Playford EG, Chen S et al (2009) Australian Candidaemia Study: determinants of mortality in non-neutropenic ICU patients with candidaemia. Crit Care 13:R115","journal-title":"Crit Care"},{"key":"8361_CR244","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","volume":"49","author":"M Morrell","year":"2005","unstructured":"Morrell M, Fraser VJ, Kollef MH (2005) Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49:3640\u20133645","journal-title":"Antimicrob Agents Chemother"},{"key":"8361_CR245","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.chest.2021.08.081","volume":"161","author":"DO Thomas-Ruddel","year":"2022","unstructured":"Thomas-Ruddel DO, Schlattmann P, Pletz M et al (2022) Risk factors for invasive Candida infection in critically ill patients: a systematic review and meta-analysis. Chest 161:345\u2013355","journal-title":"Chest"},{"key":"8361_CR246","first-page":"CD004920","volume":"2016","author":"A Cortegiani","year":"2016","unstructured":"Cortegiani A, Russotto V, Maggiore A et al (2016) Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients. Cochrane Database Syst Rev 2016:CD004920","journal-title":"Cochrane Database Syst Rev"},{"key":"8361_CR247","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1001\/jama.2016.14655","volume":"316","author":"JF Timsit","year":"2016","unstructured":"Timsit JF, Azoulay E, Schwebel C et al (2016) EMPIRICUS Trial Group: empirical micafungin treatment and survival without invasive fungal infection in adults with ICU-acquired sepsis, Candida colonization, and multiple organ failure: the EMPIRICUS randomized clinical trial. JAMA 316:1555\u20131564","journal-title":"JAMA"},{"key":"8361_CR248","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.1016\/S1473-3099(24)00749-7","volume":"25","author":"OA Cornely","year":"2025","unstructured":"Cornely OA, Sprute R, Bassetti M et al (2025) Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM. Lancet Infect Dis 25:e280\u2013e293","journal-title":"Lancet Infect Dis"},{"key":"8361_CR249","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2023.102734","volume":"81","author":"F Cobo","year":"2023","unstructured":"Cobo F, P\u00e9rez-Carrasco V, Rodr\u00edguez-Granger J et al (2023) Differences between bloodstream infections involving gram-positive and gram-negative anaerobes. Anaerobe 81:102734","journal-title":"Anaerobe"},{"key":"8361_CR250","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2025.107840","volume":"153","author":"Y Murai","year":"2025","unstructured":"Murai Y, Nagaoka K, Iwanaga N et al (2025) Effects of extended anaerobic antibiotic coverage on anaerobic bloodstream infection: a multisite retrospective study. Int J Infect Dis 153:107840","journal-title":"Int J Infect Dis"},{"key":"8361_CR251","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1089\/sur.2017.282","volume":"19","author":"SA Buckman","year":"2018","unstructured":"Buckman SA, Turnbull IR, Mazuski JE (2018) Empiric antibiotics for sepsis. Surg Infect (Larchmt) 19:147\u2013154","journal-title":"Surg Infect (Larchmt)"},{"key":"8361_CR252","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s15010-012-0389-4","volume":"41","author":"JT Ngo","year":"2013","unstructured":"Ngo JT, Parkins MD, Gregson DB et al (2013) Population-based assessment of the incidence, risk factors, and outcomes of anaerobic bloodstream infections. Infection 41:41\u201348","journal-title":"Infection"},{"key":"8361_CR253","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2024.102898","volume":"89","author":"KK Mortensen","year":"2024","unstructured":"Mortensen KK, Nielsen HL, Sogaard KK (2024) Clinical and microbiological characteristics of anaerobic bacteremia during 1994\u20132019: a Danish population-based cohort study. Anaerobe 89:102898","journal-title":"Anaerobe"},{"key":"8361_CR254","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/aas.13327","volume":"63","author":"MW Petersen","year":"2019","unstructured":"Petersen MW, Perner A, Jonsson AB et al (2019) Empirical metronidazole for patients with severe bacterial infection: a systematic review with meta-analysis and trial sequential analysis. Acta Anaesthesiol Scand 63:802\u2013813","journal-title":"Acta Anaesthesiol Scand"},{"key":"8361_CR255","doi-asserted-by":"publisher","first-page":"2300413","DOI":"10.1183\/13993003.00413-2023","volume":"61","author":"RFJ Kullberg","year":"2023","unstructured":"Kullberg RFJ, Schinkel M, Wiersinga WJ (2023) Empiric anti-anaerobic antibiotics are associated with adverse clinical outcomes in emergency department patients. Eur Respir J 61:2300413","journal-title":"Eur Respir J"},{"key":"8361_CR256","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1001\/jamainternmed.2024.0581","volume":"184","author":"R Chanderraj","year":"2024","unstructured":"Chanderraj R, Admon AJ, He Y et al (2024) Mortality of patients with sepsis administered piperacillin-tazobactam vs cefepime. JAMA Intern Med 184:769\u2013777","journal-title":"JAMA Intern Med"},{"key":"8361_CR257","doi-asserted-by":"publisher","first-page":"2200910","DOI":"10.1183\/13993003.00910-2022","volume":"61","author":"R Chanderraj","year":"2023","unstructured":"Chanderraj R, Baker JM, Kay SG et al (2023) In critically ill patients, anti-anaerobic antibiotics increase risk of adverse clinical outcomes. Eur Respir J 61:2200910","journal-title":"Eur Respir J"},{"key":"8361_CR258","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jama.2023.20583","volume":"330","author":"ET Qian","year":"2023","unstructured":"Qian ET, Casey JD, Wright A et al (2023) Vanderbilt Center for Learning Healthcare and the Pragmatic Critical Care Research Group: cefepime vs piperacillin-tazobactam in adults hospitalized with acute infection: the ACORN randomized clinical trial. JAMA 330:1557\u20131567","journal-title":"JAMA"},{"key":"8361_CR259","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC et al (2019) Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American thoracic society and infectious diseases society of America. Am J Respir Crit Care Med 200:e45\u2013e67","journal-title":"Am J Respir Crit Care Med"},{"key":"8361_CR260","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/sur.2016.261","volume":"18","author":"JE Mazuski","year":"2017","unstructured":"Mazuski JE, Tessier JM, May AK et al (2017) The surgical infection society revised guidelines on the management of intra-abdominal infection. Surg Infect (Larchmt) 18:1\u201376","journal-title":"Surg Infect (Larchmt)"},{"key":"8361_CR261","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S2213-2600(24)00257-1","volume":"13","author":"RFJ Kullberg","year":"2025","unstructured":"Kullberg RFJ, Haak BW, Chanderraj R et al (2025) Empirical antibiotic therapy for sepsis: save the anaerobic microbiota. Lancet Respir Med 13:92\u2013100","journal-title":"Lancet Respir Med"},{"key":"8361_CR262","doi-asserted-by":"publisher","first-page":"9603","DOI":"10.1007\/s00210-024-03318-x","volume":"397","author":"F Ferrara","year":"2024","unstructured":"Ferrara F, Castagna T, Pantolini B et al (2024) The challenge of antimicrobial resistance (AMR): current status and future prospects. Naunyn Schmiedebergs Arch Pharmacol 397:9603\u20139615","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"8361_CR263","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.797932","volume":"13","author":"S Spoto","year":"2022","unstructured":"Spoto S, Daniel Markley J, Valeriani E et al (2022) Active surveillance cultures and procalcitonin in combination with clinical data to guide empirical antimicrobial therapy in hospitalized medical patients with sepsis. Front Microbiol 13:797932","journal-title":"Front Microbiol"},{"key":"8361_CR264","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.ajic.2022.02.018","volume":"50","author":"F Verdugo-Paiva","year":"2022","unstructured":"Verdugo-Paiva F, Otaiza F, Roson-Rodr\u00edguez P et al (2022) Effects of screening strategies to detect carbapenem-resistant gram-negative bacteria: a systematic review. Am J Infect Control 50:1381\u20131388","journal-title":"Am J Infect Control"},{"key":"8361_CR265","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/cid\/ciy752","volume":"68","author":"S Tomczyk","year":"2019","unstructured":"Tomczyk S, Zanichelli V, Grayson ML et al (2019) Control of carbapenem-resistant enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa in healthcare facilities: a systematic review and reanalysis of quasi-experimental studies. Clin Infect Dis 68:873\u2013884","journal-title":"Clin Infect Dis"},{"key":"8361_CR266","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00134-012-2759-x","volume":"39","author":"N Brusselaers","year":"2013","unstructured":"Brusselaers N, Labeau S, Vogelaers D et al (2013) Value of lower respiratory tract surveillance cultures to predict bacterial pathogens in ventilator-associated pneumonia: systematic review and diagnostic test accuracy meta-analysis. Intensive Care Med 39:365\u2013375","journal-title":"Intensive Care Med"},{"key":"8361_CR267","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"Antimicrobial Resistance C","year":"2022","unstructured":"Antimicrobial Resistance C (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399:629\u2013655","journal-title":"Lancet"},{"key":"8361_CR268","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.cmi.2020.02.024","volume":"27","author":"D Bouzid","year":"2021","unstructured":"Bouzid D, Zanella M-C, Kerneis S et al (2021) Rapid diagnostic tests for infectious diseases in the emergency department. Clin Microbiol Infect 27:182\u2013191","journal-title":"Clin Microbiol Infect"},{"key":"8361_CR269","first-page":"CD013235","volume":"5","author":"V Anton-Vazquez","year":"2021","unstructured":"Anton-Vazquez V, Hine P, Krishna S et al (2021) Rapid versus standard antimicrobial susceptibility testing to guide treatment of bloodstream infection. Cochrane Database Syst Rev 5:CD013235","journal-title":"Cochrane Database Syst Rev"},{"key":"8361_CR270","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s10096-024-04820-z","volume":"43","author":"Y Caspar","year":"2024","unstructured":"Caspar Y, Deves A, Richarme C et al (2024) Clinical impact and cost-consequence analysis of ePlex(R) blood culture identification panels for the rapid diagnosis of bloodstream infections: a single-center randomized controlled trial. Eur J Clin Microbiol Infect Dis 43:1193\u20131203","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"8361_CR271","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/cid\/ciae234","volume":"79","author":"AM Peri","year":"2024","unstructured":"Peri AM, Chatfield MD, Ling W et al (2024) Rapid diagnostic tests and antimicrobial stewardship programs for the management of bloodstream infection: what is their relative contribution to improving clinical outcomes? A systematic review and network meta-analysis. Clin Infect Dis 79:502\u2013515","journal-title":"Clin Infect Dis"},{"key":"8361_CR272","doi-asserted-by":"publisher","first-page":"13393","DOI":"10.3390\/ijms241713393","volume":"24","author":"AM Balan","year":"2023","unstructured":"Balan AM, Bodolea C, Nemes A et al (2023) Rapid point-of-care PCR testing of drug-resistant strains on endotracheal aspirate samples: a repurposed effective tool in the stepwise approach of healthcare-acquired pneumonia\u2014a pilot study. Int J Mol Sci 24:13393","journal-title":"Int J Mol Sci"},{"key":"8361_CR273","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s00134-024-07772-2","volume":"51","author":"VI Enne","year":"2025","unstructured":"Enne VI, Stirling S, Barber JA et al (2025) INHALE WP3 Study Group and Committees: INHALE WP3, a multicentre, open-label, pragmatic randomised controlled trial assessing the impact of rapid, ICU-based, syndromic PCR, versus standard-of-care on antibiotic stewardship and clinical outcomes in hospital-acquired and ventilator-associated pneumonia. Intensive Care Med 51:272\u2013286","journal-title":"Intensive Care Med"},{"key":"8361_CR274","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/cid\/ciw649","volume":"64","author":"TT Timbrook","year":"2017","unstructured":"Timbrook TT, Morton JB, McConeghy KW et al (2017) The effect of molecular rapid diagnostic testing on clinical outcomes in bloodstream infections: a systematic review and meta-analysis. Clin Infect Dis 64:15\u201323","journal-title":"Clin Infect Dis"},{"key":"8361_CR275","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s40265-013-0069-4","volume":"73","author":"RJ Hamill","year":"2013","unstructured":"Hamill RJ (2013) Amphotericin B formulations: a comparative review of efficacy and toxicity. Drugs 73:919\u2013934","journal-title":"Drugs"},{"key":"8361_CR276","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1111\/ctr.12834","volume":"30","author":"MT Levine","year":"2016","unstructured":"Levine MT, Chandrasekar PH (2016) Adverse effects of voriconazole: over a decade of use. Clin Transplant 30:1377\u20131386","journal-title":"Clin Transplant"},{"key":"8361_CR277","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cmi.2019.03.028","volume":"25","author":"KE Pristov","year":"2019","unstructured":"Pristov KE, Ghannoum MA (2019) Resistance of Candida to azoles and echinocandins worldwide. Clin Microbiol Infect 25:792\u2013798","journal-title":"Clin Microbiol Infect"},{"key":"8361_CR278","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","volume":"17","author":"DS Perlin","year":"2017","unstructured":"Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A (2017) The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis 17:e383\u2013e392","journal-title":"Lancet Infect Dis"},{"key":"8361_CR279","doi-asserted-by":"publisher","first-page":"1","DOI":"10.37201\/req\/2260.2019","volume":"33","author":"E Bouza","year":"2020","unstructured":"Bouza E, Almirante B, Garc\u00eda Rodr\u00edguez J et al (2020) Biomarkers of fungal infection: expert opinion on the current situation. Rev Esp Quimioter 33:1\u201310","journal-title":"Rev Esp Quimioter"},{"key":"8361_CR280","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00134-022-06733-x","volume":"48","author":"F Bloos","year":"2022","unstructured":"Bloos F, Held J, Kluge S et al (2022) SepNet Study Group: (1 \u2192 3)-beta-d-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial. Intensive Care Med 48:865\u2013875","journal-title":"Intensive Care Med"},{"key":"8361_CR281","first-page":"94","volume":"78","author":"AA MohdHafiz","year":"2012","unstructured":"MohdHafiz AA, Staatz CE, Kirkpatrick CMJ et al (2012) Continuous infusion vs. bolus dosing: implications for beta-lactam antibiotics. Minerva Anestesiol 78:94\u2013104","journal-title":"Minerva Anestesiol"},{"key":"8361_CR282","doi-asserted-by":"publisher","first-page":"R206","DOI":"10.1186\/cc10441","volume":"15","author":"J Goncalves-Pereira","year":"2011","unstructured":"Goncalves-Pereira J, Povoa P (2011) Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of beta-lactams. Crit Care 15:R206","journal-title":"Crit Care"},{"key":"8361_CR283","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/jac\/dkv288","volume":"71","author":"MH Abdul-Aziz","year":"2016","unstructured":"Abdul-Aziz MH, Lipman J, Akova M et al (2016) DALI Study Group: is prolonged infusion of piperacillin\/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic\/pharmacodynamic and patient outcomes? An observation from the defining antibiotic levels in intensive care unit patients (DALI) cohort. J Antimicrob Chemother 71:196\u2013207","journal-title":"J Antimicrob Chemother"},{"key":"8361_CR284","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/cid\/cis856","volume":"56","author":"JM Dulhunty","year":"2013","unstructured":"Dulhunty JM, Roberts JA, Davis JS et al (2013) Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial. Clin Infect Dis 56:236\u2013244","journal-title":"Clin Infect Dis"},{"key":"8361_CR285","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1001\/jama.2024.9803","volume":"332","author":"MH Abdul-Aziz","year":"2024","unstructured":"Abdul-Aziz MH, Hammond NE, Brett SJ et al (2024) Prolonged vs intermittent infusions of beta-lactam antibiotics in adults with sepsis or septic shock: a systematic review and meta-analysis. JAMA 332:638\u2013648","journal-title":"JAMA"},{"key":"8361_CR286","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1001\/jama.2024.9779","volume":"332","author":"JM Dulhunty","year":"2024","unstructured":"Dulhunty JM, Brett SJ, De Waele JJ et al (2024) BLING III Study Investigators: continuous vs intermittent beta-lactam antibiotic infusions in critically ill patients with sepsis: the BLING III randomized clinical trial. JAMA 332:629\u2013637","journal-title":"JAMA"},{"key":"8361_CR287","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.ijantimicag.2015.01.007","volume":"45","author":"JJ De Waele","year":"2015","unstructured":"De Waele JJ, Lipman J, Carlier M et al (2015) Subtleties in practical application of prolonged infusion of beta-lactam antibiotics. Int J Antimicrob Agents 45:461\u2013463","journal-title":"Int J Antimicrob Agents"},{"key":"8361_CR288","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijantimicag.2007.02.002","volume":"30","author":"JA Roberts","year":"2007","unstructured":"Roberts JA, Paratz J, Paratz E et al (2007) Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role. Int J Antimicrob Agents 30:11\u201318","journal-title":"Int J Antimicrob Agents"},{"key":"8361_CR289","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1007\/s00134-024-07650-x","volume":"50","author":"G Barton","year":"2024","unstructured":"Barton G, Rickard CM, Roberts JA (2024) Continuous infusion of beta-lactam antibiotics in critically ill patients with sepsis: Implementation considerations. Intensive Care Med 50:2150\u20132153","journal-title":"Intensive Care Med"},{"key":"8361_CR290","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1186\/s12879-022-07653-3","volume":"22","author":"E Sieswerda","year":"2022","unstructured":"Sieswerda E, Bax HI, Hoogerwerf JJ et al (2022) The 2021 dutch working party on antibiotic policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults. BMC Infect Dis 22:687","journal-title":"BMC Infect Dis"},{"key":"8361_CR291","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S1473-3099(14)70036-2","volume":"14","author":"JA Roberts","year":"2014","unstructured":"Roberts JA, Abdul-Aziz MH, Lipman J et al (2014) International Society of Anti-Infective Pharmacology and the Pharmacokinetics and Pharmacodynamics Study Group of the European Society of Clinical Microbiology and Infectious Diseases: individualised antibiotic dosing for patients who are critically ill: Challenges and potential solutions. Lancet Infect Dis 14:498\u2013509","journal-title":"Lancet Infect Dis"},{"key":"8361_CR292","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/cid\/ciu027","volume":"58","author":"JA Roberts","year":"2014","unstructured":"Roberts JA, Paul SK, Akova M et al (2014) DALI Study: DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis 58:1072\u20131083","journal-title":"Clin Infect Dis"},{"key":"8361_CR293","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13054-018-2155-1","volume":"22","author":"R Veiga","year":"2018","unstructured":"Veiga R, Paiva JA (2018) Pharmacokinetics\u2013pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients. Crit Care 22:233","journal-title":"Crit Care"},{"key":"8361_CR294","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s12028-018-0583-z","volume":"30","author":"NR Nelson","year":"2019","unstructured":"Nelson NR, Morbitzer KA, Jordan JD et al (2019) The impact of capping creatinine clearance on achieving therapeutic vancomycin concentrations in neurocritically ill patients with traumatic brain injury. Neurocrit Care 30:126\u2013131","journal-title":"Neurocrit Care"},{"key":"8361_CR295","first-page":"117","volume":"74","author":"N Gregoire","year":"2019","unstructured":"Gregoire N, Marchand S, Ferrandi\u00e8re M et al (2019) Population pharmacokinetics of daptomycin in critically ill patients with various degrees of renal impairment. J Antimicrob Chemother 74:117\u2013125","journal-title":"J Antimicrob Chemother"},{"key":"8361_CR296","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2165\/11539220-000000000-00000","volume":"50","author":"M Ulldemolins","year":"2011","unstructured":"Ulldemolins M, Roberts JA, Rello J et al (2011) The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients. Clin Pharmacokinet 50:99\u2013110","journal-title":"Clin Pharmacokinet"},{"key":"8361_CR297","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1097\/CCM.0b013e3181aab3d0","volume":"37","author":"G Choi","year":"2009","unstructured":"Choi G, Gomersall CD, Tian Q et al (2009) Principles of antibacterial dosing in continuous renal replacement therapy. Crit Care Med 37:2268\u20132282","journal-title":"Crit Care Med"},{"key":"8361_CR298","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/cid\/ciaa224","volume":"72","author":"JA Roberts","year":"2021","unstructured":"Roberts JA, Joynt GM, Lee A et al (2021) SMARRT Study Collaborators and the ANZICS Clinical Trials Group: the effect of renal replacement therapy and antibiotic dose on antibiotic concentrations in critically ill patients: data from the multinational sampling antibiotics in renal replacement therapy study. Clin Infect Dis 72:1369\u20131378","journal-title":"Clin Infect Dis"},{"key":"8361_CR299","first-page":"493","volume":"38","author":"A Bougle","year":"2019","unstructured":"Bougle A, Dujardin O, Lep\u00e8re V et al (2019) PHARMECMO: Therapeutic drug monitoring and adequacy of current dosing regimens of antibiotics in patients on extracorporeal life support. Anaesth Crit Care Pain Med 38:493\u2013497","journal-title":"Anaesth Crit Care Pain Med"},{"key":"8361_CR300","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/17425255.2019.1563596","volume":"15","author":"V Cheng","year":"2019","unstructured":"Cheng V, Abdul-Aziz MH, Roberts JA et al (2019) Overcoming barriers to optimal drug dosing during ECMO in critically ill adult patients. Expert Opin Drug Metab Toxicol 15:103\u2013112","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"8361_CR301","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","volume":"46","author":"MH Abdul-Aziz","year":"2020","unstructured":"Abdul-Aziz MH, Alffenaar JC, Bassetti M et al (2020) Infection Section of European Society of Intensive Care Medicine (ESICM): antimicrobial therapeutic drug monitoring in critically ill adult patients: a position Paper(). Intensive Care Med 46:1127\u20131153","journal-title":"Intensive Care Med"},{"key":"8361_CR302","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.cmi.2023.03.018","volume":"29","author":"M Sanz-Codina","year":"2023","unstructured":"Sanz-Codina M, Bozkir HO, Jorda A et al (2023) Individualized antimicrobial dose optimization: a systematic review and meta-analysis of randomized controlled trials. Clin Microbiol Infect 29:845\u2013857","journal-title":"Clin Microbiol Infect"},{"key":"8361_CR303","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00134-020-05929-3","volume":"46","author":"N Arulkumaran","year":"2020","unstructured":"Arulkumaran N, Routledge M, Schlebusch S et al (2020) Antimicrobial-associated harm in critical care: a narrative review. Intensive Care Med 46:225\u2013235","journal-title":"Intensive Care Med"},{"key":"8361_CR304","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S1473-3099(16)00065-7","volume":"16","author":"EC Schuts","year":"2016","unstructured":"Schuts EC, Hulscher MEJL, Mouton JW et al (2016) Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect Dis 16:847\u2013856","journal-title":"Lancet Infect Dis"},{"key":"8361_CR305","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/cid\/ciw118","volume":"62","author":"TF Barlam","year":"2016","unstructured":"Barlam TF, Cosgrove SE, Abbo LM et al (2016) Implementing an antibiotic stewardship program: guidelines by the infectious diseases society of America and the society for healthcare epidemiology of America. Clin Infect Dis 62:e51\u2013e77","journal-title":"Clin Infect Dis"},{"key":"8361_CR306","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00134-019-05866-w","volume":"46","author":"A Tabah","year":"2020","unstructured":"Tabah A, Bassetti M, Kollef MH et al (2020) Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European society of intensive care medicine (ESICM) and European society of clinical microbiology and infectious diseases (ESCMID) critically ill patients study group (ESGCIP). Intensive Care Med 46:245\u2013265","journal-title":"Intensive Care Med"},{"key":"8361_CR307","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s00134-014-3411-8","volume":"40","author":"M Leone","year":"2014","unstructured":"Leone M, Bechis C, Baumstarck K et al (2014) AZUREA Network Investigators: de-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial. Intensive Care Med 40:1399\u20131408","journal-title":"Intensive Care Med"},{"key":"8361_CR308","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1473-3099(23)00686-2","volume":"24","author":"LE Lopez-Cortes","year":"2024","unstructured":"Lopez-Cortes LE, Delgado-Valverde M, Moreno-Mellado E et al (2024) SIMPLIFY study group: efficacy and safety of a structured de-escalation from antipseudomonal beta-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial. Lancet Infect Dis 24:375\u2013385","journal-title":"Lancet Infect Dis"},{"key":"8361_CR309","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/cid\/civ1199","volume":"62","author":"A Tabah","year":"2016","unstructured":"Tabah A, Cotta MO, Garnacho-Montero J et al (2016) A systematic review of the definitions, determinants, and clinical outcomes of antimicrobial de-escalation in the intensive care unit. Clin Infect Dis 62:1009\u20131017","journal-title":"Clin Infect Dis"},{"key":"8361_CR310","unstructured":"NICE Organization (2018) Surveillance report 2018\u2014antimicrobial stewardship: systems and processes for effective antimicrobial medicine use (2015) NICE guideline NG15. https:\/\/www.nice.org.uk\/guidance\/ng15\/resources\/surveillance-report-2018-antimicrobial-stewardship-systems-and-processes-for-effective-antimicrobial-medicine-use-2015-nice-guideline-ng15-pdf-6119358364357. Accessed 18 July 2025"},{"key":"8361_CR311","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1007\/s00134-020-06111-5","volume":"46","author":"L De Bus","year":"2020","unstructured":"De Bus L, Depuydt P, Steen J et al (2020) DIANA study group: antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study. Intensive Care Med 46:1404\u20131417","journal-title":"Intensive Care Med"},{"key":"8361_CR312","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00725-23","volume":"67","author":"T Erb","year":"2023","unstructured":"Erb T, Mihai S, Strau\u00df R et al (2023) beta-(1\u21923)-d-glucan- and mannan-guided early termination of antifungal therapy in ICU patients: a randomized controlled study. Antimicrob Agents Chemother 67:e0072523","journal-title":"Antimicrob Agents Chemother"},{"key":"8361_CR313","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13054-020-03265-y","volume":"24","author":"G De Pascale","year":"2020","unstructured":"De Pascale G, Posteraro B, D\u2019Arrigo S et al (2020) (1,3)-Beta-d-glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial. Crit Care 24:550","journal-title":"Crit Care"},{"key":"8361_CR314","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1007\/s00134-017-4932-8","volume":"43","author":"A Rouze","year":"2017","unstructured":"Rouze A, Loridant S, Poissy J et al (2017) S-TAFE study group: biomarker-based strategy for early discontinuation of empirical antifungal treatment in critically ill patients: a randomized controlled trial. Intensive Care Med 43:1668\u20131677","journal-title":"Intensive Care Med"},{"key":"8361_CR315","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1001\/jama.2024.26458","volume":"333","author":"P Dark","year":"2025","unstructured":"Dark P, Hossain A, McAuley DF et al (2025) ADAPT-Sepsis Collaborators: biomarker-guided antibiotic duration for hospitalized patients with suspected sepsis: the ADAPT-sepsis randomized clinical trial. JAMA 333:682\u2013693","journal-title":"JAMA"},{"key":"8361_CR316","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/BF00259435","volume":"10","author":"CP Stoutenbeek","year":"1984","unstructured":"Stoutenbeek CP, van Saene HK, Miranda DR et al (1984) The effect of selective decontamination of the digestive tract on colonisation and infection rate in multiple trauma patients. Intensive Care Med 10:185\u2013192","journal-title":"Intensive Care Med"},{"key":"8361_CR317","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1164\/rccm.200908-1210OC","volume":"181","author":"EA Oostdijk","year":"2010","unstructured":"Oostdijk EA, de Smet AMGA, Blok HEM et al (2010) Ecological effects of selective decontamination on resistant gram-negative bacterial colonization. Am J Respir Crit Care Med 181:452\u2013457","journal-title":"Am J Respir Crit Care Med"},{"key":"8361_CR318","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13054-019-2480-z","volume":"23","author":"S Buitinck","year":"2019","unstructured":"Buitinck S, Jansen R, Rijkenberg S et al (2019) The ecological effects of selective decontamination of the digestive tract (SDD) on antimicrobial resistance: a 21-year longitudinal single-centre study. Crit Care 23:208","journal-title":"Crit Care"},{"key":"8361_CR319","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1001\/jama.2022.19709","volume":"328","author":"NE Hammond","year":"2022","unstructured":"Hammond NE, Myburgh J, Seppelt I et al (2022) Association between selective decontamination of the digestive tract and in-hospital mortality in intensive care unit patients receiving mechanical ventilation: a systematic review and meta-analysis. JAMA 328:1922\u20131934","journal-title":"JAMA"},{"key":"8361_CR320","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1001\/jama.2022.17927","volume":"328","author":"SuDdicu Investigators for the Australian New Zealand Intensive Care Society Clinical Trials, G","year":"2022","unstructured":"SuDdicu Investigators for the Australian New Zealand Intensive Care Society Clinical Trials, G et al (2022) Effect of selective decontamination of the digestive tract on hospital mortality in critically ill patients receiving mechanical ventilation: a randomized clinical trial. JAMA 328:1911\u20131921","journal-title":"JAMA"},{"key":"8361_CR321","unstructured":"Cuthbertson BH, Billot L, Campbell MK et al (2025) Selective decontamination of the digestive tract during ventilation in the ICU. N Engl J Med ( online ahead of print)"},{"key":"8361_CR322","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1097\/ALN.0000000000000008","volume":"120","author":"HB Gershengorn","year":"2014","unstructured":"Gershengorn HB, Garland A, Kramer A et al (2014) Variation of arterial and central venous catheter use in United States intensive care units. Anesthesiology 120:650\u2013664","journal-title":"Anesthesiology"},{"key":"8361_CR323","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1177\/0885066620962450","volume":"36","author":"M Mahendra","year":"2021","unstructured":"Mahendra M, McQuillen P, Dudley RA et al (2021) Variation in arterial and central venous catheter use in pediatric intensive care units. J Intensive Care Med 36:1250\u20131257","journal-title":"J Intensive Care Med"},{"key":"8361_CR324","first-page":"A4783","volume":"209","author":"T Wong","year":"2024","unstructured":"Wong T et al (2024) Pragmatic randomized trial for arterial catheters in the critical care environment (GRACE) [abstract]. Am J Respir Crit Care Med 209:A4783","journal-title":"Am J Respir Crit Care Med"},{"key":"8361_CR325","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1001\/jamainternmed.2014.3297","volume":"174","author":"HB Gershengorn","year":"2014","unstructured":"Gershengorn HB, Wunsch H, Scales DC et al (2014) Association between arterial catheter use and hospital mortality in intensive care units. JAMA Intern Med 174:1746\u20131754","journal-title":"JAMA Intern Med"},{"key":"8361_CR326","doi-asserted-by":"publisher","first-page":"A642","DOI":"10.1016\/j.chest.2020.08.604","volume":"158","author":"A Barros","year":"2020","unstructured":"Barros A, Nguyen H, Lee H et al (2020) Effect of arterial catheter on vasopressor use in patients with shock: a propensity score matching analysis on a multi-center prospective cohort. Chest 158:A642","journal-title":"Chest"},{"key":"8361_CR327","doi-asserted-by":"publisher","first-page":"A336","DOI":"10.1016\/j.chest.2017.08.362","volume":"152","author":"S Rasla","year":"2017","unstructured":"Rasla S, Mohamed A, Qureshi R et al (2017) Association between the use of arterial catheters and hospital outcomes in critically ill patients. Chest 152:A336","journal-title":"Chest"},{"key":"8361_CR328","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12871-022-01722-5","volume":"22","author":"Q Ou","year":"2022","unstructured":"Ou Q, Cai G, Zhou Y et al (2022) Arterial catheterization and in-hospital mortality in sepsis: a propensity score-matched study. BMC Anesthesiol 22:178","journal-title":"BMC Anesthesiol"},{"key":"8361_CR329","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/353628","volume":"2014","author":"S Ribezzo","year":"2014","unstructured":"Ribezzo S, Spina E, Di Bartolomeo S et al (2014) Noninvasive techniques for blood pressure measurement are not a reliable alternative to direct measurement: a randomized crossover trial in ICU. Sci World J 2014:353628","journal-title":"Sci World J"},{"key":"8361_CR330","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/00003246-200002000-00014","volume":"28","author":"A Bur","year":"2000","unstructured":"Bur A, Hirschl MM, Herkner H et al (2000) Accuracy of oscillometric blood pressure measurement according to the relation between cuff size and upper-arm circumference in critically ill patients. Crit Care Med 28:371\u2013376","journal-title":"Crit Care Med"},{"key":"8361_CR331","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1097\/CCM.0b013e31823dae42","volume":"40","author":"K Lakhal","year":"2012","unstructured":"Lakhal K, Macq C, Ehrmann S et al (2012) Noninvasive monitoring of blood pressure in the critically ill: Reliability according to the cuff site (arm, thigh, or ankle). Crit Care Med 40:1207\u20131213","journal-title":"Crit Care Med"},{"key":"8361_CR332","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/MBP.0000000000000258","volume":"22","author":"LE Riley","year":"2017","unstructured":"Riley LE, Chen GJ, Latham HE (2017) Comparison of noninvasive blood pressure monitoring with invasive arterial pressure monitoring in medical ICU patients with septic shock. Blood Press Monit 22:202\u2013207","journal-title":"Blood Press Monit"},{"key":"8361_CR333","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1177\/08850666231225173","volume":"39","author":"EN Haber","year":"2024","unstructured":"Haber EN, Sonti R, Simkovich SM et al (2024) Accuracy of noninvasive blood pressure monitoring in critically ill adults. J Intensive Care Med 39:665\u2013671","journal-title":"J Intensive Care Med"},{"key":"8361_CR334","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1097\/CCM.0000000000005945","volume":"51","author":"K Lakhal","year":"2023","unstructured":"Lakhal K, Dauvergne JE, Kamel T et al (2023) Noninvasive monitoring of arterial pressure: finger or lower leg as alternatives to the upper arm: a prospective study in three ICUs. Crit Care Med 51:1350\u20131362","journal-title":"Crit Care Med"},{"key":"8361_CR335","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jcrc.2020.02.013","volume":"57","author":"T Kaufmann","year":"2020","unstructured":"Kaufmann T, Cox EGM, Wiersema R et al (2020) SICS Study Group: non-invasive oscillometric versus invasive arterial blood pressure measurements in critically ill patients: a post hoc analysis of a prospective observational study. J Crit Care 57:118\u2013123","journal-title":"J Crit Care"},{"key":"8361_CR336","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10877-020-00482-2","volume":"35","author":"AS Meidert","year":"2021","unstructured":"Meidert AS, Dolch ME, M\u00fchlbauer K et al (2021) Oscillometric versus invasive blood pressure measurement in patients with shock: a prospective observational study in the emergency department. J Clin Monit Comput 35:387\u2013393","journal-title":"J Clin Monit Comput"},{"key":"8361_CR337","doi-asserted-by":"publisher","first-page":"173","DOI":"10.5847\/wjem.j.1920-8642.2023.035","volume":"14","author":"E Engelbrecht-Wiggans","year":"2023","unstructured":"Engelbrecht-Wiggans E, Palmer J, Hollis G et al (2023) Most patients with non-hypertensive diseases at a critical care resuscitation unit require arterial pressure monitoring: a prospective observational study. World J Emerg Med 14:173\u2013178","journal-title":"World J Emerg Med"},{"key":"8361_CR338","doi-asserted-by":"publisher","first-page":"P139","DOI":"10.1186\/cc8371","volume":"14","author":"SK Macedo","year":"2010","unstructured":"Macedo SK, Bissoli T, Dias LC et al (2010) Comparative study to evaluate blood pressure levels measured by an invasive method versus a non-invasive method in patients in an intensive care unit. Crit Care 14:P139","journal-title":"Crit Care"},{"key":"8361_CR339","first-page":"92","volume":"7","author":"L Tijsma","year":"2019","unstructured":"Tijsma L et al (2019) Non-invasive blood pressure measurements versus invasive blood pressure measurements in critically ill patients with shock. Intensive Care Med Exp 7:92","journal-title":"Intensive Care Med Exp"},{"key":"8361_CR340","doi-asserted-by":"publisher","first-page":"358","DOI":"10.5811\/westjem.2022.1.53211","volume":"23","author":"QK Tran","year":"2022","unstructured":"Tran QK, Gelmann D, Alam Z et al (2022) Discrepancy between invasive and noninvasive blood pressure measurements in patients with sepsis by vasopressor status. West J Emerg Med 23:358\u2013367","journal-title":"West J Emerg Med"},{"key":"8361_CR341","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1056\/NEJMoa2502136","volume":"393","author":"G Muller","year":"2025","unstructured":"Muller G, Contou D, Ehrmann S et al (2025) Deferring arterial catheterization in critically ill patients with shock. N Engl J Med 393:1875\u20131888","journal-title":"N Engl J Med"},{"key":"8361_CR342","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0176292","volume":"12","author":"NE Hammond","year":"2017","unstructured":"Hammond NE, Taylor C, Finfer S et al (2017) Fluid-TRIPS and Fluidos Investigators: patterns of intravenous fluid resuscitation use in adult intensive care patients between 2007 and 2014: an international cross-sectional study. PLoS ONE 12:e0176292","journal-title":"PLoS ONE"},{"key":"8361_CR343","doi-asserted-by":"publisher","first-page":"2100010","DOI":"10.1056\/EVIDoa2100010","volume":"1","author":"NE Hammond","year":"2022","unstructured":"Hammond NE, Zampieri FG, Di Tanna GL et al (2022) Balanced crystalloids versus saline in critically ill adults\u2014a systematic review with meta-analysis. NEJM Evid 1:2100010","journal-title":"NEJM Evid"},{"key":"8361_CR344","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S2213-2600(23)00417-4","volume":"12","author":"FG Zampieri","year":"2024","unstructured":"Zampieri FG, Cavalcanti AB, Di Tanna GL et al (2024) Balanced crystalloids versus saline for critically ill patients (BEST-Living): a systematic review and individual patient data meta-analysis. Lancet Respir Med 12:237\u2013246","journal-title":"Lancet Respir Med"},{"key":"8361_CR345","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1711584","volume":"378","author":"MW Semler","year":"2018","unstructured":"Semler MW, Self WH, Wanderer JP et al (2018) SMART Investigators and the Pragmatic Critical Care Research Group: balanced crystalloids versus saline in critically ill adults. N Engl J Med 378:829\u2013839","journal-title":"N Engl J Med"},{"key":"8361_CR346","first-page":"1","volume":"326","author":"FG Zampieri","year":"2021","unstructured":"Zampieri FG, Machado FR, Biondi RS et al (2021) BaSICS Investigators and the BRICNet Members: effect of intravenous fluid treatment with a balanced Solution vs 0.9% saline solution on mortality in critically ill patients: the BaSICS randomized clinical trial. JAMA 326:1\u201312","journal-title":"JAMA"},{"key":"8361_CR347","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1056\/NEJMoa2114464","volume":"386","author":"S Finfer","year":"2022","unstructured":"Finfer S, Micallef S, Hammond N, PLUS Study Investigators and the Australian New Zealand Intensive Care Society Clinical Trials Group et al (2022) Balanced multielectrolyte solution versus saline in critically ill adults. N Engl J Med 386:815\u2013826","journal-title":"N Engl J Med"},{"key":"8361_CR348","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.chest.2020.08.2068","volume":"159","author":"KE Jackson","year":"2021","unstructured":"Jackson KE, Wang L, Casey JD, SMART Investigators and the Pragmatic Critical Care Research Group et al (2021) Effect of early balanced crystalloids before ICU admission on sepsis outcomes. Chest 159:585\u2013595","journal-title":"Chest"},{"key":"8361_CR349","doi-asserted-by":"publisher","first-page":"e1140","DOI":"10.1097\/CCM.0000000000006601","volume":"53","author":"G Gelbenegger","year":"2025","unstructured":"Gelbenegger G, Shapiro NI, Zeitlinger M et al (2025) Lactated ringer\u2019s or normal saline for initial fluid resuscitation in sepsis-induced hypotension. Crit Care Med 53:e1140\u2013e1144","journal-title":"Crit Care Med"},{"key":"8361_CR350","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1164\/rccm.202111-2484OC","volume":"205","author":"FG Zampieri","year":"2022","unstructured":"Zampieri FG, Machado FR, Biondi RS et al (2022) Association between type of fluid received prior to enrollment, type of admission, and effect of balanced crystalloid in critically ill adults: a secondary exploratory analysis of the BaSICS clinical trial. Am J Respir Crit Care Med 205:1419\u20131428","journal-title":"Am J Respir Crit Care Med"},{"key":"8361_CR351","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMoa1305727","volume":"370","author":"P Caironi","year":"2014","unstructured":"Caironi P, Tognoni G, Masson S, ALBIOS Study Investigators et al (2014) Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 370:1412\u20131421","journal-title":"N Engl J Med"},{"key":"8361_CR352","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000040983","volume":"103","author":"Z Bai","year":"2024","unstructured":"Bai Z, Lai Y, Han K et al (2024) Human albumin for adults with sepsis: an updated systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore) 103:e40983","journal-title":"Medicine (Baltimore)"},{"key":"8361_CR353","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1177\/08850666231170778","volume":"38","author":"L Geng","year":"2023","unstructured":"Geng L, Tian X, Gao Z et al (2023) Different concentrations of albumin versus crystalloid in patients with sepsis and septic shock: A meta-analysis of randomized clinical trials. J Intensive Care Med 38:679\u2013689","journal-title":"J Intensive Care Med"},{"key":"8361_CR354","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1177\/17511437241259437","volume":"25","author":"J Bannard-Smith","year":"2024","unstructured":"Bannard-Smith J, Elrakhawy M, Norman G et al (2024) The efficacy, safety and effectiveness of hyperoncotic albumin solutions in patients with sepsis: a systematic review and meta-analysis. J Intensive Care Soc 25:308\u2013318","journal-title":"J Intensive Care Soc"},{"key":"8361_CR355","first-page":"275","volume":"19","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chen K, Li X et al (2024) Clinical efficacy of various resuscitation fluids in the management of sepsis in postoperative surgical and trauma patients: a systematic review and meta-analysis. Wideochir Inne Tech Maloinwazyjne 19:275\u2013288","journal-title":"Wideochir Inne Tech Maloinwazyjne"},{"key":"8361_CR356","doi-asserted-by":"publisher","first-page":"5919","DOI":"10.3390\/jcm12185919","volume":"12","author":"CJ Wiedermann","year":"2023","unstructured":"Wiedermann CJ (2023) Human albumin infusion in critically ill and perioperative patients: narrative rapid review of meta-analyses from the last five years. J Clin Med 12:5919","journal-title":"J Clin Med"},{"key":"8361_CR357","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.chest.2024.02.049","volume":"166","author":"J Callum","year":"2024","unstructured":"Callum J, Skubas NJ, Bathla A et al (2024) International Collaboration for Transfusion Medicine Guidelines Intravenous Albumin Guideline Group: Use of intravenous albumin: a guideline from the international collaboration for transfusion medicine guidelines. Chest 166:321\u2013338","journal-title":"Chest"},{"key":"8361_CR358","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jhep.2022.03.043","volume":"77","author":"R Maiwall","year":"2022","unstructured":"Maiwall R, Kumar A, Pasupuleti SSR et al (2022) A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial]. J Hepatol 77:670\u2013682","journal-title":"J Hepatol"},{"key":"8361_CR359","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1097\/CCM.0000000000006348","volume":"52","author":"AJ Gray","year":"2024","unstructured":"Gray AJ, Oatey K, Grahamslaw J, Albumin, Balanced, and Crystalloid-Sepsis (ABC-Sepsis) Investigators et al (2024) Albumin versus balanced crystalloid for the early resuscitation of sepsis: an open parallel-group randomized feasibility trial\u2014the ABC-sepsis trial. Crit Care Med 52:1520\u20131532","journal-title":"Crit Care Med"},{"key":"8361_CR360","doi-asserted-by":"publisher","first-page":"e798","DOI":"10.1097\/CCM.0000000000003900","volume":"47","author":"CHL Park","year":"2019","unstructured":"Park CHL, de Almeida JP, de Oliveira GQ et al (2019) Lactated ringer\u2019s versus 4% albumin on lactated ringer\u2019s in early sepsis therapy in cancer patients: a pilot single-center randomized trial. Crit Care Med 47:e798\u2013e805","journal-title":"Crit Care Med"},{"key":"8361_CR361","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1001\/jama.2013.280502","volume":"310","author":"D Annane","year":"2013","unstructured":"Annane D, Siami S, Jaber S, CRISTAL Investigators et al (2013) Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA 310:1809\u20131817","journal-title":"JAMA"},{"key":"8361_CR362","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1056\/NEJMoa040232","volume":"350","author":"S Finfer","year":"2004","unstructured":"Finfer S, Bellomo R, Boyce N, SAFE Study Investigators et al (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350:2247\u20132256","journal-title":"N Engl J Med"},{"key":"8361_CR363","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1213\/ANE.0000000000007368","volume":"141","author":"JC Diz","year":"2025","unstructured":"Diz JC, Luna-Rojas P, D\u00edaz-Vidal P et al (2025) Effect of treatment with balanced crystalloids versus normal saline on the mortality of critically ill patients with and without traumatic brain injury: a systematic review and meta-analysis. Anesth Analg 141:152\u2013161","journal-title":"Anesth Analg"},{"key":"8361_CR364","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1056\/NEJMoa067514","volume":"357","author":"SS Investigators","year":"2007","unstructured":"Investigators SS et al (2007) Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 357:874\u2013884","journal-title":"N Engl J Med"},{"key":"8361_CR365","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s12072-021-10164-z","volume":"15","author":"CA Philips","year":"2021","unstructured":"Philips CA, Maiwall R, Sharma MK et al (2021) Comparison of 5% human albumin and normal saline for fluid resuscitation in sepsis induced hypotension among patients with cirrhosis (FRISC study): a randomized controlled trial. Hepatol Int 15:983\u2013994","journal-title":"Hepatol Int"},{"key":"8361_CR366","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jcrc.2018.11.031","volume":"50","author":"GS Martin","year":"2019","unstructured":"Martin GS, Bassett P (2019) Crystalloids vs. colloids for fluid resuscitation in the intensive care unit: a systematic review and meta-analysis. J Crit Care 50:144\u2013154","journal-title":"J Crit Care"},{"key":"8361_CR367","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00134-024-07369-9","volume":"50","author":"YM Arabi","year":"2024","unstructured":"Arabi YM, Belley-Cote E, Carsetti A et al (2024) European Society of Intensive Care Medicine: European Society of Intensive Care Medicine clinical practice guideline on fluid therapy in adult critically ill patients. Part 1: the choice of resuscitation fluids. Intensive Care Med 50:813\u2013831","journal-title":"Intensive Care Med"},{"key":"8361_CR368","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1378\/chest.15-1525","volume":"148","author":"C Chen","year":"2015","unstructured":"Chen C, Kollef MH (2015) Targeted fluid minimization following initial resuscitation in septic shock: a pilot study. Chest 148:1462\u20131469","journal-title":"Chest"},{"key":"8361_CR369","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1097\/CCM.0000000000003779","volume":"47","author":"KA Corl","year":"2019","unstructured":"Corl KA, Prodromou M, Merchant RC et al (2019) The restrictive IV fluid trial in severe sepsis and septic shock (RIFTS): a randomized pilot study. Crit Care Med 47:951\u2013959","journal-title":"Crit Care Med"},{"key":"8361_CR370","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s00134-016-4500-7","volume":"42","author":"PB Hjortrup","year":"2016","unstructured":"Hjortrup PB, Haase N, Bundgaard H, CLASSIC Trial Group et al (2016) Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial. Intensive Care Med 42:1695\u20131705","journal-title":"Intensive Care Med"},{"key":"8361_CR371","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1007\/s00134-018-5433-0","volume":"44","author":"SPJ Macdonald","year":"2018","unstructured":"Macdonald SPJ, Keijzers G, Taylor DM et al (2018) REFRESH trial investigators: restricted fluid resuscitation in suspected sepsis associated hypotension (REFRESH): a pilot randomised controlled trial. Intensive Care Med 44:2070\u20132078","journal-title":"Intensive Care Med"},{"key":"8361_CR372","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1177\/0885066618823183","volume":"35","author":"MW Semler","year":"2020","unstructured":"Semler MW, Janz DR, Casey JD et al (2020) Conservative fluid management after sepsis resuscitation: a pilot randomized trial. J Intensive Care Med 35:1374\u20131382","journal-title":"J Intensive Care Med"},{"key":"8361_CR373","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/acem.14546","volume":"29","author":"MK Jessen","year":"2022","unstructured":"Jessen MK, Andersen LW, Thomsen MH et al (2022) Restrictive fluids versus standard care in adults with sepsis in the emergency department (REFACED): a multicenter, randomized feasibility trial. Acad Emerg Med 29:1172\u20131184","journal-title":"Acad Emerg Med"},{"key":"8361_CR374","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1056\/NEJMoa2202707","volume":"386","author":"TS Meyhoff","year":"2022","unstructured":"Meyhoff TS, Hjortrup PB, Wetterslev J, CLASSIC Trial Group et al (2022) Restriction of intravenous fluid in ICU patients with septic shock. N Engl J Med 386:2459\u20132470","journal-title":"N Engl J Med"},{"key":"8361_CR375","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1097\/CCM.0000000000002554","volume":"45","author":"JM Bednarczyk","year":"2017","unstructured":"Bednarczyk JM, Fridfinnson JA, Kumar A et al (2017) Incorporating dynamic assessment of fluid responsiveness into goal-directed therapy: a systematic review and meta-analysis. Crit Care Med 45:1538\u20131545","journal-title":"Crit Care Med"},{"key":"8361_CR376","volume":"1","author":"RR Ehrman","year":"2019","unstructured":"Ehrman RR, Gallien JZ, Smith RK et al (2019) Resuscitation guided by volume responsiveness does not reduce mortality in sepsis: a meta-analysis. Crit Care Explor 1:e0015","journal-title":"Crit Care Explor"},{"key":"8361_CR377","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1177\/08850666211019713","volume":"37","author":"M Azadian","year":"2022","unstructured":"Azadian M, Win S, Abdipour A et al (2022) Mortality benefit from the passive leg raise maneuver in guiding resuscitation of septic shock patients: a systematic review and meta-analysis of randomized trials. J Intensive Care Med 37:611\u2013617","journal-title":"J Intensive Care Med"},{"key":"8361_CR378","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.chest.2020.04.025","volume":"158","author":"IS Douglas","year":"2020","unstructured":"Douglas IS, Alapat PM, Corl KA et al (2020) Fluid response evaluation in sepsis hypotension and shock: a randomized clinical trial. Chest 158:1431\u20131445","journal-title":"Chest"},{"key":"8361_CR379","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1097\/CCM.0000000000006399","volume":"52","author":"J Basmaji","year":"2024","unstructured":"Basmaji J, Arntfield R, Desai K et al (2024) The impact of point-of-care ultrasound-guided resuscitation on clinical outcomes in patients with shock: a systematic review and meta-analysis. Crit Care Med 52:1661\u20131673","journal-title":"Crit Care Med"},{"key":"8361_CR380","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1113\/jphysiol.1897.sp000684","volume":"22","author":"GN Stewart","year":"1897","unstructured":"Stewart GN (1897) Researches on the circulation time and on the influences which affect it. J Physiol 22:159\u2013183","journal-title":"J Physiol"},{"key":"8361_CR381","first-page":"153","volume":"39","author":"G Fegler","year":"1954","unstructured":"Fegler G (1954) Measurement of cardiac output in anaesthetized animals by a thermodilution method. Q J Exp Physiol Cogn Med Sci 39:153\u2013164","journal-title":"Q J Exp Physiol Cogn Med Sci"},{"key":"8361_CR382","first-page":"290","volume":"36","author":"A Fick","year":"1870","unstructured":"Fick A (1870) Uber die messung des Blutquantums in den Hertzvent rikeln. Sitzber Physik Med Ges Wurzburg 36:290\u2013291","journal-title":"Sitzber Physik Med Ges Wurzburg"},{"key":"8361_CR383","doi-asserted-by":"publisher","first-page":"769","DOI":"10.14740\/jocmr2719w","volume":"8","author":"D Velissaris","year":"2016","unstructured":"Velissaris D, Karamouzos V, Kotroni I et al (2016) The use of pulmonary artery catheter in sepsis patients: a literature review. J Clin Med Res 8:769\u2013776","journal-title":"J Clin Med Res"},{"key":"8361_CR384","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1001\/jama.294.13.1664","volume":"294","author":"MR Shah","year":"2005","unstructured":"Shah MR, Hasselblad V, Stevenson LW et al (2005) Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials. JAMA 294:1664\u20131670","journal-title":"JAMA"},{"key":"8361_CR385","first-page":"340","volume":"28","author":"VK Arya","year":"2022","unstructured":"Arya VK, Al-Moustadi W, Dutta V (2022) Cardiac output monitoring\u2014invasive and noninvasive. Curr Opin Crit Care 28:340\u2013347","journal-title":"Curr Opin Crit Care"},{"issue":"Suppl 3","key":"8361_CR386","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1186\/cc4834","volume":"10","author":"M Hadian","year":"2006","unstructured":"Hadian M, Pinsky MR (2006) Evidence-based review of the use of the pulmonary artery catheter: impact data and complications. Crit Care 10(Suppl 3):S8","journal-title":"Crit Care"},{"key":"8361_CR387","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40560-018-0356-y","volume":"7","author":"TG Scully","year":"2019","unstructured":"Scully TG, Grealy R, McLean AS et al (2019) Calibrated cardiac output monitoring versus standard care for fluid management in the shocked ICU patient: a pilot randomised controlled trial. J Intensive Care 7:1","journal-title":"J Intensive Care"},{"key":"8361_CR388","first-page":"486","volume":"29","author":"S Ma","year":"2017","unstructured":"Ma S, Zhang R, Wang S et al (2017) Effect of global end diastolic volume index guidance fluid resuscitation in elderly patients with septic shock. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 29:486\u2013490","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"8361_CR389","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.ajem.2015.04.031","volume":"33","author":"NF Lu","year":"2015","unstructured":"Lu NF, Zheng R-Q, Lin H et al (2015) Improved sepsis bundles in the treatment of septic shock: a prospective clinical study. Am J Emerg Med 33:1045\u20131049","journal-title":"Am J Emerg Med"},{"key":"8361_CR390","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/SHK.0000000000000564","volume":"46","author":"PC Hou","year":"2016","unstructured":"Hou PC, Filbin MR, Napoli A et al (2016) Cardiac output monitoring managing intravenous therapy (COMMIT) to treat emergency department patients with sepsis. Shock 46:132\u2013138","journal-title":"Shock"},{"key":"8361_CR391","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.annemergmed.2015.09.010","volume":"67","author":"WS Kuan","year":"2016","unstructured":"Kuan WS, Ibrahim I, Leong BSH et al (2016) Emergency department management of sepsis patients: a randomized, goal-oriented, noninvasive sepsis trial. Ann Emerg Med 67:367-378.e3","journal-title":"Ann Emerg Med"},{"key":"8361_CR392","doi-asserted-by":"publisher","first-page":"e447","DOI":"10.1097\/CCM.0000000000006530","volume":"53","author":"JL Diaz-Gomez","year":"2025","unstructured":"Diaz-Gomez JL, Sharif S, Ablordeppey E et al (2025) Society of critical care medicine guidelines on adult critical care ultrasonography: focused update 2024. Crit Care Med 53:e447\u2013e458","journal-title":"Crit Care Med"},{"key":"8361_CR393","first-page":"315","volume":"12","author":"B Levy","year":"2006","unstructured":"Levy B (2006) Lactate and shock state: the metabolic view. Curr Opin Crit Care 12:315\u2013321","journal-title":"Curr Opin Crit Care"},{"key":"8361_CR394","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12967-018-1700-7","volume":"16","author":"XF Ding","year":"2018","unstructured":"Ding XF, Yang Z-Y, Xu Z-T et al (2018) Early goal-directed and lactate-guided therapy in adult patients with severe sepsis and septic shock: a meta-analysis of randomized controlled trials. J Transl Med 16:331","journal-title":"J Transl Med"},{"key":"8361_CR395","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014453","volume":"98","author":"J Pan","year":"2019","unstructured":"Pan J, Peng M, Liao C et al (2019) Relative efficacy and safety of early lactate clearance-guided therapy resuscitation in patients with sepsis: a meta-analysis. Medicine (Baltim) 98:e14453","journal-title":"Medicine (Baltim)"},{"key":"8361_CR396","doi-asserted-by":"publisher","DOI":"10.1002\/ams2.914","volume":"10","author":"T Yumoto","year":"2023","unstructured":"Yumoto T, Kuribara T, Yamada K et al (2023) Clinical parameter-guided initial resuscitation in adult patients with septic shock: a systematic review and network meta-analysis. Acute Med Surg 10:e914","journal-title":"Acute Med Surg"},{"key":"8361_CR397","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1007\/s00134-015-3955-2","volume":"41","author":"WJ Gu","year":"2015","unstructured":"Gu WJ, Zhang Z, Bakker J (2015) Early lactate clearance-guided therapy in patients with sepsis: a meta-analysis with trial sequential analysis of randomized controlled trials. Intensive Care Med 41:1862\u20131863","journal-title":"Intensive Care Med"},{"key":"8361_CR398","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jcrc.2016.06.017","volume":"36","author":"SQ Simpson","year":"2016","unstructured":"Simpson SQ, Gaines M, Hussein Y et al (2016) Early goal-directed therapy for severe sepsis and septic shock: a living systematic review. J Crit Care 36:43\u201348","journal-title":"J Crit Care"},{"key":"8361_CR399","first-page":"559","volume":"21","author":"I Baelani","year":"2012","unstructured":"Baelani I, Jochberger S, Laimer T et al (2012) Identifying resource needs for sepsis care and guideline implementation in the Democratic Republic of the Congo: a cluster survey of 66 hospitals in four eastern provinces. Middle East J Anaesthesiol 21:559\u2013575","journal-title":"Middle East J Anaesthesiol"},{"key":"8361_CR400","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1001\/jama.2019.0071","volume":"321","author":"G Hernandez","year":"2019","unstructured":"Hernandez G, Ospina-Tasc\u00f3n GA, Damiani LP, ANDROMEDA SHOCK Investigators and the Latin America Intensive Care Network (LIVEN) et al (2019) The effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: the ANDROMEDA-SHOCK randomized clinical trial. JAMA 321:654\u2013664","journal-title":"JAMA"},{"key":"8361_CR401","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S1473-3099(17)30453-X","volume":"17","author":"GS Shrestha","year":"2017","unstructured":"Shrestha GS, Kwizera A, Lundeg G et al (2017) International Surviving Sepsis Campaign Guidelines 2016: the perspective from low-income and middle-income countries. Lancet Infect Dis 17:893\u2013895","journal-title":"Lancet Infect Dis"},{"key":"8361_CR402","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13054-025-05285-y","volume":"29","author":"A Morin","year":"2025","unstructured":"Morin A, Missri L, Urbina T et al (2025) Relationship between skin microvascular blood flow and capillary refill time in critically ill patients. Crit Care 29:57","journal-title":"Crit Care"},{"key":"8361_CR403","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s00134-024-07361-3","volume":"50","author":"G Hernandez","year":"2024","unstructured":"Hernandez G, Carmona P, Ait-Oufella H (2024) Monitoring capillary refill time in septic shock. Intensive Care Med 50:580\u2013582","journal-title":"Intensive Care Med"},{"key":"8361_CR404","doi-asserted-by":"crossref","unstructured":"Hansen M, Gillespie J, Riddick T et al (2023) Evaluation of electronic measurement of capillary refill for sepsis screening at ED triage. Am J Emerg Med 70:61\u201365","DOI":"10.1016\/j.ajem.2023.05.009"},{"key":"8361_CR405","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.ajem.2018.07.010","volume":"37","author":"R Jouffroy","year":"2019","unstructured":"Jouffroy R, Saade A, Tourtier JP et al (2019) Skin mottling score and capillary refill time to assess mortality of septic shock since pre-hospital setting. Am J Emerg Med 37:664\u2013671","journal-title":"Am J Emerg Med"},{"key":"8361_CR406","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ajem.2024.01.041","volume":"79","author":"M Wang","year":"2024","unstructured":"Wang M, Tong M, Tian Z (2024) Prolonged capillary refill time and short-term mortality of critically ill patients: a meta-analysis. Am J Emerg Med 79:127\u2013135","journal-title":"Am J Emerg Med"},{"key":"8361_CR407","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1177\/08850666231168038","volume":"38","author":"Z Putowski","year":"2023","unstructured":"Putowski Z, Go\u0142dyn M, Pluta MP et al (2023) Correlation between mean arterial pressure and capillary refill time in patients with septic shock: a systematic review and meta-analysis. J Intensive Care Med 38:838\u2013846","journal-title":"J Intensive Care Med"},{"key":"8361_CR408","doi-asserted-by":"publisher","first-page":"5782","DOI":"10.3390\/jcm13195782","volume":"13","author":"F Wesolek","year":"2024","unstructured":"Wesolek F, Putowski Z, Staniszewska W et al (2024) Capillary refill time as a part of routine physical examination in critically ill patients undergoing vasoactive therapy: a prospective study. J Clin Med 13:5782","journal-title":"J Clin Med"},{"key":"8361_CR409","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13613-022-01049-x","volume":"12","author":"L Raia","year":"2022","unstructured":"Raia L, Gabarre P, Bonny V et al (2022) Kinetics of capillary refill time after fluid challenge. Ann Intensive Care 12:74","journal-title":"Ann Intensive Care"},{"key":"8361_CR410","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13613-020-00767-4","volume":"10","author":"R Castro","year":"2020","unstructured":"Castro R, Kattan E, Ferri G et al (2020) Effects of capillary refill time-vs. lactate-targeted fluid resuscitation on regional, microcirculatory and hypoxia-related perfusion parameters in septic shock: a randomized controlled trial. Ann Intensive Care 10:150","journal-title":"Ann Intensive Care"},{"key":"8361_CR411","doi-asserted-by":"publisher","first-page":"96","DOI":"10.5935\/0103-507X.20220004-en","volume":"34","author":"E Kattan","year":"2022","unstructured":"Kattan E, Bakker J, Estenssoro E et al (2022) Hemodynamic phenotype-based, capillary refill time-targeted resuscitation in early septic shock: the ANDROMEDA-SHOCK-2 randomized clinical trial study protocol. Rev Bras Ter Intensiva 34:96\u2013106","journal-title":"Rev Bras Ter Intensiva"},{"key":"8361_CR412","doi-asserted-by":"crossref","unstructured":"Andromeda-Shock-2 Investigators for the Andromeda Research Network, S.S.o.A.R. et al (2025) Personalized hemodynamic resuscitation targeting capillary refill time in early septic shock: the ANDROMEDA-SHOCK-2 randomized clinical trial. JAMA 334:1988\u20131999","DOI":"10.1001\/jama.2025.20962"},{"key":"8361_CR413","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/cc8224","volume":"15","author":"JA Russell","year":"2011","unstructured":"Russell JA (2011) Bench-to-bedside review: vasopressin in the management of septic shock. Crit Care 15:226","journal-title":"Crit Care"},{"key":"8361_CR414","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/jama.2016.10485","volume":"316","author":"AC Gordon","year":"2016","unstructured":"Gordon AC, Mason AJ, Thirunavukkarasu N, VANISH Investigators et al (2016) Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA 316:509\u2013518","journal-title":"JAMA"},{"key":"8361_CR415","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1097\/CCM.0000000000004023","volume":"47","author":"LA Hajjar","year":"2019","unstructured":"Hajjar LA, Zambolim C, Belletti A et al (2019) Vasopressin versus norepinephrine for the management of septic shock in cancer patients: the VANCS II randomized clinical trial. Crit Care Med 47:1743\u20131750","journal-title":"Crit Care Med"},{"key":"8361_CR416","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1056\/NEJMoa1704154","volume":"377","author":"A Khanna","year":"2017","unstructured":"Khanna A, English SW, Wang XS, ATHOS-3 Investigators et al (2017) Angiotensin II for the treatment of vasodilatory shock. N Engl J Med 377:419\u2013430","journal-title":"N Engl J Med"},{"key":"8361_CR417","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s13054-014-0534-9","volume":"18","author":"LS Chawla","year":"2014","unstructured":"Chawla LS, Busse L, Brasha-Mitchell E et al (2014) Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study. Crit Care 18:534","journal-title":"Crit Care"},{"key":"8361_CR418","unstructured":"Drugs.com. Comparing levophed vs vasopressin. https:\/\/www.drugs.com\/compare\/levophed-vs-vasopressin Accessted 22 July 2025"},{"key":"8361_CR419","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa067373","volume":"358","author":"JA Russell","year":"2008","unstructured":"Russell JA, Walley KR, Singer J, VASST Investigators et al (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358:877\u2013887","journal-title":"N Engl J Med"},{"key":"8361_CR420","first-page":"15","volume":"54","author":"E Barzegar","year":"2016","unstructured":"Barzegar E, Ahmadi A, Mousavi S et al (2016) The therapeutic role of vasopressin on improving lactate clearance during and after vasogenic shock: microcirculation, is it the black box? Acta Med Iran 54:15\u201323","journal-title":"Acta Med Iran"},{"key":"8361_CR421","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1161\/01.CIR.0000066692.71008.BB","volume":"107","author":"MW Dunser","year":"2003","unstructured":"Dunser MW, Mayr AJ, Ulmer H et al (2003) Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 107:2313\u20132319","journal-title":"Circulation"},{"key":"8361_CR422","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/phar.2105","volume":"38","author":"DA Hammond","year":"2018","unstructured":"Hammond DA, Ficek OA, Painter JT et al (2018) Prospective open-label trial of early concomitant vasopressin and norepinephrine therapy versus initial norepinephrine monotherapy in septic shock. Pharmacotherapy 38:531\u2013538","journal-title":"Pharmacotherapy"},{"key":"8361_CR423","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1007\/s00134-006-0378-0","volume":"32","author":"F Lauzier","year":"2006","unstructured":"Lauzier F, L\u00e9vy B, Lamarre P et al (2006) Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial. Intensive Care Med 32:1782\u20131789","journal-title":"Intensive Care Med"},{"key":"8361_CR424","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1097\/00005373-199910000-00014","volume":"47","author":"MB Malay","year":"1999","unstructured":"Malay MB, Ashton RC, Landry DW et al (1999) Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 47:699\u2013703 (discussion 703)","journal-title":"J Trauma"},{"issue":"Suppl 1","key":"8361_CR425","doi-asserted-by":"publisher","first-page":"P158","DOI":"10.1186\/cc13348","volume":"18","author":"S Oliveira","year":"2014","unstructured":"Oliveira S, Dessa F, Rocha C et al (2014) Early vasopressin application in shock study. Crit Care 18(Suppl 1):P158","journal-title":"Crit Care"},{"key":"8361_CR426","first-page":"114","volume":"13","author":"NJF Ruiz","year":"2013","unstructured":"Fonseca-Ruiz NJ, Cano AL, Carmona DPO et al (2013) Uso de vasopresina en pacientes con choque s\u00e9ptico refractario a catecolaminas. Estudio piloto Acta Colombiana de Cuidado Intensivo 13:114\u2013123","journal-title":"Estudio pilotoActa Colombiana de Cuidado Intensivo"},{"key":"8361_CR427","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1007\/s00134-019-05620-2","volume":"45","author":"M Nagendran","year":"2019","unstructured":"Nagendran M, Russell JA, Walley KR et al (2019) Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials. Intensive Care Med 45:844\u2013855","journal-title":"Intensive Care Med"},{"key":"8361_CR428","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1001\/jama.2025.3046","volume":"333","author":"A Kalimouttou","year":"2025","unstructured":"Kalimouttou A, Kennedy JN, Feng J et al (2025) Optimal vasopressin initiation in septic shock: the OVISS reinforcement learning study. JAMA 333:1688\u20131698","journal-title":"JAMA"},{"key":"8361_CR429","doi-asserted-by":"publisher","first-page":"535","DOI":"10.21037\/atm.2019.09.134","volume":"7","author":"C Chen","year":"2019","unstructured":"Chen C, Pang L, Wang Y et al (2019) Combination era, using combined vasopressors showed benefits in treating septic shock patients: a network meta-analysis of randomized controlled trials. Ann Transl Med 7:535","journal-title":"Ann Transl Med"},{"key":"8361_CR430","doi-asserted-by":"publisher","first-page":"794","DOI":"10.21037\/atm.2020.04.24","volume":"8","author":"R Shi","year":"2020","unstructured":"Shi R, Hamzaoui O, De Vita N et al (2020) Vasopressors in septic shock: Which, when, and how much? Ann Transl Med 8:794","journal-title":"Ann Transl Med"},{"key":"8361_CR431","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1007\/s00134-008-1219-0","volume":"34","author":"JA Myburgh","year":"2008","unstructured":"Myburgh JA, Higgins A, Jovanovska A, CAT Study Investigators et al (2008) A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 34:2226\u20132234","journal-title":"Intensive Care Med"},{"key":"8361_CR432","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jcrc.2016.08.010","volume":"37","author":"A Belletti","year":"2017","unstructured":"Belletti A, Benedetto U, Biondi-Zoccai G et al (2017) The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials. J Crit Care 37:91\u201398","journal-title":"J Crit Care"},{"key":"8361_CR433","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1097\/SHK.0000000000002193","volume":"60","author":"L Jia","year":"2023","unstructured":"Jia L, Wang P, Li C et al (2023) The efficacy and safety of vasopressors for septic shock patients: a systemic review and network meta-analysis. Shock 60:746\u2013752","journal-title":"Shock"},{"key":"8361_CR434","volume":"6","author":"SM Fernando","year":"2024","unstructured":"Fernando SM, Tran A, Soliman K et al (2024) Methylene blue in septic shock: a systematic review and meta-analysis. Crit Care Explor 6:e1110","journal-title":"Crit Care Explor"},{"key":"8361_CR435","doi-asserted-by":"publisher","first-page":"1431321","DOI":"10.3389\/fmed.2024.1431321","volume":"11","author":"F Luis-Silva","year":"2024","unstructured":"Luis-Silva F, Menegueti MG, Peres LM et al (2024) Methylene blue therapy in addition to standard treatment for acute-phase septic shock: a pilot randomized controlled trial. Front Med (Lausanne) 11:1431321","journal-title":"Front Med (Lausanne)"},{"key":"8361_CR436","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/01.ccm.0000510127.34774.13","volume":"44","author":"H Yune","year":"2016","unstructured":"Yune H, Kim K, Jo YH et al (2016) 1453: Infusion of methylene blue in severe sepsis and septic shock: a randomized controlled trial. Crit Care Med 44:439\u2013439","journal-title":"Crit Care Med"},{"key":"8361_CR437","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/01.CCM.0000105581.01815.C6","volume":"32","author":"A Lopez","year":"2004","unstructured":"Lopez A, Lorente JA, Steingrub J et al (2004) Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 32:21\u201330","journal-title":"Crit Care Med"},{"key":"8361_CR438","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13054-023-04397-7","volume":"27","author":"M Ibarra-Estrada","year":"2023","unstructured":"Ibarra-Estrada M, Kattan E, Aguilera-Gonz\u00e1lez P et al (2023) Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial. Crit Care 27:110","journal-title":"Crit Care"},{"key":"8361_CR439","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1177\/08850666231180526","volume":"38","author":"D Hasegawa","year":"2023","unstructured":"Hasegawa D, Ishisaka Y, Maeda T et al (2023) Prevalence and prognosis of sepsis-induced cardiomyopathy: a systematic review and meta-analysis. J Intensive Care Med 38:797\u2013808","journal-title":"J Intensive Care Med"},{"key":"8361_CR440","doi-asserted-by":"publisher","first-page":"1200441","DOI":"10.3389\/fcvm.2023.1200441","volume":"10","author":"T Shvilkina","year":"2023","unstructured":"Shvilkina T, Shapiro N (2023) Sepsis-Induced myocardial dysfunction: heterogeneity of functional effects and clinical significance. Front Cardiovasc Med 10:1200441","journal-title":"Front Cardiovasc Med"},{"key":"8361_CR441","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3390\/medicina60050751","volume":"60","author":"A Dubin","year":"2024","unstructured":"Dubin A, Mugno M (2024) The effects of dobutamine in septic shock: an updated narrative review of clinical and experimental studies. Medicina (Kaunas) 60:751","journal-title":"Medicina (Kaunas)"},{"key":"8361_CR442","doi-asserted-by":"publisher","first-page":"2484464","DOI":"10.1080\/07853890.2025.2484464","volume":"57","author":"S Tongyoo","year":"2025","unstructured":"Tongyoo S, Chobngam S, Yolsiriwat N et al (2025) Effects of adjunctive milrinone versus placebo on hemodynamics in patients with septic shock: a randomized controlled trial. Ann Med 57:2484464","journal-title":"Ann Med"},{"key":"8361_CR443","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13613-021-00806-8","volume":"11","author":"TWL Scheeren","year":"2021","unstructured":"Scheeren TWL, Bakker J, Kaufmann T et al (2021) Current use of inotropes in circulatory shock. Ann Intensive Care 11:21","journal-title":"Ann Intensive Care"},{"key":"8361_CR444","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40360-016-0063-z","volume":"17","author":"C Thongprayoon","year":"2016","unstructured":"Thongprayoon C, Cheungpasitporn W, Harrison AM et al (2016) Temporal trends in the utilization of vasopressors in intensive care units: an epidemiologic study. BMC Pharmacol Toxicol 17:19","journal-title":"BMC Pharmacol Toxicol"},{"key":"8361_CR445","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s00134-019-05801-z","volume":"45","author":"JA Russell","year":"2019","unstructured":"Russell JA (2019) Vasopressor therapy in critically ill patients with shock. Intensive Care Med 45:1503\u20131517","journal-title":"Intensive Care Med"},{"key":"8361_CR446","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1212\/WNL.0000000000000815","volume":"83","author":"A Izcovich","year":"2014","unstructured":"Izcovich A, Gonz\u00e1lez Malla C, Manzotti M et al (2014) Midodrine for orthostatic hypotension and recurrent reflex syncope: a systematic review. Neurology 83:1170\u20131177","journal-title":"Neurology"},{"key":"8361_CR447","doi-asserted-by":"publisher","first-page":"299","DOI":"10.34067\/KID.0007432021","volume":"4","author":"AA House","year":"2023","unstructured":"House AA, McIntyre CW (2023) Midodrine is an effective therapy for resistant intradialytic hypotension: PRO. Kidney360 4:299\u2013301","journal-title":"Kidney360"},{"key":"8361_CR448","doi-asserted-by":"publisher","first-page":"e384","DOI":"10.1097\/CCM.0000000000006519","volume":"53","author":"SJ Kilcommons","year":"2025","unstructured":"Kilcommons SJ, Hammal F, Kamaleldin M et al (2025) Adjunctive midodrine therapy for vasopressor-dependent shock in the ICU: a systematic review and meta-analysis. Crit Care Med 53:e384\u2013e399","journal-title":"Crit Care Med"},{"key":"8361_CR449","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1097\/01.CCM.0000182796.11329.3B","volume":"33","author":"T Suzuki","year":"2005","unstructured":"Suzuki T, Morisaki H, Serita R et al (2005) Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats. Crit Care Med 33:2294\u20132301","journal-title":"Crit Care Med"},{"key":"8361_CR450","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1007\/s00134-024-07587-1","volume":"50","author":"S Rehberg","year":"2024","unstructured":"Rehberg S, Frank S, \u010cern\u00fd V, LANDI-SEP Study Group et al (2024) Landiolol for heart rate control in patients with septic shock and persistent tachycardia. A multicenter randomized clinical trial (Landi-SEP). Intensive Care Med 50:1622\u20131634","journal-title":"Intensive Care Med"},{"key":"8361_CR451","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1001\/jama.2023.20134","volume":"330","author":"T Whitehouse","year":"2023","unstructured":"Whitehouse T, Hossain A, Perkins GD, STRESS-L Collaborators et al (2023) Landiolol and organ failure in patients with septic shock: the STRESS-L randomized clinical trial. JAMA 330:1641\u20131652","journal-title":"JAMA"},{"key":"8361_CR452","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jama.2013.278477","volume":"310","author":"A Morelli","year":"2013","unstructured":"Morelli A, Ertmer C, Westphal M et al (2013) Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA 310:1683\u20131691","journal-title":"JAMA"},{"key":"8361_CR453","doi-asserted-by":"publisher","first-page":"e1125","DOI":"10.1097\/CCM.0000000000006604","volume":"53","author":"C McChesney","year":"2025","unstructured":"McChesney C, Orozco N, Fiorini K et al (2025) Impact of short-acting beta-blockers on the outcomes of patients with septic shock: a systematic review and meta-analysis. Crit Care Med 53:e1125\u2013e1139","journal-title":"Crit Care Med"},{"key":"8361_CR454","unstructured":"Chaudhuri D, Lazarte J, Shah K et al (2026) Approaches to Converting Spo2\/FIO2 ratio to PaO2\/FIO2 ratio for assessment of respiratory failure in critically ill patients: A systematic review. Crit Care Med (online ahead of print)"},{"key":"8361_CR455","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1378\/chest.07-0617","volume":"132","author":"TW Rice","year":"2007","unstructured":"Rice TW, Wheeler AP, Bernard GR, National Institutes of Health, National Heart, Lung, and Blood Institute ARDS Network et al (2007) Comparison of the SpO2\/FIO2 ratio and the PaO2\/FIO2 ratio in patients with acute lung injury or ARDS. Chest 132:410\u2013417","journal-title":"Chest"},{"key":"8361_CR456","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMc2029240","volume":"383","author":"MW Sjoding","year":"2020","unstructured":"Sjoding MW, Dickson RP, Iwashyna TJ et al (2020) Racial bias in pulse oximetry measurement. N Engl J Med 383:2477\u20132478","journal-title":"N Engl J Med"},{"key":"8361_CR457","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bja.2024.01.023","volume":"132","author":"D Martin","year":"2024","unstructured":"Martin D, Johns C, Sorrell L et al (2024) Effect of skin tone on the accuracy of the estimation of arterial oxygen saturation by pulse oximetry: a systematic review. Br J Anaesth 132:945\u2013956","journal-title":"Br J Anaesth"},{"key":"8361_CR458","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1164\/rccm.202303-0558WS","volume":"209","author":"MA Matthay","year":"2024","unstructured":"Matthay MA, Arabi Y, Arroliga AC et al (2024) A new global definition of acute respiratory distress syndrome. Am J Respir Crit Care Med 209:37\u201347","journal-title":"Am J Respir Crit Care Med"},{"key":"8361_CR459","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1164\/rccm.202308-1441VP","volume":"209","author":"N Alipanah-Lechner","year":"2024","unstructured":"Alipanah-Lechner N, Cavalcanti AB, Diaz J et al (2024) From berlin to global: the need for syndromic definitions of acute respiratory distress syndrome. Am J Respir Crit Care Med 209:21\u201323","journal-title":"Am J Respir Crit Care Med"},{"key":"8361_CR460","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1056\/NEJMoa1916431","volume":"382","author":"L Barrot","year":"2020","unstructured":"Barrot L, Asfar P, Mauny F, LOCO2 Investigators and REVA Research Network et al (2020) Liberal or conservative oxygen therapy for acute respiratory distress syndrome. N Engl J Med 382:999\u20131008","journal-title":"N Engl J Med"},{"key":"8361_CR461","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/jama.2021.13011","volume":"326","author":"H Gelissen","year":"2021","unstructured":"Gelissen H, de Grooth H-J, Smulders Y et al (2021) Effect of low-normal vs high-normal oxygenation targets on organ dysfunction in critically ill patients: a randomized clinical trial. JAMA 326:940\u2013948","journal-title":"JAMA"},{"key":"8361_CR462","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa1903297","volume":"382","author":"I-R Investigators","year":"2020","unstructured":"Investigators I-R et al (2020) Conservative oxygen therapy during mechanical ventilation in the ICU. N Engl J Med 382:989\u2013998","journal-title":"N Engl J Med"},{"key":"8361_CR463","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1177\/17511437211010031","volume":"22","author":"DS Martin","year":"2021","unstructured":"Martin DS, McNeil M, Brew-Graves C et al (2021) A feasibility randomised controlled trial of targeted oxygen therapy in mechanically ventilated critically ill patients. J Intensive Care Soc 22:280\u2013287","journal-title":"J Intensive Care Soc"},{"key":"8361_CR464","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1001\/jama.2025.9663","volume":"334","author":"DS Martin","year":"2025","unstructured":"Martin DS et al (2025) Conservative oxygen therapy in mechanically ventilated critically ill adult patients: the UK-ROX randomized clinical trial. JAMA 334:398\u2013408","journal-title":"JAMA"},{"key":"8361_CR465","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1001\/jama.2024.2934","volume":"331","author":"FM Nielsen","year":"2024","unstructured":"Nielsen FM, Klitgaard TL, Siegemund M, HOT-COVID Trial Group et al (2024) Lower vs higher oxygenation target and days alive without life support in COVID-19: the HOT-COVID randomized clinical trial. JAMA 331:1185\u20131194","journal-title":"JAMA"},{"key":"8361_CR466","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1164\/rccm.201505-1019OC","volume":"193","author":"R Panwar","year":"2016","unstructured":"Panwar R, Hardie M, Bellomo R, CLOSE Study Investigators et al (2016) Conservative versus liberal oxygenation targets for mechanically ventilated patients. A pilot multicenter randomized controlled trial. Am J Respir Crit Care Med 193:43\u201351","journal-title":"Am J Respir Crit Care Med"},{"key":"8361_CR467","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1056\/NEJMoa2032510","volume":"384","author":"OL Schjorring","year":"2021","unstructured":"Schjorring OL, Klitgaard TL, Perner A, HOT-ICU Investigators et al (2021) Lower or higher oxygenation targets for acute hypoxemic respiratory failure. N Engl J Med 384:1301\u20131311","journal-title":"N Engl J Med"},{"key":"8361_CR468","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1164\/rccm.202303-0560OC","volume":"208","author":"LI van der Wal","year":"2023","unstructured":"van der Wal LI, Grim CCA, Del Prado MR, ICONIC investigators et al (2023) Conservative versus liberal oxygenation targets in intensive care unit patients (ICONIC): a randomized clinical trial. Am J Respir Crit Care Med 208:770\u2013779","journal-title":"Am J Respir Crit Care Med"},{"key":"8361_CR469","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1056\/NEJMoa2208415","volume":"387","author":"MW Semler","year":"2022","unstructured":"Semler MW, Casey JD, Lloyd BD, PILOT Investigators and the Pragmatic Critical Care Research Group et al (2022) Oxygen-saturation targets for critically ill adults receiving mechanical ventilation. N Engl J Med 387:1759\u20131769","journal-title":"N Engl J Med"},{"key":"8361_CR470","doi-asserted-by":"crossref","unstructured":"Nafae RM, Shouman W, Abdelmoneam SH et al (2023) Conservative versus conventional oxygen therapy in type I acute respiratory failure patients in respiratory intensive care unit, Zagazig University. Monaldi Arch Chest Dis 94","DOI":"10.4081\/monaldi.2023.2536"},{"key":"8361_CR471","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/aas.14366","volume":"68","author":"MH Moller","year":"2024","unstructured":"Moller MH, Granholm A, Al Duhailib Z et al (2024) Higher versus lower oxygenation targets in adult ICU patients: a rapid practice guideline. Acta Anaesthesiol Scand 68:302\u2013310","journal-title":"Acta Anaesthesiol Scand"},{"key":"8361_CR472","first-page":"CD012631","volume":"9","author":"TL Klitgaard","year":"2023","unstructured":"Klitgaard TL, Schj\u00f8rring OL, Nielsen FM et al (2023) Higher versus lower fractions of inspired oxygen or targets of arterial oxygenation for adults admitted to the intensive care unit. Cochrane Database Syst Rev 9:CD012631","journal-title":"Cochrane Database Syst Rev"},{"key":"8361_CR473","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/jama.2024.2933","volume":"331","author":"KG Buell","year":"2024","unstructured":"Buell KG, Spicer AB, Casey JD et al (2024) Individualized treatment effects of oxygen targets in mechanically ventilated critically ill adults. JAMA 331:1195\u20131204","journal-title":"JAMA"},{"key":"8361_CR474","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1056\/NEJMoa1503326","volume":"372","author":"JP Frat","year":"2015","unstructured":"Frat JP, Thille AW, Mercat A, FLORALI Study Group et al (2015) High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 372:2185\u20132196","journal-title":"N Engl J Med"},{"key":"8361_CR475","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1001\/jama.2018.14282","volume":"320","author":"E Azoulay","year":"2018","unstructured":"Azoulay E, Lemiale V, Mokart D et al (2018) Effect of high-flow nasal oxygen vs standard oxygen on 28-day mortality in immunocompromised patients with acute respiratory failure: the HIGH randomized clinical trial. JAMA 320:2099\u20132107","journal-title":"JAMA"},{"key":"8361_CR476","doi-asserted-by":"publisher","first-page":"175346662095645","DOI":"10.1177\/1753466620956459","volume":"14","author":"R Andino","year":"2020","unstructured":"Andino R, Vega G, Pacheco SK et al (2020) High-flow nasal oxygen reduces endotracheal intubation: a randomized clinical trial. Ther Adv Respir Dis 14:1753466620956459","journal-title":"Ther Adv Respir Dis"},{"key":"8361_CR477","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1001\/jama.2021.20714","volume":"326","author":"GA Ospina-Tascon","year":"2021","unstructured":"Ospina-Tascon GA, Calder\u00f3n-Tapia LE, Garc\u00eda AF, HiFLo-Covid Investigators et al (2021) Effect of high-flow oxygen therapy vs conventional oxygen therapy on invasive mechanical ventilation and clinical recovery in patients with severe COVID-19: a randomized clinical trial. JAMA 326:2161\u20132171","journal-title":"JAMA"},{"key":"8361_CR478","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.3906\/sag-2007-228","volume":"51","author":"N Alptekinoglu Mendil","year":"2021","unstructured":"Alptekinoglu Mendil N, Temel S, Y\u00fcksel RC et al (2021) The use of high-flow nasal oxygen vs. standard oxygen therapy in hematological malignancy patients with acute respiratory failure in hematology wards. Turk J Med Sci 51:1756\u20131763","journal-title":"Turk J Med Sci"},{"key":"8361_CR479","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1001\/jama.2022.15613","volume":"328","author":"JP Frat","year":"2022","unstructured":"Frat JP, Quenot J-P, Badie J, SOHO-COVID Study Group and the REVA Network et al (2022) Effect of high-flow nasal cannula oxygen vs standard oxygen therapy on mortality in patients with respiratory failure due to COVID-19: the SOHO-COVID randomized clinical trial. JAMA 328:1212\u20131222","journal-title":"JAMA"},{"key":"8361_CR480","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1001\/jama.2022.0028","volume":"327","author":"GD Perkins","year":"2022","unstructured":"Perkins GD, Ji C, Connolly BA, RECOVERY-RS Collaborators et al (2022) Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: the RECOVERY-RS randomized clinical trial. JAMA 327:546\u2013558","journal-title":"JAMA"},{"key":"8361_CR481","doi-asserted-by":"publisher","first-page":"644","DOI":"10.4103\/ija.ija_507_22","volume":"66","author":"B Thota","year":"2022","unstructured":"Thota B, Samantaray A, Vengamma B et al (2022) A randomised controlled trial of high-flow nasal oxygen versus non-rebreathing oxygen face mask therapy in acute hypoxaemic respiratory failure. Indian J Anaesth 66:644\u2013650","journal-title":"Indian J Anaesth"},{"key":"8361_CR482","doi-asserted-by":"crossref","unstructured":"Nazir N, Saxena A (2022) The effectiveness of high-flow nasal cannula and standard non-rebreathing mask for oxygen therapy in moderate category COVID-19 pneumonia: randomised controlled trial. Afr J Thorac Crit Care Med 28","DOI":"10.21203\/rs.3.rs-659154\/v1"},{"key":"8361_CR483","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1001\/jamainternmed.2022.2168","volume":"182","author":"L Bouadma","year":"2022","unstructured":"Bouadma L, Mekontso-Dessap A, Burdet C, COVIDICUS Study Group et al (2022) High-dose dexamethasone and oxygen support strategies in intensive care unit patients with severe COVID-19 acute hypoxemic respiratory failure: the COVIDICUS randomized clinical trial. JAMA Intern Med 182:906\u2013916","journal-title":"JAMA Intern Med"},{"key":"8361_CR484","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1136\/thoraxjnl-2022-218806","volume":"78","author":"C Crimi","year":"2023","unstructured":"Crimi C, Noto A, Madotto F, COVID-HIGH Investigators et al (2023) High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial. Thorax 78:354\u2013361","journal-title":"Thorax"},{"key":"8361_CR485","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.4187\/respcare.09130","volume":"66","author":"PR Nair","year":"2021","unstructured":"Nair PR, Haritha D, Behera S et al (2021) Comparison of high-flow nasal cannula and noninvasive ventilation in acute hypoxemic respiratory failure due to severe COVID-19 pneumonia. Respir Care 66:1824\u20131830","journal-title":"Respir Care"},{"key":"8361_CR486","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1001\/jama.2021.4682","volume":"325","author":"DL Grieco","year":"2021","unstructured":"Grieco DL, Menga LS, Cesarano M, COVID-ICU Gemelli Study Group et al (2021) Effect of helmet noninvasive ventilation vs high-flow nasal oxygen on days free of respiratory support in patients with COVID-19 and moderate to severe hypoxemic respiratory failure: the HENIVOT randomized clinical trial. JAMA 325:1731\u20131743","journal-title":"JAMA"},{"key":"8361_CR487","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1097\/CCM.0000000000005963","volume":"51","author":"AH Al Hashim","year":"2023","unstructured":"Al Hashim AH, Al Reesi A, Al Lawati NM et al (2023) Comparison of noninvasive mechanical ventilation with high-flow nasal cannula, face-mask, and helmet in hypoxemic respiratory failure in patients with COVID-19: a randomized controlled trial. Crit Care Med 51:1515\u20131526","journal-title":"Crit Care Med"},{"key":"8361_CR488","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/resp.14588","volume":"29","author":"K Nagata","year":"2024","unstructured":"Nagata K, Yokoyama T, Tsugitomi R, JaNP-Hi Study Investigators et al (2024) Continuous positive airway pressure versus high-flow nasal cannula oxygen therapy for acute hypoxemic respiratory failure: a randomized controlled trial. Respirology 29:36\u201345","journal-title":"Respirology"},{"key":"8361_CR489","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1001\/jama.2024.26244","volume":"333","author":"R Investigators","year":"2025","unstructured":"Investigators R et al (2025) High-flow nasal oxygen vs noninvasive ventilation in patients with acute respiratory failure: the RENOVATE randomized clinical trial. JAMA 333:875\u2013890","journal-title":"JAMA"},{"key":"8361_CR490","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1080\/11101849.2021.1978744","volume":"37","author":"AE Elagamy","year":"2021","unstructured":"Elagamy AE, Taha SS, Elfawy DM (2021) High flow nasal cannula versus non-invasive ventilation in prevention of intubation in immunocompromised patient with acute hypoxemic respiratory failure. Egypt J Anaesth 37:432\u2013439","journal-title":"Egypt J Anaesth"},{"key":"8361_CR491","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S2213-2600(22)00096-0","volume":"10","author":"R Coudroy","year":"2022","unstructured":"Coudroy R, Frat J-P, Ehrmann S, FLORALI-IM study group and the REVA Research Network et al (2022) High-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: a randomised controlled trial. Lancet Respir Med 10:641\u2013649","journal-title":"Lancet Respir Med"},{"key":"8361_CR492","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.4269\/ajtmh.22-0793","volume":"108","author":"M Botta","year":"2023","unstructured":"Botta M, Caritg O, van Meenen DMP et al (2023) Oxygen consumption with high-flow nasal oxygen versus mechanical ventilation\u2014an international multicenter observational study in COVID-19 patients (PROXY-COVID). Am J Trop Med Hyg 108:1035\u20131041","journal-title":"Am J Trop Med Hyg"},{"key":"8361_CR493","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1001\/jamainternmed.2025.0011","volume":"185","author":"J Luo","year":"2025","unstructured":"Luo J, Pavlov I, Tavernier E, Awake Prone Positioning Meta-Analysis Group et al (2025) Awake prone positioning in adults with COVID-19: an individual participant data meta-analysis. JAMA Intern Med 185:572\u2013581","journal-title":"JAMA Intern Med"},{"key":"8361_CR494","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1001\/jama.2022.7993","volume":"327","author":"W Alhazzani","year":"2022","unstructured":"Alhazzani W, Parhar KKS, Weatherald J, COVI-PRONE Trial Investigators and the Saudi Critical Care Trials Group et al (2022) Effect of awake prone positioning on endotracheal intubation in patients with COVID-19 and acute respiratory failure: a randomized clinical trial. JAMA 327:2104\u20132113","journal-title":"JAMA"},{"key":"8361_CR495","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/S2213-2600(21)00356-8","volume":"9","author":"S Ehrmann","year":"2021","unstructured":"Ehrmann S, Li J, Ibarra-Estrada M, Awake Prone Positioning Meta-Trial Group et al (2021) Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial. Lancet Respir Med 9:1387\u20131395","journal-title":"Lancet Respir Med"},{"key":"8361_CR496","doi-asserted-by":"publisher","first-page":"00181","DOI":"10.1183\/23120541.00181-2023","volume":"9","author":"M Fezzi","year":"2023","unstructured":"Fezzi M, Antolini L, Soria A et al (2023) Early prone positioning does not improve the outcome of patients with mild pneumonia due to SARS-CoV-2: results from an open-label randomised controlled trial\u2014the EPCoT study. ERJ Open Res 9:00181\u201302023","journal-title":"ERJ Open Res"},{"key":"8361_CR497","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2024.101295","volume":"39","author":"TRE Harris","year":"2024","unstructured":"Harris TRE, Bhutta ZA, Qureshi I et al (2024) A randomised clinical trial of awake prone positioning in COVID-19 suspects with acute hypoxemic respiratory failure. Contemp Clin Trials Commun 39:101295","journal-title":"Contemp Clin Trials Commun"},{"key":"8361_CR498","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-068585","volume":"376","author":"M Fralick","year":"2022","unstructured":"Fralick M, Colacci M, Munshi L, COVID Prone Study Investigators et al (2022) Prone positioning of patients with moderate hypoxaemia due to covid-19: multicentre pragmatic randomised trial (COVID-PRONE). BMJ 376:e068585","journal-title":"BMJ"},{"key":"8361_CR499","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1177\/08850666211014480","volume":"36","author":"D Jayakumar","year":"2021","unstructured":"Jayakumar D, Ramachandran Dnb P, Rabindrarajan Dnb E et al (2021) Standard care versus awake prone position in adult nonintubated patients with acute hypoxemic respiratory failure secondary to COVID-19 infection\u2014a multicenter feasibility randomized controlled trial. J Intensive Care Med 36:918\u2013924","journal-title":"J Intensive Care Med"},{"key":"8361_CR500","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1513\/AnnalsATS.202011-1466RL","volume":"18","author":"SA Johnson","year":"2021","unstructured":"Johnson SA, Horton DJ, Fuller MJ et al (2021) Patient-directed prone positioning in awake patients with COVID-19 requiring hospitalization (PAPR). Ann Am Thorac Soc 18:1424\u20131426","journal-title":"Ann Am Thorac Soc"},{"key":"8361_CR501","doi-asserted-by":"publisher","first-page":"00692","DOI":"10.1183\/23120541.00692-2020","volume":"7","author":"A Kharat","year":"2021","unstructured":"Kharat A, Dupuis-Lozeron E, Cantero C et al (2021) Self-proning in COVID-19 patients on low-flow oxygen therapy: a cluster randomised controlled trial. ERJ Open Res 7:00692\u201302020","journal-title":"ERJ Open Res"},{"key":"8361_CR502","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s13054-023-04529-z","volume":"27","author":"MA Nay","year":"2023","unstructured":"Nay MA, Hindre R, Perrin C et al (2023) Prone position versus usual care in hypoxemic COVID-19 patients in medical wards: a randomised controlled trial. Crit Care 27:240","journal-title":"Crit Care"},{"key":"8361_CR503","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.chest.2022.05.009","volume":"162","author":"G Rampon","year":"2022","unstructured":"Rampon G, Jia S, Agrawal R et al (2022) Smartphone-guided self-prone positioning vs usual care in nonintubated hospital ward patients with COVID-19: a pragmatic randomized clinical trial. Chest 162:782\u2013791","journal-title":"Chest"},{"key":"8361_CR504","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1513\/AnnalsATS.202009-1164OC","volume":"18","author":"SP Taylor","year":"2021","unstructured":"Taylor SP, Bundy H, Smith WM et al (2021) Awake prone positioning strategy for nonintubated hypoxic patients with COVID-19: a pilot trial with embedded implementation evaluation. Ann Am Thorac Soc 18:1360\u20131368","journal-title":"Ann Am Thorac Soc"},{"key":"8361_CR505","doi-asserted-by":"crossref","unstructured":"Gopalakrishnan M, Khichar S, Saurabh S et al (2022) Effectiveness of early awake self proning strategy in non-intubated patients with COVID-19 hypoxemia: an open-labelled randomized clinical trial from Jodhpur, India. Monaldi Arch Chest Dis 93","DOI":"10.4081\/monaldi.2022.2431"},{"key":"8361_CR506","doi-asserted-by":"publisher","first-page":"68","DOI":"10.55519\/JAMC-01-11069","volume":"35","author":"H Javed","year":"2023","unstructured":"Javed H, Qayyum F, Aslam Khan MN et al (2023) Effect of eight hours per day of intermittent self prone positioning for seven days on the severity of Covid-19 pneumonia\/acute respiratory distress syndrome. J Ayub Med Coll Abbottabad 35:68\u201375","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"8361_CR507","doi-asserted-by":"publisher","first-page":"543","DOI":"10.12688\/wellcomeopenres.22792.1","volume":"9","author":"NT Phong","year":"2024","unstructured":"Phong NT, Duc DH, Hai HB, Oucru Covid Reseach Group et al (2024) Awake prone positioning effectiveness in moderate to severe COVID-19 a randomized controlled trial. Wellcome Open Res 9:543","journal-title":"Wellcome Open Res"},{"key":"8361_CR508","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s13054-021-03602-9","volume":"25","author":"J Rosen","year":"2021","unstructured":"Rosen J, von Oelreich E, Fors D, PROFLO Study Group et al (2021) Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial. Crit Care 25:209","journal-title":"Crit Care"},{"key":"8361_CR509","doi-asserted-by":"publisher","first-page":"351","DOI":"10.35975\/apic.v27i3.2079","volume":"27","author":"BZN Nasrallah","year":"2023","unstructured":"Nasrallah BZN, Mahmoud MS, ElGendy HMA et al (2023) Patients self-proning with high-flow nasal cannula improves oxygenation in mild ARDS patients: a randomized clinical trial. Anesth Pain Intensive Care 27:351\u2013355","journal-title":"Anesth Pain Intensive Care"},{"key":"8361_CR510","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-071966","volume":"379","author":"J Weatherald","year":"2022","unstructured":"Weatherald J, Parhar KKS, Al Duhailib Z et al (2022) Efficacy of awake prone positioning in patients with covid-19 related hypoxemic respiratory failure: Systematic review and meta-analysis of randomized trials. BMJ 379:e071966","journal-title":"BMJ"},{"key":"8361_CR511","doi-asserted-by":"publisher","first-page":"1172434","DOI":"10.3389\/fmed.2023.1172434","volume":"10","author":"C de Haro","year":"2023","unstructured":"de Haro C, Neto AS, Gom\u00e0 G et al (2023) Effect of a low versus intermediate tidal volume strategy on pulmonary complications in patients at risk of acute respiratory distress syndrome-a randomized clinical trial. Front Med (Lausanne) 10:1172434","journal-title":"Front Med (Lausanne)"},{"key":"8361_CR512","doi-asserted-by":"crossref","unstructured":"Writing Group for the PI et al (2018) Effect of a low vs intermediate tidal volume strategy on ventilator-free days in intensive care unit patients without ARDS: a randomized clinical trial. JAMA 320:1872\u20131880","DOI":"10.1001\/jama.2018.14280"},{"key":"8361_CR513","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1513\/AnnalsATS.201807-459OC","volume":"16","author":"MJ Lanspa","year":"2019","unstructured":"Lanspa MJ, Gong MN, Schoenfeld DA, The National Heart, Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network et al (2019) Prospective assessment of the feasibility of a trial of low-tidal volume ventilation for patients with acute respiratory failure. Ann Am Thorac Soc 16:356\u2013362","journal-title":"Ann Am Thorac Soc"},{"key":"8361_CR514","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1097\/01.CCM.0000181529.08630.49","volume":"33","author":"ND Ferguson","year":"2005","unstructured":"Ferguson ND, Frutos-Vivar F, Esteban A et al (2005) Acute respiratory distress syndrome: underrecognition by clinicians and diagnostic accuracy of three clinical definitions. Crit Care Med 33:2228\u20132234","journal-title":"Crit Care Med"},{"key":"8361_CR515","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2016.0291","volume":"315","author":"G Bellani","year":"2016","unstructured":"Bellani G, Laffey JG, Pham T, LUNG SAFE Investigators et al (2016) Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315:788\u2013800","journal-title":"JAMA"},{"key":"8361_CR516","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1097\/CCM.0b013e31816fc3d0","volume":"36","author":"NJ Umoh","year":"2008","unstructured":"Umoh NJ, Fan E, Mendez-Tellez PA et al (2008) Patient and intensive care unit organizational factors associated with low tidal volume ventilation in acute lung injury. Crit Care Med 36:1463\u20131468","journal-title":"Crit Care Med"},{"key":"8361_CR517","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e2124","volume":"344","author":"DM Needham","year":"2012","unstructured":"Needham DM, Colantuoni E, Mendez-Tellez PA et al (2012) Lung protective mechanical ventilation and two year survival in patients with acute lung injury: prospective cohort study. BMJ 344:e2124","journal-title":"BMJ"},{"key":"8361_CR518","volume":"6","author":"T Pitre","year":"2024","unstructured":"Pitre T, Drover K, Chaudhuri D et al (2024) Corticosteroids in sepsis and septic shock: a systematic review, pairwise, and dose-response meta-analysis. Crit Care Explor 6:e1000","journal-title":"Crit Care Explor"},{"key":"8361_CR519","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1164\/rccm.202311-2011ST","volume":"209","author":"N Qadir","year":"2024","unstructured":"Qadir N, Sahetya S, Munshi L et al (2024) An update on management of adult patients with acute respiratory distress syndrome: an official american thoracic society clinical practice guideline. Am J Respir Crit Care Med 209:24\u201336","journal-title":"Am J Respir Crit Care Med"},{"key":"8361_CR520","first-page":"24","volume":"212","author":"BE Jones","year":"2025","unstructured":"Jones BE, Ramirez JA, Oren E et al (2025) Diagnosis and management of community-acquired pneumonia. An official American thoracic society clinical practice guideline. Am J Respir Crit Care Med 212:24\u201344","journal-title":"Am J Respir Crit Care Med"},{"key":"8361_CR521","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1705835","volume":"378","author":"B Venkatesh","year":"2018","unstructured":"Venkatesh B, Finfer S, Cohen J, ADRENAL Trial Investigators and the Australian-New Zealand Intensive Care Society Clinical Trials Group et al (2018) Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med 378:797\u2013808","journal-title":"N Engl J Med"},{"key":"8361_CR522","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jcrc.2020.10.016","volume":"61","author":"A Sakkat","year":"2021","unstructured":"Sakkat A, Alquraini M, Aljazeeri J et al (2021) Temperature control in critically ill patients with fever: a meta-analysis of randomized controlled trials. J Crit Care 61:89\u201395","journal-title":"J Crit Care"},{"key":"8361_CR523","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/aas.14311","volume":"67","author":"A Reintam Blaser","year":"2023","unstructured":"Reintam Blaser A, Alhazzani W, Belley-Cote E et al (2023) Intravenous vitamin C therapy in adult patients with sepsis: a rapid practice guideline. Acta Anaesthesiol Scand 67:1423\u20131431","journal-title":"Acta Anaesthesiol Scand"},{"key":"8361_CR524","doi-asserted-by":"publisher","first-page":"EVIDoa2200105","DOI":"10.1056\/EVIDoa2200105","volume":"1","author":"A Agarwal","year":"2022","unstructured":"Agarwal A, Basmaji J, Fernando SM et al (2022) Parenteral Vitamin C in patients with severe infection: a systematic review. NEJM Evid 1:EVIDoa2200105","journal-title":"NEJM Evid"},{"key":"8361_CR525","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2023.154369","volume":"78","author":"MH Anstey","year":"2023","unstructured":"Anstey MH, Aljeaidi MS, Palmer R et al (2023) Intravenous vitamin C for vasoplegia: a double-blinded randomised clinical trial (VALENCIA trial). J Crit Care 78:154369","journal-title":"J Crit Care"},{"key":"8361_CR526","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12871-023-02265-z","volume":"23","author":"E Belousoviene","year":"2023","unstructured":"Belousoviene E, Pranskuniene Z, Vaitkaitiene E et al (2023) Effect of high-dose intravenous ascorbic acid on microcirculation and endothelial glycocalyx during sepsis and septic shock: a double-blind, randomized, placebo-controlled study. BMC Anesthesiol 23:309","journal-title":"BMC Anesthesiol"},{"key":"8361_CR527","doi-asserted-by":"publisher","first-page":"20230637","DOI":"10.1515\/med-2023-0637","volume":"18","author":"F Feng","year":"2023","unstructured":"Feng F, Yang H, Yang W et al (2023) Metabolic resuscitation therapy in critically ill patients with sepsis and septic shock: a pilot prospective randomized controlled trial. Open Med (Wars) 18:20230637","journal-title":"Open Med (Wars)"},{"key":"8361_CR528","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037838","volume":"103","author":"W Li","year":"2024","unstructured":"Li W, Zhao R, Liu S et al (2024) High-dose vitamin C improves norepinephrine level in patients with septic shock: a single-center, prospective, randomized controlled trial. Medicine (Baltim) 103:e37838","journal-title":"Medicine (Baltim)"},{"key":"8361_CR529","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/SHK.0000000000002110","volume":"59","author":"A Mohamed","year":"2023","unstructured":"Mohamed A, Abdelaty M, Saad MO et al (2023) Evaluation of hydrocortisone, Vitamin C, and thiamine for the treatment of septic shock: a randomized controlled trial (the Hyvits Trial). Shock 59:697\u2013701","journal-title":"Shock"},{"key":"8361_CR530","doi-asserted-by":"publisher","first-page":"910","DOI":"10.5005\/jp-journals-10071-24587","volume":"27","author":"BKT Vijayaraghavan","year":"2023","unstructured":"Vijayaraghavan BKT, Venkataraman R, Ramanathan Y et al (2023) A pilot feasibility randomized controlled trial of intravenous vitamin c in adults with sepsis in the intensive care unit: the lessening organ dysfunction with vitamin C-India (LOVIT-India) trial. Indian J Crit Care Med 27:910\u2013916","journal-title":"Indian J Crit Care Med"},{"key":"8361_CR531","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa2200644","volume":"386","author":"F Lamontagne","year":"2022","unstructured":"Lamontagne F, Masse M-H, Menard J, LOVIT Investigators and the Canadian Critical Care Trials Group et al (2022) Intravenous Vitamin C in adults with sepsis in the intensive care unit. N Engl J Med 386:2387\u20132398","journal-title":"N Engl J Med"},{"key":"8361_CR532","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1186\/s12967-023-04592-8","volume":"21","author":"B Pan","year":"2023","unstructured":"Pan B, Sun P, Pei R et al (2023) Efficacy of IVIG therapy for patients with sepsis: a systematic review and meta-analysis. J Transl Med 21:765","journal-title":"J Transl Med"},{"key":"8361_CR533","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2018.14618","volume":"320","author":"RP Dellinger","year":"2018","unstructured":"Dellinger RP, Bagshaw SM, Antonelli M, EUPHRATES Trial Investigators et al (2018) Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial. JAMA 320:1455\u20131463","journal-title":"JAMA"},{"key":"8361_CR534","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1097\/CCM.0000000000005991","volume":"51","author":"JJ Chen","year":"2023","unstructured":"Chen JJ, Lai P-C, Lee T-H et al (2023) Blood purification for adult patients with severe infection or sepsis\/septic shock: a network meta-analysis of randomized controlled trials. Crit Care Med 51:1777\u20131789","journal-title":"Crit Care Med"},{"key":"8361_CR535","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1186\/s13054-014-0699-2","volume":"18","author":"E Rimmer","year":"2014","unstructured":"Rimmer E, Houston BL, Kumar A et al (2014) The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis. Crit Care 18:699","journal-title":"Crit Care"},{"key":"8361_CR536","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s000110050442","volume":"48","author":"T Nakamura","year":"1999","unstructured":"Nakamura T, Ebihara I, Shoji H et al (1999) Treatment with polymyxin B-immobilized fiber reduces platelet activation in septic shock patients: decrease in plasma levels of soluble P-selectin, platelet factor 4 and beta-thromboglobulin. Inflamm Res 48:171\u2013175","journal-title":"Inflamm Res"},{"key":"8361_CR537","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1081\/JDI-100100867","volume":"22","author":"T Nakamura","year":"2000","unstructured":"Nakamura T, Ushiyama C, Suzuki S et al (2000) Polymyxin b-immobilized fiber reduces increased plasma endothelin-1 concentrations in hemodialysis patients with sepsis. Ren Fail 22:225\u2013234","journal-title":"Ren Fail"},{"key":"8361_CR538","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/s13054-023-04717-x","volume":"27","author":"G Tomlinson","year":"2023","unstructured":"Tomlinson G, Al-Khafaji A, Conrad SA et al (2023) Bayesian methods: a potential path forward for sepsis trials. Crit Care 27:432","journal-title":"Crit Care"},{"key":"8361_CR539","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1007\/s00134-018-5463-7","volume":"44","author":"DJ Klein","year":"2018","unstructured":"Klein DJ, Foster D, Walker PM et al (2018) Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial. Intensive Care Med 44:2205\u20132212","journal-title":"Intensive Care Med"},{"key":"8361_CR540","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1056\/NEJMoa1911124","volume":"381","author":"National Heart L","year":"2019","unstructured":"National Heart L et al (2019) Early high-dose vitamin D(3) for critically ill, vitamin D-deficient patients. N Engl J Med 381:2529\u20132540","journal-title":"N Engl J Med"},{"key":"8361_CR541","doi-asserted-by":"publisher","first-page":"853","DOI":"10.5005\/jp-journals-10071-24260","volume":"26","author":"M Kaur","year":"2022","unstructured":"Kaur M, Soni KD, Trikha A (2022) Does vitamin D improve all-cause mortality in critically ill adults? An updated systematic review and meta-analysis of randomized controlled trials. Indian J Crit Care Med 26:853\u2013862","journal-title":"Indian J Crit Care Med"},{"key":"8361_CR542","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1001\/jamainternmed.2023.0780","volume":"183","author":"S Liu","year":"2023","unstructured":"Liu S, Yao C, Xie J, EXIT-SEP Investigators et al (2023) Effect of an herbal-based injection on 28-day mortality in patients with sepsis: the EXIT-SEP randomized clinical trial. JAMA Intern Med 183:647\u2013655","journal-title":"JAMA Intern Med"},{"key":"8361_CR543","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jep.2018.05.043","volume":"224","author":"C Li","year":"2018","unstructured":"Li C, Wang P, Zhang L et al (2018) Efficacy and safety of Xuebijing injection (a Chinese patent) for sepsis: a meta-analysis of randomized controlled trials. J Ethnopharmacol 224:512\u2013521","journal-title":"J Ethnopharmacol"},{"key":"8361_CR544","doi-asserted-by":"publisher","first-page":"9605793","DOI":"10.1155\/2020\/9605793","volume":"2020","author":"J Wang","year":"2020","unstructured":"Wang J, Zhu J, Guo J et al (2020) Could xuebijing injection reduce the mortality of severe pneumonia patients? A systematic review and meta-analysis. Evid Based Complement Altern Med 2020:9605793","journal-title":"Evid Based Complement Altern Med"},{"key":"8361_CR545","doi-asserted-by":"publisher","first-page":"e735","DOI":"10.1097\/CCM.0000000000003842","volume":"47","author":"Y Song","year":"2019","unstructured":"Song Y, Yao C, Yao Y et al (2019) XueBiJing injection versus placebo for critically ill patients with severe community-acquired pneumonia: a randomized controlled trial. Crit Care Med 47:e735\u2013e743","journal-title":"Crit Care Med"},{"key":"8361_CR546","doi-asserted-by":"publisher","first-page":"EVIDoa2400134","DOI":"10.1056\/EVIDoa2400134","volume":"3","author":"Y Wang","year":"2024","unstructured":"Wang Y, Parpia S, Ge L et al (2024) Proton-pump inhibitors to prevent gastrointestinal bleeding\u2014an updated meta-analysis. NEJM Evid 3:EVIDoa2400134","journal-title":"NEJM Evid"},{"key":"8361_CR547","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2404245","volume":"391","author":"D Cook","year":"2024","unstructured":"Cook D, Deane A, Lauzier F, REVISE Investigators et al (2024) Stress ulcer prophylaxis during Invasive mechanical ventilation. N Engl J Med 391:9\u201320","journal-title":"N Engl J Med"},{"key":"8361_CR548","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s00134-019-05751-6","volume":"45","author":"A Granholm","year":"2019","unstructured":"Granholm A, Zeng L, Dionne JC, GUIDE Group et al (2019) Predictors of gastrointestinal bleeding in adult ICU patients: a systematic review and meta-analysis. Intensive Care Med 45:1347\u20131359","journal-title":"Intensive Care Med"},{"key":"8361_CR549","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1007\/s00134-017-4831-z","volume":"43","author":"M Mer","year":"2017","unstructured":"Mer M, Schultz MJ, Adhikari NK, European Society of Intensive Care Medicine (ESICM) Global Intensive Care Working Group and the Mahidol-Oxford Research Unit (MORU), Bangkok, Thailand (2017) Core elements of general supportive care for patients with sepsis and septic shock in resource-limited settings. Intensive Care Med 43:1690\u20131694","journal-title":"Intensive Care Med"},{"key":"8361_CR550","doi-asserted-by":"publisher","first-page":"e421","DOI":"10.1097\/CCM.0000000000006330","volume":"52","author":"R MacLaren","year":"2024","unstructured":"MacLaren R, Dionne JC, Granholm A et al (2024) Society of Critical Care Medicine and American Society of Health-System Pharmacists guideline for the prevention of stress-related gastrointestinal bleeding in critically ill adults. Crit Care Med 52:e421\u2013e430","journal-title":"Crit Care Med"},{"key":"8361_CR551","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1056\/NEJMoa1714919","volume":"379","author":"M Krag","year":"2018","unstructured":"Krag M, Marker S, Perner A, SUP-ICU Trial Group et al (2018) Pantoprazole in patients at risk for gastrointestinal bleeding in the ICU. N Engl J Med 379:2199\u20132208","journal-title":"N Engl J Med"},{"key":"8361_CR552","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1001\/jama.2019.22190","volume":"323","author":"PIft Australian","year":"2020","unstructured":"Australian PIft et al (2020) Effect of stress ulcer prophylaxis with proton pump inhibitors vs histamine-2 receptor blockers on in-hospital mortality among ICU patients receiving invasive mechanical ventilation: the PEPTIC randomized clinical trial. JAMA 323:616\u2013626","journal-title":"JAMA"},{"key":"8361_CR553","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S2213-2600(15)00427-0","volume":"4","author":"RP Dickson","year":"2016","unstructured":"Dickson RP (2016) The microbiome and critical illness. Lancet Respir Med 4:59\u201372","journal-title":"Lancet Respir Med"},{"key":"8361_CR554","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.3389\/fimmu.2018.02042","volume":"9","author":"BW Haak","year":"2018","unstructured":"Haak BW, Prescott HC, Wiersinga WJ (2018) Therapeutic potential of the gut microbiota in the prevention and treatment of sepsis. Front Immunol 9:2042","journal-title":"Front Immunol"},{"key":"8361_CR555","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1097\/CCM.0000000000005580","volume":"50","author":"S Sharif","year":"2022","unstructured":"Sharif S, Greer A, Skorupski C et al (2022) Probiotics in critical illness: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med 50:1175\u20131186","journal-title":"Crit Care Med"},{"key":"8361_CR556","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1001\/jama.2021.13355","volume":"326","author":"J Johnstone","year":"2021","unstructured":"Johnstone J, Meade M, Lauzier F, Prevention of Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT) Investigators and the Canadian Critical Care Trials Group et al (2021) Effect of probiotics on incident ventilator-associated pneumonia in critically ill patients: a randomized clinical trial. JAMA 326:1024\u20131033","journal-title":"JAMA"},{"key":"8361_CR557","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s13054-015-0970-1","volume":"19","author":"A Acheampong","year":"2015","unstructured":"Acheampong A, Vincent JL (2015) A positive fluid balance is an independent prognostic factor in patients with sepsis. Crit Care 19:251","journal-title":"Crit Care"},{"key":"8361_CR558","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13613-018-0402-x","volume":"8","author":"M Malbrain","year":"2018","unstructured":"Malbrain M et al (2018) Principles of fluid management and stewardship in septic shock: it is time to consider the four D\u2019s and the four phases of fluid therapy. Ann Intensive Care 8:66","journal-title":"Ann Intensive Care"},{"key":"8361_CR559","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41581-018-0044-0","volume":"14","author":"S Finfer","year":"2018","unstructured":"Finfer S, Myburgh J, Bellomo R (2018) Intravenous fluid therapy in critically ill adults. Nat Rev Nephrol 14:541\u2013557","journal-title":"Nat Rev Nephrol"},{"key":"8361_CR560","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1007\/s00134-025-08058-x","volume":"51","author":"M Ostermann","year":"2025","unstructured":"Ostermann M, Alshamsi F, Artigas Raventos A et al (2025) European society of intensive care medicine clinical practice guideline on fluid therapy in adult critically ill patients: part 3-fluid removal at de-escalation phase. Intensive Care Med 51:1749\u20131763","journal-title":"Intensive Care Med"},{"key":"8361_CR561","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/aas.13124","volume":"62","author":"RE Berthelsen","year":"2018","unstructured":"Berthelsen RE, Perner A, Jensen AK et al (2018) Forced fluid removal in intensive care patients with acute kidney injury: the randomised FFAKI feasibility trial. Acta Anaesthesiol Scand 62:936\u2013944","journal-title":"Acta Anaesthesiol Scand"},{"key":"8361_CR562","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s00134-021-06596-8","volume":"48","author":"JA Silversides","year":"2022","unstructured":"Silversides JA, McMullan R, Emerson LM et al (2022) Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the role of active deresuscitation after resuscitation-2 (RADAR-2) randomised clinical trial. Intensive Care Med 48:190\u2013200","journal-title":"Intensive Care Med"},{"key":"8361_CR563","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jcrc.2017.07.030","volume":"42","author":"SM Bagshaw","year":"2017","unstructured":"Bagshaw SM, Gibney RTN, Kruger P et al (2017) The effect of low-dose furosemide in critically ill patients with early acute kidney injury: a pilot randomized blinded controlled trial (the SPARK study). J Crit Care 42:138\u2013146","journal-title":"J Crit Care"},{"key":"8361_CR564","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13054-021-03509-5","volume":"25","author":"R Cinotti","year":"2021","unstructured":"Cinotti R, Lascarrou J-B, Azais M-A et al (2021) Diuretics decrease fluid balance in patients on invasive mechanical ventilation: the randomized-controlled single blind. IRIHS study Crit Care 25:98","journal-title":"IRIHS study Crit Care"},{"key":"8361_CR565","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00134-021-06401-6","volume":"47","author":"ST Vaara","year":"2021","unstructured":"Vaara ST, Ostermann M, Bitker L, REVERSE-AKI Study Team et al (2021) Restrictive fluid management versus usual care in acute kidney injury (REVERSE-AKI): a pilot randomized controlled feasibility trial. Intensive Care Med 47:665\u2013673","journal-title":"Intensive Care Med"},{"key":"8361_CR566","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S0272-6386(04)00810-8","volume":"44","author":"F Cantarovich","year":"2004","unstructured":"Cantarovich F, Rangoonwala B, Lorenz H, High-Dose Flurosemide in Acute Renal Failure Study Group et al (2004) High-dose furosemide for established ARF: a prospective, randomized, double-blind, placebo-controlled, multicenter trial. Am J Kidney Dis 44:402\u2013409","journal-title":"Am J Kidney Dis"},{"key":"8361_CR567","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1056\/NEJMoa062200","volume":"354","author":"National Heart L","year":"2006","unstructured":"National Heart L et al (2006) Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354:2564\u20132575","journal-title":"N Engl J Med"},{"key":"8361_CR568","doi-asserted-by":"publisher","first-page":"442","DOI":"10.4103\/ijccm.IJCCM_93_17","volume":"21","author":"H Hamishehkar","year":"2017","unstructured":"Hamishehkar H, Sanaie S, Fattahi V et al (2017) The effect of furosemide on the level of neutrophil gelatinase-associated lipocalin in critically hospitalized patients with acute kidney injury. Indian J Crit Care Med 21:442\u2013447","journal-title":"Indian J Crit Care Med"},{"key":"8361_CR569","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1164\/ajrccm\/145.5.990","volume":"145","author":"JP Mitchell","year":"1992","unstructured":"Mitchell JP, Schuller D, Calandrino FS et al (1992) Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization. Am Rev Respir Dis 145:990\u2013998","journal-title":"Am Rev Respir Dis"},{"key":"8361_CR570","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1164\/rccm.201205-0939OC","volume":"186","author":"A Mekontso Dessap","year":"2012","unstructured":"Mekontso Dessap A, Roche-Campo F, Kouatchet A et al (2012) Natriuretic peptide-driven fluid management during ventilator weaning: a randomized controlled trial. Am J Respir Crit Care Med 186:1256\u20131263","journal-title":"Am J Respir Crit Care Med"},{"key":"8361_CR571","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/aas.14196","volume":"67","author":"S Wichmann","year":"2023","unstructured":"Wichmann S, Sch\u00f8nemann-Lund M, Perner A et al (2023) Goal-directed fluid removal with furosemide versus placebo in intensive care patients with fluid overload: a randomised, blinded trial (GODIF trial-First version). Acta Anaesthesiol Scand 67:470\u2013478","journal-title":"Acta Anaesthesiol Scand"},{"key":"8361_CR572","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1513\/AnnalsATS.202410-1041OC","volume":"22","author":"LM Cagino","year":"2025","unstructured":"Cagino LM, Walzl E, McSparron JI et al (2025) Goals of care assessment during hospitalization for sepsis. Ann Am Thorac Soc 22:1035\u20131041","journal-title":"Ann Am Thorac Soc"},{"key":"8361_CR573","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jpainsymman.2022.11.012","volume":"65","author":"AM Uyeda","year":"2023","unstructured":"Uyeda AM, Lee RY, Pollack LR et al (2023) Predictors of documented goals-of-care discussion for hospitalized patients with chronic illness. J Pain Symptom Manag 65:233\u2013241","journal-title":"J Pain Symptom Manag"},{"key":"8361_CR574","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jpainsymman.2020.08.024","volume":"61","author":"RY Lee","year":"2021","unstructured":"Lee RY, Brumback LC, Lober WB et al (2021) Identifying goals of care conversations in the electronic health record using natural language processing and machine learning. J Pain Symptom Manag 61:136-142.e2","journal-title":"J Pain Symptom Manag"},{"key":"8361_CR575","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1055\/s-0044-1788652","volume":"08","author":"N Mahendraker","year":"2024","unstructured":"Mahendraker N, Gutierrez-Asis E, Park S et al (2024) Using electronic health record mortality data to promote goals-of-care discussions in seriously ill transferred patients: a pilot study. ACI Open 08:e69\u2013e78","journal-title":"ACI Open"},{"key":"8361_CR576","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1097\/01.CCM.0000266533.06543.0C","volume":"35","author":"SA Norton","year":"2007","unstructured":"Norton SA, Hogan LA, Holloway RG et al (2007) Proactive palliative care in the medical intensive care unit: effects on length of stay for selected high-risk patients. Crit Care Med 35:1530\u20131535","journal-title":"Crit Care Med"},{"key":"8361_CR577","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1177\/0269216309346540","volume":"24","author":"S O\u2019Mahony","year":"2010","unstructured":"O\u2019Mahony S, McHenry J, Blank AE et al (2010) Preliminary report of the integration of a palliative care team into an intensive care unit. Palliat Med 24:154\u2013165","journal-title":"Palliat Med"},{"key":"8361_CR578","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1177\/1049909118824546","volume":"36","author":"AZ Deptola","year":"2019","unstructured":"Deptola AZ, Riggs J (2019) Inpatient goals-of-care conversations reduce intensive care unit transfers in high-risk patients. Am J Hosp Palliat Care 36:583\u2013586","journal-title":"Am J Hosp Palliat Care"},{"key":"8361_CR579","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1001\/jama.290.9.1166","volume":"290","author":"LJ Schneiderman","year":"2003","unstructured":"Schneiderman LJ, Gilmer T, Teetzel HD et al (2003) Effect of ethics consultations on nonbeneficial life-sustaining treatments in the intensive care setting: a randomized controlled trial. JAMA 290:1166\u20131172","journal-title":"JAMA"},{"key":"8361_CR580","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1097\/CCM.0000000000004016","volume":"47","author":"J Ma","year":"2019","unstructured":"Ma J, Chi S, Buettner B et al (2019) Early palliative care consultation in the medical ICU: a cluster randomized crossover trial. Crit Care Med 47:1707\u20131715","journal-title":"Crit Care Med"},{"key":"8361_CR581","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1001\/jama.2023.8812","volume":"329","author":"JR Curtis","year":"2023","unstructured":"Curtis JR, Lee RY, Brumback LC et al (2023) Intervention to promote communication about goals of care for hospitalized patients with serious illness: a randomized clinical trial. JAMA 329:2028\u20132037","journal-title":"JAMA"},{"key":"8361_CR582","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.chest.2023.12.014","volume":"165","author":"JM Kruser","year":"2024","unstructured":"Kruser JM, Nadig NR, Viglianti EM et al (2024) Time-limited trials for patients with critical illness: a review of the literature. Chest 165:881\u2013891","journal-title":"Chest"},{"key":"8361_CR583","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1513\/AnnalsATS.202310-925ST","volume":"21","author":"JM Kruser","year":"2024","unstructured":"Kruser JM, Ashana DC, Courtright KR et al (2024) Defining the time-limited trial for patients with critical illness: an official American thoracic society workshop report. Ann Am Thorac Soc 21:187\u2013199","journal-title":"Ann Am Thorac Soc"},{"key":"8361_CR584","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1007\/s00134-017-4873-2","volume":"43","author":"AE Turnbull","year":"2017","unstructured":"Turnbull AE, Hartog CS (2017) Goal-concordant care in the ICU: a conceptual framework for future research. Intensive Care Med 43:1847\u20131849","journal-title":"Intensive Care Med"},{"key":"8361_CR585","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1513\/AnnalsATS.201611-931OI","volume":"14","author":"JM Kruser","year":"2017","unstructured":"Kruser JM, Cox CE, Schwarze ML (2017) Clinical momentum in the intensive care unit. A latent contributor to unwanted care. Ann Am Thorac Soc 14:426\u2013431","journal-title":"Ann Am Thorac Soc"},{"key":"8361_CR586","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1001\/jamainternmed.2021.1000","volume":"181","author":"DW Chang","year":"2021","unstructured":"Chang DW, Neville TH, Parrish J et al (2021) Evaluation of time-limited trials among critically ill patients with advanced medical illnesses and reduction of nonbeneficial ICU treatments. JAMA Intern Med 181:786\u2013794","journal-title":"JAMA Intern Med"},{"key":"8361_CR587","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1177\/00221465221143088","volume":"65","author":"KE Hauschildt","year":"2024","unstructured":"Hauschildt KE (2024) Whose good death? Valuation and standardization as mechanisms of inequality in hospitals. J Health Soc Behav 65:221\u2013236","journal-title":"J Health Soc Behav"},{"key":"8361_CR588","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1001\/jamainternmed.2023.8433","volume":"184","author":"DC Ashana","year":"2024","unstructured":"Ashana DC, Welsh W, Preiss D et al (2024) Racial differences in shared decision-making about critical illness. JAMA Intern Med 184:424\u2013432","journal-title":"JAMA Intern Med"},{"key":"8361_CR589","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1177\/0897190018761412","volume":"32","author":"BL Kram","year":"2019","unstructured":"Kram BL, Schultheis JM, Kram SJ et al (2019) A pharmacy-based electronic handoff tool to reduce discharge prescribing of atypical antipsychotics initiated in the intensive care unit: a quality improvement initiative. J Pharm Pract 32:434\u2013441","journal-title":"J Pharm Pract"},{"key":"8361_CR590","first-page":"1203","volume":"6","author":"D Nulph","year":"2023","unstructured":"Nulph D et al (2023) Impact of a computer-assisted pharmacy transitions of care process on medication de-prescribing when transferring from the intensive care unit. Clin Pharm Res Rep 6:1203\u20131209","journal-title":"Clin Pharm Res Rep"},{"key":"8361_CR591","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1001\/jamainternmed.2015.0822","volume":"175","author":"TS Walsh","year":"2015","unstructured":"Walsh TS, Salisbury LG, Merriweather JL, RECOVER Investigators et al (2015) Increased hospital-based physical rehabilitation and information provision after intensive care unit discharge: the RECOVER randomized clinical trial. JAMA Intern Med 175:901\u2013910","journal-title":"JAMA Intern Med"},{"key":"8361_CR592","first-page":"63","volume":"39","author":"M Gilmartin","year":"2018","unstructured":"Gilmartin M, Moran F, Segurado R et al (2018) Intensive care discharge facilitation using the REhabilitation after Critical illness Assisted discharge Pack (RECAP) model: a pilot randomized controlled trial. Physiother Pract Res 39:63\u201374","journal-title":"Physiother Pract Res"},{"key":"8361_CR593","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1001\/jama.2016.7207","volume":"315","author":"K Schmidt","year":"2016","unstructured":"Schmidt K, Worrack S, Von Korff M, SMOOTH Study Group et al (2016) Effect of a primary care management intervention on mental health-related quality of life among survivors of sepsis: a randomized clinical trial. JAMA 315:2703\u20132711","journal-title":"JAMA"},{"key":"8361_CR594","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1097\/CCM.0000000000004586","volume":"48","author":"ME Mikkelsen","year":"2020","unstructured":"Mikkelsen ME, Still M, Anderson BJ et al (2020) Society of critical care medicine\u2019s international consensus conference on prediction and identification of long-term impairments after critical illness. Crit Care Med 48:1670\u20131679","journal-title":"Crit Care Med"},{"key":"8361_CR595","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1097\/CCM.0000000000003909","volume":"47","author":"SL Bloom","year":"2019","unstructured":"Bloom SL, Stollings JL, Kirkpatrick O et al (2019) Randomized clinical trial of an ICU recovery pilot program for survivors of critical illness. Crit Care Med 47:1337\u20131345","journal-title":"Crit Care Med"},{"key":"8361_CR596","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b3723","volume":"339","author":"BH Cuthbertson","year":"2009","unstructured":"Cuthbertson BH, Rattray J, Campbell MK, PRaCTICaL Study Group et al (2009) The PRaCTICaL study of nurse led, intensive care follow-up programmes for improving long term outcomes from critical illness: a pragmatic randomised controlled trial. BMJ 339:b3723","journal-title":"BMJ"},{"key":"8361_CR597","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1378\/chest.128.2.507","volume":"128","author":"BJ Daly","year":"2005","unstructured":"Daly BJ, Douglas SL, Kelley CG et al (2005) Trial of a disease management program to reduce hospital readmissions of the chronically critically ill. Chest 128:507\u2013517","journal-title":"Chest"},{"key":"8361_CR598","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12871-023-02255-1","volume":"23","author":"KP Drewitz","year":"2023","unstructured":"Drewitz KP, Hasenpusch C, Bernardi C et al (2023) Piloting an ICU follow-up clinic to improve health-related quality of life in ICU survivors after a prolonged intensive care stay (PINA): feasibility of a pragmatic randomised controlled trial. BMC Anesthesiol 23:344","journal-title":"BMC Anesthesiol"},{"key":"8361_CR599","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.aucc.2024.01.006","volume":"37","author":"KJ Haines","year":"2024","unstructured":"Haines KJ, Hibbert E, Skinner EH et al (2024) In-person peer support for critical care survivors: the ICU REcovery solutions cO-Led through surVivor Engagement (ICURESOLVE) pilot randomised controlled trial. Aust Crit Care 37:859\u2013865","journal-title":"Aust Crit Care"},{"key":"8361_CR600","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.redar.2023.05.008","volume":"71","author":"A Ojeda","year":"2024","unstructured":"Ojeda A, Calvo A, Cu\u00f1at T et al (2024) Effectiveness of a specific follow up program for the management of the mental components of post-intensive care syndrome and chronic pain after COVID-19: results from the PAIN-COVID randomized clinical trial. Rev Esp Anestesiol Reanim (Engl Ed) 71:349\u2013359","journal-title":"Rev Esp Anestesiol Reanim (Engl Ed)"},{"key":"8361_CR601","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/CCM.0000000000005300","volume":"50","author":"SP Taylor","year":"2022","unstructured":"Taylor SP, Murphy S, Rios A et al (2022) Effect of a multicomponent sepsis transition and recovery program on mortality and readmissions after sepsis: the improving morbidity during post-acute care transitions for sepsis randomized clinical trial. Crit Care Med 50:469\u2013479","journal-title":"Crit Care Med"},{"key":"8361_CR602","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjao.2024.100259","volume":"9","author":"J McPeake","year":"2024","unstructured":"McPeake J, Iwashyna TJ, MacTavish P et al (2024) Could an integrated model of health and social care after critical illness reduce socioeconomic disparities in outcomes? A Bayesian analysis. BJA Open 9:100259","journal-title":"BJA Open"},{"key":"8361_CR603","doi-asserted-by":"publisher","first-page":"R46","DOI":"10.1186\/cc7769","volume":"13","author":"S Prinjha","year":"2009","unstructured":"Prinjha S, Field K, Rowan K (2009) What patients think about ICU follow-up services: a qualitative study. Crit Care 13:R46","journal-title":"Crit Care"},{"key":"8361_CR604","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1016\/S2213-2600(24)00298-4","volume":"12","author":"J McPeake","year":"2024","unstructured":"McPeake J, Oakes M, Graham C, James Lind Alliance Sepsis PSP Steering Group et al (2024) Top ten research priorities for sepsis research: UK james lind alliance priority setting partnershi. Lancet Respir Med 12:e68\u2013e69","journal-title":"Lancet Respir Med"},{"key":"8361_CR605","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1001\/jama.2010.1553","volume":"304","author":"TJ Iwashyna","year":"2010","unstructured":"Iwashyna TJ, Ely EW, Smith DM et al (2010) Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 304:1787\u20131794","journal-title":"JAMA"},{"key":"8361_CR606","volume":"7","author":"S De Silva","year":"2025","unstructured":"De Silva S, Urwin A, Grimwood C et al (2025) Health-related quality of life of adult sepsis survivors following critical illness: a systematic review. Crit Care Explor 7:e1238","journal-title":"Crit Care Explor"},{"key":"8361_CR607","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13054-022-04041-w","volume":"26","author":"CL Hodgson","year":"2022","unstructured":"Hodgson CL, Higgins AM, Bailey M, PREDICT Study Investigators et al (2022) Comparison of 6-month outcomes of sepsis versus non-sepsis critically ill patients receiving mechanical ventilation. Crit Care 26:174","journal-title":"Crit Care"},{"key":"8361_CR608","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2022-001377","volume":"10","author":"A Asimakos","year":"2023","unstructured":"Asimakos A, Spetsioti S, Mavronasou A et al (2023) Additive benefit of rehabilitation on physical status, symptoms and mental health after hospitalisation for severe COVID-19 pneumonia. BMJ Open Respir Res 10:e001377","journal-title":"BMJ Open Respir Res"},{"key":"8361_CR609","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/1751143718767061","volume":"20","author":"C Battle","year":"2019","unstructured":"Battle C, James K, Temblett P et al (2019) Supervised exercise rehabilitation in survivors of critical illness: a randomised controlled trial. J Intensive Care Soc 20:18\u201326","journal-title":"J Intensive Care Soc"},{"key":"8361_CR610","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-061285","volume":"12","author":"JJ Capin","year":"2022","unstructured":"Capin JJ, Jolley SE, Morrow M et al (2022) Safety, feasibility and initial efficacy of an app-facilitated telerehabilitation (AFTER) programme for COVID-19 survivors: a pilot randomised study. BMJ Open 12:e061285","journal-title":"BMJ Open"},{"key":"8361_CR611","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jcrc.2015.02.002","volume":"30","author":"B Connolly","year":"2015","unstructured":"Connolly B, Thompson A, Douiri A et al (2015) Exercise-based rehabilitation after hospital discharge for survivors of critical illness with intensive care unit-acquired weakness: a pilot feasibility trial. J Crit Care 30:589\u2013598","journal-title":"J Crit Care"},{"key":"8361_CR612","doi-asserted-by":"publisher","first-page":"R156","DOI":"10.1186\/cc12835","volume":"17","author":"L Denehy","year":"2013","unstructured":"Denehy L, Skinner EH, Edbrooke L et al (2013) Exercise rehabilitation for patients with critical illness: a randomized controlled trial with 12 months of follow-u. Crit Care 17:R156","journal-title":"Crit Care"},{"key":"8361_CR613","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1097\/CCM.0b013e3182373115","volume":"40","author":"JC Jackson","year":"2012","unstructured":"Jackson JC, Ely EW, Morey MC et al (2012) Cognitive and physical rehabilitation of intensive care unit survivors: results of the RETURN randomized controlled pilot investigation. Crit Care Med 40:1088\u20131097","journal-title":"Crit Care Med"},{"key":"8361_CR614","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1136\/bjsports-2022-106681","volume":"57","author":"I Longobardi","year":"2023","unstructured":"Longobardi I, Goessler K, de Oliveira J\u00fanior GN et al (2023) Effects of a 16-week home-based exercise training programme on health-related quality of life, functional capacity, and persistent symptoms in survivors of severe\/critical COVID-19: a randomised controlled trial. Br J Sports Med 57:1295\u20131303","journal-title":"Br J Sports Med"},{"key":"8361_CR615","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1136\/thoraxjnl-2016-208723","volume":"72","author":"K McDowell","year":"2017","unstructured":"McDowell K, O\u2019Neill B, Blackwood B et al (2017) Effectiveness of an exercise programme on physical function in patients discharged from hospital following critical illness: a randomised controlled trial (the REVIVE trial). Thorax 72:594\u2013595","journal-title":"Thorax"},{"key":"8361_CR616","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3109\/09593985.2015.1137663","volume":"32","author":"DJ McWilliams","year":"2016","unstructured":"McWilliams DJ, Benington S, Atkinson D (2016) Outpatient-based physical rehabilitation for survivors of prolonged critical illness: a randomized controlled trial. Physiother Theory Pract 32:179\u2013190","journal-title":"Physiother Theory Pract"},{"key":"8361_CR617","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4103\/ijccm.IJCCM_433_16","volume":"21","author":"AG Shelly","year":"2017","unstructured":"Shelly AG, Prabhu NS, Jirange P et al (2017) Quality of life improves with individualized home-based exercises in critical care survivors. Indian J Crit Care Med 21:89\u201393","journal-title":"Indian J Crit Care Med"},{"key":"8361_CR618","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/PHM.0000000000000441","volume":"95","author":"M Vitacca","year":"2016","unstructured":"Vitacca M, Barbano L, Vanoglio F et al (2016) Does 6-month home caregiver-supervised physiotherapy improve post-critical care outcomes? A randomized controlled trial. Am J Phys Med Rehabil 95:571\u2013579","journal-title":"Am J Phys Med Rehabil"},{"key":"8361_CR619","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.genhosppsych.2025.02.001","volume":"93","author":"S Sell","year":"2025","unstructured":"Sell S, Fleischmann-Struzek C, Spoden M et al (2025) Mental health in the first year after ICU-treated sepsis: analysis of administrative diagnoses in German health claims data. Gen Hosp Psychiatry 93:109\u2013115","journal-title":"Gen Hosp Psychiatry"},{"key":"8361_CR620","doi-asserted-by":"publisher","DOI":"10.1016\/j.chstcc.2024.100063","volume":"2","author":"CE Cox","year":"2024","unstructured":"Cox CE, Gallis JA, Olsen MK et al (2024) Mobile app-based mindfulness intervention for addressing psychological distress among survivors of hospitalization for COVID-19 infection. CHEST Crit Care 2:100063","journal-title":"CHEST Crit Care"},{"key":"8361_CR621","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1513\/AnnalsATS.202210-890OC","volume":"20","author":"CE Cox","year":"2023","unstructured":"Cox CE, Kelleher SA, Parish A et al (2023) Feasibility of mobile app-based coping skills training for cardiorespiratory failure survivors: the blueprint pilot randomized controlled trial. Ann Am Thorac Soc 20:861\u2013871","journal-title":"Ann Am Thorac Soc"},{"key":"8361_CR622","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/jama.2019.0073","volume":"321","author":"DM Wade","year":"2019","unstructured":"Wade DM, Mouncey PR, Richards-Belle A, POPPI Trial Investigators et al (2019) Effect of a nurse-led preventive psychological intervention on symptoms of posttraumatic stress disorder among critically ill patients: a randomized clinical trial. JAMA 321:665\u2013675","journal-title":"JAMA"},{"key":"8361_CR623","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.20807","volume":"3","author":"AM Vranceanu","year":"2020","unstructured":"Vranceanu AM, Bannon S, Mace R et al (2020) Feasibility and efficacy of a resiliency intervention for the prevention of chronic emotional distress among survivor-caregiver dyads admitted to the neuroscience intensive care unit: a randomized clinical trial. JAMA Netw Open 3:e2020807","journal-title":"JAMA Netw Open"},{"key":"8361_CR624","doi-asserted-by":"publisher","DOI":"10.2196\/32368","volume":"24","author":"JH Vlake","year":"2022","unstructured":"Vlake JH, van Bommel J, Wils E-J et al (2022) Intensive care unit-specific virtual reality for critically ill patients with COVID-19: multicenter randomized controlled trial. J Med Internet Res 24:e32368","journal-title":"J Med Internet Res"},{"key":"8361_CR625","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/17511437221136828","volume":"24","author":"A Bates","year":"2023","unstructured":"Bates A, Golding H, Rushbrook S et al (2023) A randomised pilot feasibility study of eye movement desensitisation and reprocessing recent traumatic episode protocol, to improve psychological recovery following intensive care admission for COVID-19. J Intensive Care Soc 24:309\u2013319","journal-title":"J Intensive Care Soc"},{"key":"8361_CR626","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.53158","volume":"7","author":"BA Khan","year":"2024","unstructured":"Khan BA, Perkins AJ, Khan SH et al (2024) Mobile critical care recovery program for survivors of acute respiratory failure: a randomized clinical trial. JAMA Netw Open 7:e2353158","journal-title":"JAMA Netw Open"},{"key":"8361_CR627","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s00134-013-3136-0","volume":"40","author":"NE Brummel","year":"2014","unstructured":"Brummel NE, Girard TD, Ely EW et al (2014) Feasibility and safety of early combined cognitive and physical therapy for critically ill medical and surgical patients: the activity and cognitive therapy in ICU (ACT-ICU) trial. Intensive Care Med 40:370\u2013379","journal-title":"Intensive Care Med"},{"key":"8361_CR628","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.aucc.2022.10.015","volume":"36","author":"Q Dong","year":"2023","unstructured":"Dong Q, Yang Y, Tang Q et al (2023) Effects of early cognitive rehabilitation training on cognitive function and quality of life in critically ill patients with cognitive impairment: a randomised controlled trial. Aust Crit Care 36:708\u2013715","journal-title":"Aust Crit Care"},{"key":"8361_CR629","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/09602011.2015.1078246","volume":"27","author":"J Zhao","year":"2017","unstructured":"Zhao J, Yao L, Wang C et al (2017) The effects of cognitive intervention on cognitive impairments after intensive care unit admission. Neuropsychol Rehabil 27:301\u2013317","journal-title":"Neuropsychol Rehabil"}],"updated-by":[{"DOI":"10.1007\/s00134-026-08410-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000}}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-026-08361-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-026-08361-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-026-08361-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:03:27Z","timestamp":1780988607000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-026-08361-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":629,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["8361"],"URL":"https:\/\/doi.org\/10.1007\/s00134-026-08361-1","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"23 March 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00134-026-08410-9","URL":"https:\/\/doi.org\/10.1007\/s00134-026-08410-9","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Fox-Robichaud reported serving as the scientific director of Sepsis Canada and as principal investigator (PI) on a study funded by the Canadian Institutes of Health Research. Dr. Rhodes reported serving as an advisor for Maquet. Dr. Kwizera reported receiving research support from Fisher and Paykel and Vygon and serving as primary author on a trial funded by Wellcome Trust. Dr. Du reported serving as president of the Chinese Association of Critical Care Physicians and the Chinese College of Critical Care Medicine. Dr. Rochwerg reported membership on the American Thoracic Society (ATS) guideline committee for non-invasive respiratory support and the corticosteroids in sepsis guideline committee. Dr. Hodgson reported an executive role at Monash Partners, research support from the National Health and Medical Research Council (NHMRC), and membership on the European Respiratory Society\/ATS ICU rehabilitation guideline committee. Dr. Angus reported serving as a senior editor for JAMA. Dr. Azoulay reported receiving lecture fees from Baxter, Gilead, Alexion, and Pfizer. Dr. Machado reported serving as PI on the NOVA trial funded by Biolab, receiving speaking fees from BioM\u00e9rieux, and serving as an advisor for Baxter. Dr. Prescott reported serving as a consultant for Aurobac Therapeutics. Dr. De Waele reported serving as a consultant for Roche Diagnostics. Dr. Roberts reported serving as a consultant for BioM\u00e9rieux and as primary author on a study funded by the NHMRC. Dr. McPeake reported serving as a consultant for AstraZeneca, with payments made to her institution. Dr. Wiersinga reported receiving research support from Moderna and serving as PI on a study funded by Amsterdam UMC. Dr. Kesecioglu reported receiving lecture honoraria from Dr\u00e4ger Medical Equipment. Dr. Doi reported receiving research support from Nipro and is a Council member of the Japanese Society of Intensive Care. Dr. Honarmand reported receiving research support from the Lawson Health Research Institute and serving on the ATS guideline committee for early mobilization. Dr. Evans reported serving as vice-chair of rapid response for CHEST and chair of the ABIM council. Dr. Alberto reported membership in the World Federation of Critical Care Nurses and serving as a reviewer for a systematic review funded by Universidad del Salvador. Dr. Heunks reported serving as a consultant for Liberate Medical and receiving research support from the ATS. Dr. Derde reported involvement in the IMPRINT and ECRAID-Base trials; receiving financial and drug contributions for the REMAP-CAP trial from Roche, Sanofi, SOBI, Faron, and Dimerix (all paid to her institution). Dr. Azevedo reported receiving speaking fees from Baxter, MSD, and Nestle. Dr. Hashmi reported membership in Asia Pacific Sepsis Alliance and ISARIC. Dr. Nunnally reported serving as co-chair of the Surviving Sepsis Campaign Research Committee and participating in activities for ASA, AHA, and SOCCA. Dr. Ostermann reported research support from Baxter and BioM\u00e9rieux (paid to her institution) and coauthoring articles on hemoadsorption. Dr. Antonelli reported serving as an advisor for AstraZeneca, Grifols, Menarini, and Shionogi, and as a consultant for Baxter. Dr. Klompas reported receiving royalties from UpToDate and research support from the AHRQ and CDC. Dr. Gong reported serving as a section editor for Wolters Kluwer. Dr. Ego reported serving as vice-chair of the Japanese Society of Intensive Care Medicine. Dr. Moller reported sponsorship of the EMPRESS RCT. Dr. Leeies reported membership in the Canadian Critical Care Society and the Canadian Society for Transplantation. Dr. Hammond reported receiving research support and IV fluids from Baxter Healthcare. Dr. Mohr reported serving as primary author on a study funded by AHRQ and HRSA and serving on the board of Society for Academic Emergency Medicine. Dr. Ferrer reported receiving speaking fees from Pfizer and owning stock in Grifols. Dr. Rosa reported receiving grants from the Brazilian Ministry of Health paid to his company. Dr. Sawyer reported receiving consultancy fees from Molnlycke, Shionogi, and AbbVie and research support from the NIH. Dr. Maves reported research support from AiCuris, Biotest, Geovax, and Merck (paid to his institution) and serving as a consultant for Shionogi. Dr. Peake reported serving as co-PI on the ARISE FLUIDS trial. Dr. Jacob reported serving as PI and CSO for the STAIRS study. Dr. Oczkowski reported serving as a consultant for VitalAire. Dr. McGloughlin reported serving as a consultant for the WHO and as clinical director for the Australian Living Evidence Collaboration. Dr. Simpson reported serving on the editorial board of CHEST SEEK. Dr. Iwashyna reported coauthoring the Haines article. Dr. Arabi reported serving as PI on the SCREEN trial and chair of the Saudi Critical Care Society trials group. Dr. Freund reported serving as PI on the 1BED trial.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}